import { Gender } from "@prisma/client";

interface Report {
    category_name: string;
    gender: Gender;
    snps: Snp[];
    version: number;
}

interface Snp {
    rsID: string;
    pathogenicity: string;
    genotype: string;
    sources: string[];
    description: string;
}

export const organizationId = 2;

export const reports: Report[] = [
    {
        "version": 1,
        "category_name": "Stress Response & Emotional Regulation Pathway Function",
        "gender": Gender.FEMALE,
        "snps": [
            {
                "rsID": "rs2267735",
                "pathogenicity": "likely pathogenic",
                "genotype": "CC",
                "sources": [
                    "PMID33021709",
                    "PMID29874672",
                    "PMID25636177",
                    "PMID33994278",
                    "PMID25913301",
                    "PMID33396472",
                    "PMID32425759",
                    "PMID31631413",
                    "PMID32932645",
                    "PMID24080187",
                    "PMID22776899",
                    "PMID26334183",
                    "PMID23505260",
                    "PMID29503977",
                    "PMID28242325",
                    "PMID28439228",
                    "PMID28610473",
                    "PMID31883848",
                    "PMID23107307",
                    "PMID23394710",
                    "PMID28691784",
                    "PMID33976954",
                    "PMID21524255",
                    "PMID23328528",
                    "PMID22832657",
                    "PMID24103155",
                    "PMID31540472",
                    "PMID34163384",
                    "PMID33608499",
                    "PMID27109180",
                    "PMID26335830",
                    "PMID31839899",
                    "PMID28746747",
                    "PMID33690643",
                    "PMID26377804",
                    "PMID30781888",
                    "PMID25796471",
                    "PMID27196537",
                    "PMID23280952",
                    "PMID25129683",
                    "PMID31967330",
                    "PMID30273884",
                    "PMID33997155",
                    "PMID32599917",
                    "PMID25680674",
                    "PMID32747715",
                    "PMID30556326",
                    "PMID24161451",
                    "PMID25188543",
                    "PMID31291018",
                    "PMID23734144",
                    "PMID21350482",
                    "PMID32216170",
                    "PMID23710355",
                    "PMID30054570",
                    "PMID22266773",
                    "PMID32590837",
                    "PMID28652748",
                    "PMID34799556",
                    "PMID27479489",
                    "PMID27959335",
                    "PMID28179812"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs2267735 in the Context of Stress Response & Emotional Regulation Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs2267735 is located within the ADCYAP1R1 gene, which encodes the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. This receptor is critically involved in the modulation of various neurobiological processes, including stress response and emotional regulation. The specific genotype of interest, CC, has been associated with altered receptor expression and function, particularly in the context of the hippocampus, a brain region integral to memory and emotional processing. The PACAP signaling pathway, mediated by ADCYAP1R1, plays a pivotal role in contextual fear conditioning, a process that is essential for the formation of memories related to stressful or traumatic events.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct diseases have been conclusively linked to rs2267735, substantial evidence suggests its association with post-traumatic stress disorder (PTSD). A meta-analysis by Lind et al. highlighted the relationship between this SNP and PTSD, indicating that individuals with the CC genotype may exhibit heightened vulnerability to developing PTSD following traumatic experiences. The variant has been implicated in fear discrimination and emotional regulation, with studies indicating that the CC genotype may lead to differential responses to stressors, particularly in females. This is supported by findings from Ressler et al., which demonstrated that the presence of the CC genotype was associated with increased susceptibility to PTSD symptoms, particularly in the context of traumatic events.\n\n**Clinical Implications**\n\nThe clinical implications of the rs2267735 variant are significant, particularly in the realm of mental health and stress-related disorders. Given its association with PTSD, individuals carrying the CC genotype may benefit from targeted interventions aimed at enhancing emotional regulation and coping strategies in response to stress. Understanding the genetic predisposition conferred by this variant can inform personalized treatment approaches, including psychotherapy and pharmacotherapy, tailored to the individual's genetic background. Furthermore, the identification of this variant as a potential biomarker for PTSD risk could facilitate early intervention strategies in at-risk populations, thereby improving outcomes for individuals exposed to trauma.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding rs2267735 and its role in stress response and emotional regulation is robust, with multiple studies corroborating its association with PTSD and related phenotypes. The evidence quality is bolstered by meta-analyses and genome-wide studies that have consistently identified this SNP as a significant factor in the modulation of stress responses. For instance, Uddin et al. demonstrated that methylation patterns of ADCYAP1R1 were associated with PTSD, further linking epigenetic modifications to the expression of this gene and its functional outcomes in stress response. The findings from these studies underscore the importance of the PACAP signaling pathway in the neurobiology of stress and emotional regulation, providing a solid foundation for the clinical relevance of rs2267735.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the identification of the rs2267735 variant presents opportunities for preventive and therapeutic strategies in managing stress-related disorders. Genetic testing for this variant could be integrated into clinical practice to identify individuals at higher risk for PTSD, particularly in populations exposed to traumatic events. Such testing could guide clinicians in developing personalized treatment plans that incorporate both psychological and pharmacological interventions aimed at enhancing emotional resilience. Additionally, ongoing research into the functional implications of this variant may yield novel therapeutic targets within the PACAP signaling pathway, potentially leading to the development of new pharmacological agents designed to modulate stress responses and improve emotional regulation.\n\nIn conclusion, the rs2267735 variant in the ADCYAP1R1 gene is a significant genetic factor in the context of stress response and emotional regulation. Its association with PTSD and related phenotypes highlights the critical role of the PACAP signaling pathway in the neurobiology of stress. The evidence supporting this variant's clinical relevance underscores the potential for personalized approaches to mental health care, paving the way for improved outcomes in individuals affected by stress-related disorders. As research continues to elucidate the mechanisms underlying this variant's effects, it is imperative that clinical practices evolve to incorporate genetic insights into the management of stress and emotional regulation."
            },
            {
                "rsID": "rs2267735",
                "pathogenicity": "uncertain significance",
                "genotype": "CG",
                "sources": [
                    "PMID33021709",
                    "PMID29874672",
                    "PMID25636177",
                    "PMID33994278",
                    "PMID25913301",
                    "PMID33396472",
                    "PMID32425759",
                    "PMID31631413",
                    "PMID32932645",
                    "PMID24080187",
                    "PMID22776899",
                    "PMID26334183",
                    "PMID23505260",
                    "PMID29503977",
                    "PMID28242325",
                    "PMID28439228",
                    "PMID28610473",
                    "PMID31883848",
                    "PMID23107307",
                    "PMID23394710",
                    "PMID28691784",
                    "PMID33976954",
                    "PMID21524255",
                    "PMID23328528",
                    "PMID22832657",
                    "PMID24103155",
                    "PMID31540472",
                    "PMID34163384",
                    "PMID33608499",
                    "PMID27109180",
                    "PMID26335830",
                    "PMID31839899",
                    "PMID28746747",
                    "PMID33690643",
                    "PMID26377804",
                    "PMID30781888",
                    "PMID25796471",
                    "PMID27196537",
                    "PMID23280952",
                    "PMID25129683",
                    "PMID31967330",
                    "PMID30273884",
                    "PMID33997155",
                    "PMID32599917",
                    "PMID25680674",
                    "PMID32747715",
                    "PMID30556326",
                    "PMID24161451",
                    "PMID25188543",
                    "PMID31291018",
                    "PMID23734144",
                    "PMID21350482",
                    "PMID32216170",
                    "PMID23710355",
                    "PMID30054570",
                    "PMID22266773",
                    "PMID32590837",
                    "PMID28652748",
                    "PMID34799556",
                    "PMID27479489",
                    "PMID27959335",
                    "PMID28179812"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs2267735 in the Context of Stress Response & Emotional Regulation Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs2267735 is located within the ADCYAP1R1 gene, which encodes the receptor for the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP). This receptor plays a crucial role in the modulation of various physiological processes, including stress response and emotional regulation. The specific genotype of interest for this variant is CG, which represents a heterozygous state. The functional significance of this variant is underscored by its association with altered expression levels of ADCYAP1R1, particularly in the context of stress-related disorders. Research indicates that individuals with the CC genotype exhibit a statistically significant reduction in ADCYAP1R1 mRNA expression compared to those with the CG or GG genotypes, suggesting that the CC genotype may confer a heightened vulnerability to stress-related phenotypes.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no specific diseases have been directly associated with rs2267735, its implications in stress response and emotional regulation are noteworthy. Studies have shown that individuals carrying the CC genotype demonstrate higher levels of post-traumatic stress disorder (PTSD) symptoms, particularly in females. This suggests that the variant may influence the susceptibility to stress-related disorders, even in the absence of a direct disease association. The phenotypic effects of this variant are further supported by evidence indicating that carriers of the CC genotype experience a significant decrease in ADCYAP1R1 expression, which is linked to the modulation of emotional responses and stress resilience.\n\n**Clinical Implications**\n\nThe clinical implications of rs2267735 are particularly relevant in the context of mental health and emotional regulation. Given its association with PTSD symptoms and the modulation of ADCYAP1R1 expression, this variant may serve as a potential biomarker for identifying individuals at risk for stress-related disorders. Understanding the genotype distribution in populations could inform targeted interventions and therapeutic strategies aimed at enhancing emotional regulation and resilience to stress. Furthermore, the identification of this variant in clinical settings may guide mental health professionals in tailoring treatment approaches for individuals exhibiting heightened stress responses or emotional dysregulation.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding rs2267735 and its role in stress response and emotional regulation is growing, with several studies providing evidence of its significance. Notably, a study demonstrated that females with the CC genotype not only had reduced ADCYAP1R1 expression but also exhibited higher PTSD symptomatology compared to those with the CG or GG genotypes. This finding is critical as it highlights the potential for sex-specific effects of the variant, suggesting that genetic predispositions may interact with biological sex to influence stress responses. The quality of evidence is bolstered by statistical analyses that consistently show significant associations between the rs2267735 genotype and emotional regulation outcomes, although further research is warranted to elucidate the underlying mechanisms.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the identification of rs2267735 as a potential risk factor for stress-related disorders opens avenues for personalized medicine approaches in mental health care. Genetic testing for this variant could be integrated into routine assessments for individuals presenting with stress-related symptoms, allowing for early identification of those at increased risk. Additionally, understanding the role of ADCYAP1R1 in the stress response pathway may inform the development of targeted pharmacological interventions aimed at modulating receptor activity or expression. Such interventions could enhance emotional regulation and resilience in individuals identified as high-risk based on their genetic profile.\n\nIn conclusion, the genetic variant rs2267735 in the ADCYAP1R1 gene holds significant relevance in the context of stress response and emotional regulation pathway function. Its association with altered gene expression and increased PTSD symptoms underscores the importance of this variant in understanding individual differences in stress resilience and emotional health. As research continues to evolve, the potential for clinical applications based on this variant may lead to improved outcomes for individuals affected by stress-related disorders."
            },
            {
                "rsID": "rs2267735",
                "pathogenicity": "likely pathogenic",
                "genotype": "GG",
                "sources": [
                    "PMID33021709",
                    "PMID29874672",
                    "PMID25636177",
                    "PMID33994278",
                    "PMID25913301",
                    "PMID33396472",
                    "PMID32425759",
                    "PMID31631413",
                    "PMID32932645",
                    "PMID24080187",
                    "PMID22776899",
                    "PMID26334183",
                    "PMID23505260",
                    "PMID29503977",
                    "PMID28242325",
                    "PMID28439228",
                    "PMID28610473",
                    "PMID31883848",
                    "PMID23107307",
                    "PMID23394710",
                    "PMID28691784",
                    "PMID33976954",
                    "PMID21524255",
                    "PMID23328528",
                    "PMID22832657",
                    "PMID24103155",
                    "PMID31540472",
                    "PMID34163384",
                    "PMID33608499",
                    "PMID27109180",
                    "PMID26335830",
                    "PMID31839899",
                    "PMID28746747",
                    "PMID33690643",
                    "PMID26377804",
                    "PMID30781888",
                    "PMID25796471",
                    "PMID27196537",
                    "PMID23280952",
                    "PMID25129683",
                    "PMID31967330",
                    "PMID30273884",
                    "PMID33997155",
                    "PMID32599917",
                    "PMID25680674",
                    "PMID32747715",
                    "PMID30556326",
                    "PMID24161451",
                    "PMID25188543",
                    "PMID31291018",
                    "PMID23734144",
                    "PMID21350482",
                    "PMID32216170",
                    "PMID23710355",
                    "PMID30054570",
                    "PMID22266773",
                    "PMID32590837",
                    "PMID28652748",
                    "PMID34799556",
                    "PMID27479489",
                    "PMID27959335",
                    "PMID28179812"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs2267735 in the Context of Stress Response & Emotional Regulation Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs2267735 is located within the ADCYAP1R1 gene, which encodes the receptor for the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP). This receptor plays a crucial role in various physiological processes, including stress response and emotional regulation. The specific genotype of interest, GG, represents one of the allelic variations at this locus, with the other alleles being CC and CG. The functional significance of this variant is underscored by its involvement in the modulation of intracellular signaling pathways that are critical for neuronal function and plasticity, particularly in response to stressors.\n\nResearch indicates that the ADCYAP1R1 gene is implicated in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis, which is a central component of the body's response to stress. Variants in this gene may influence the sensitivity of the HPA axis, thereby affecting the physiological and psychological responses to stress. The GG genotype has been associated with altered receptor activity, which may lead to differential responses in emotional regulation and stress resilience.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs2267735 variant, its role in stress response and emotional regulation suggests potential implications for stress-related disorders, particularly post-traumatic stress disorder (PTSD). A significant finding from research indicates that the interaction between the ADCYAP1R1 variant (rs2267735) and another gene variant in FKBP5 (rs1360780) affects PTSD severity, with a reported p-value of 0.049. This suggests that individuals with the GG genotype may experience heightened sensitivity to stress and trauma, potentially leading to more severe PTSD symptoms when exposed to traumatic events.\n\nAdditionally, neuroimaging studies have shown that individuals carrying the risk allele (CC) exhibit increased activation in the amygdala and hippocampus during threat-processing tasks. This heightened response may correlate with emotional dysregulation and increased anxiety, further emphasizing the role of ADCYAP1R1 in the neurobiological underpinnings of stress response.\n\n**Clinical Implications**\n\nThe clinical implications of the rs2267735 variant in the context of stress response and emotional regulation are significant. Understanding the genetic predisposition conferred by this variant can aid in the identification of individuals at higher risk for stress-related disorders. For clinicians, this knowledge can inform personalized treatment approaches, including targeted psychotherapeutic interventions and pharmacological strategies aimed at modulating the stress response.\n\nFurthermore, the identification of the GG genotype may prompt clinicians to monitor patients more closely for signs of emotional dysregulation and stress-related symptoms, particularly in populations exposed to high levels of trauma. Early intervention strategies could be developed to mitigate the impact of stress on mental health, potentially improving outcomes for individuals with this genetic predisposition.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs2267735 variant is derived from a combination of genetic association studies and neuroimaging research. The interaction between ADCYAP1R1 and FKBP5 in relation to PTSD severity is particularly noteworthy, as it highlights the complex interplay of genetic factors in emotional regulation and stress response. The quality of evidence is bolstered by the use of diverse cohorts, including highly traumatized populations, which enhances the generalizability of findings.\n\nHowever, it is important to note that while the association with PTSD severity is statistically significant, further research is needed to elucidate the precise mechanisms by which the rs2267735 variant influences stress response and emotional regulation. Longitudinal studies examining the effects of this variant over time, particularly in relation to environmental stressors, would provide valuable insights into its clinical relevance.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs2267735 variant presents opportunities for personalized medicine approaches in the management of stress-related disorders. Genetic testing for this variant could be integrated into clinical practice, particularly for individuals with a history of trauma or those presenting with symptoms of anxiety and emotional dysregulation. \n\nBy identifying individuals with the GG genotype, clinicians can tailor interventions that specifically address the heightened risk for stress-related disorders. This may include cognitive-behavioral therapy (CBT) focused on emotional regulation strategies, as well as pharmacotherapy aimed at modulating the HPA axis and improving stress resilience.\n\nIn conclusion, the rs2267735 variant in the ADCYAP1R1 gene plays a significant role in the stress response and emotional regulation pathway. Its association with PTSD severity and neurobiological responses to stress underscores the importance of this variant in understanding individual differences in stress resilience and vulnerability. Continued research into this variant will enhance our understanding of its clinical implications and potential for personalized interventions in mental health care."
            }
        ]
    },
    {
        "version": 1,
        "category_name": "Stress Modulation of Sex Hormones",
        "gender": Gender.FEMALE,
        "snps": [
            {
                "rsID": "rs41423247",
                "pathogenicity": "uncertain significance",
                "genotype": "GG",
                "sources": [
                    "PMID30647901",
                    "PMID28714126",
                    "PMID21232135",
                    "PMID22083731",
                    "PMID29100174",
                    "PMID22468037",
                    "PMID25009637",
                    "PMID25282474",
                    "PMID25944971",
                    "PMID32957930",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID25104270",
                    "PMID29085208",
                    "PMID25583614",
                    "PMID26106668",
                    "PMID22427805",
                    "PMID28487205",
                    "PMID22889053",
                    "PMID26938822",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID27428087",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID31008420",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID25879559",
                    "PMID23407653",
                    "PMID27003716",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID22410078",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID27081784",
                    "PMID34634320",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID23295978",
                    "PMID23073785",
                    "PMID33290991",
                    "PMID23176645",
                    "PMID26823689",
                    "PMID33923891",
                    "PMID28089639",
                    "PMID18952539",
                    "PMID25709928",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID22760121",
                    "PMID32801837",
                    "PMID26685668",
                    "PMID32969491",
                    "PMID27427275",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID22714792",
                    "PMID32032633",
                    "PMID34320993",
                    "PMID23761749",
                    "PMID32085857",
                    "PMID24379738",
                    "PMID19783104",
                    "PMID25220664",
                    "PMID26595470",
                    "PMID26647360",
                    "PMID29981236",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID30897718",
                    "PMID25086452",
                    "PMID33427169",
                    "PMID27400218",
                    "PMID34433889",
                    "PMID29279201",
                    "PMID26821164",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID21803757",
                    "PMID27397864",
                    "PMID31820730",
                    "PMID28237884",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID30925934",
                    "PMID29802709"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs41423247 in the Context of Stress Modulation of Sex Hormones\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs41423247 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor plays a pivotal role in mediating the effects of glucocorticoids, hormones that are crucial for stress response and metabolic regulation. The GG genotype at this locus indicates homozygosity for the G allele, which has been associated with altered receptor function and downstream signaling pathways. The functional significance of this variant lies in its potential influence on the modulation of sex hormones under stress conditions, as glucocorticoids can interact with sex hormone pathways, affecting their synthesis and action.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for rs41423247, its role in stress modulation suggests implications for conditions influenced by hormonal balance, such as asthma and other stress-related disorders. Research indicates that the G allele may enhance the glucocorticoid receptor's sensitivity to glucocorticoids, potentially leading to improved lung function in asthmatic children treated with inhaled corticosteroids (ICS). Specifically, studies have shown that children with the GG genotype exhibit a significant improvement in forced expiratory volume in one second (FEV1) following high-dose ICS treatment, suggesting a phenotypic effect that may be mediated through enhanced glucocorticoid signaling.\n\n**Clinical Implications**\n\nThe clinical implications of the rs41423247 variant are particularly relevant in the context of stress-related conditions where sex hormones play a role. Given that glucocorticoids can modulate the hypothalamic-pituitary-gonadal (HPG) axis, the GG genotype may influence the balance of sex hormones during stress responses. This modulation could have downstream effects on reproductive health, mood disorders, and stress resilience. In clinical practice, understanding the genotype of patients with stress-related conditions may guide personalized treatment strategies, particularly in the use of glucocorticoids for managing asthma and other inflammatory conditions.\n\n**Research Findings and Evidence Quality**\n\nResearch findings surrounding rs41423247 indicate a nuanced relationship between glucocorticoid signaling and stress modulation of sex hormones. For instance, studies have demonstrated that children with the GG genotype show a higher improvement in FEV1 after ICS treatment, with statistical significance (p = 0.006). This suggests that the G allele may confer a beneficial response to glucocorticoid therapy, potentially through enhanced modulation of sex hormones during stress. However, the evidence quality is mixed, as other studies have not consistently linked this variant to long-term outcomes in lung function or stress-related exacerbations. The variability in findings underscores the complexity of genetic influences on stress responses and the need for further research to elucidate the mechanisms involved.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the identification of the rs41423247 GG genotype may inform treatment decisions in patients with asthma or other stress-related conditions. For instance, patients with this genotype may be more likely to benefit from high-dose glucocorticoid therapy, leading to improved lung function and reduced exacerbations. Additionally, understanding the role of this variant in stress modulation of sex hormones could prompt clinicians to monitor hormonal levels and reproductive health in patients undergoing glucocorticoid treatment. However, it is essential to consider the broader context of each patient's clinical presentation and the multifactorial nature of stress responses when applying this genetic information in practice.\n\nIn conclusion, the rs41423247 variant in the NR3C1 gene represents a significant genetic factor in the context of stress modulation of sex hormones. Its association with enhanced glucocorticoid sensitivity and improved lung function in asthmatic children highlights the potential for personalized medicine approaches in managing stress-related conditions. Continued research is necessary to fully understand the implications of this variant on hormonal balance and stress responses, paving the way for more targeted therapeutic strategies."
            },
            {
                "rsID": "rs41423247",
                "pathogenicity": "uncertain significance",
                "genotype": "GC",
                "sources": [
                    "PMID30647901",
                    "PMID28714126",
                    "PMID21232135",
                    "PMID22083731",
                    "PMID29100174",
                    "PMID22468037",
                    "PMID25009637",
                    "PMID25282474",
                    "PMID25944971",
                    "PMID32957930",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID25104270",
                    "PMID29085208",
                    "PMID25583614",
                    "PMID26106668",
                    "PMID22427805",
                    "PMID28487205",
                    "PMID22889053",
                    "PMID26938822",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID27428087",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID31008420",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID25879559",
                    "PMID23407653",
                    "PMID27003716",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID22410078",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID27081784",
                    "PMID34634320",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID23295978",
                    "PMID23073785",
                    "PMID33290991",
                    "PMID23176645",
                    "PMID26823689",
                    "PMID33923891",
                    "PMID28089639",
                    "PMID18952539",
                    "PMID25709928",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID22760121",
                    "PMID32801837",
                    "PMID26685668",
                    "PMID32969491",
                    "PMID27427275",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID22714792",
                    "PMID32032633",
                    "PMID34320993",
                    "PMID23761749",
                    "PMID32085857",
                    "PMID24379738",
                    "PMID19783104",
                    "PMID25220664",
                    "PMID26595470",
                    "PMID26647360",
                    "PMID29981236",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID30897718",
                    "PMID25086452",
                    "PMID33427169",
                    "PMID27400218",
                    "PMID34433889",
                    "PMID29279201",
                    "PMID26821164",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID21803757",
                    "PMID27397864",
                    "PMID31820730",
                    "PMID28237884",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID30925934",
                    "PMID29802709"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs41423247 in the Context of Stress Modulation of Sex Hormones\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs41423247 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor plays a pivotal role in mediating the effects of glucocorticoids, hormones that are crucial for the regulation of various physiological processes, including stress response, metabolism, and immune function. The GC genotype (GC) at this locus suggests a heterozygous state that may influence the receptor's functionality and, consequently, the modulation of sex hormones under stress conditions. The NR3C1 gene is known to be involved in the feedback regulation of the hypothalamic-pituitary-adrenal (HPA) axis, which is integral to the body's response to stress. Variants in this gene can alter the sensitivity of the glucocorticoid receptor, potentially impacting the balance of sex hormones such as estrogen and testosterone, which are also influenced by stress levels.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for rs41423247, its role in stress modulation suggests potential implications for conditions where stress and hormonal balance are critical. For instance, dysregulation of the HPA axis and glucocorticoid signaling has been implicated in various stress-related disorders, including anxiety, depression, and metabolic syndrome. The GC genotype may influence the body's response to stress, potentially leading to altered levels of sex hormones, which can have downstream effects on reproductive health and mood regulation. \n\nResearch indicates that glucocorticoid receptor polymorphisms, including those in NR3C1, can affect the therapeutic response to glucocorticoids in conditions like asthma, as evidenced by studies showing that certain genotypes correlate with lung function and treatment efficacy. Although these findings primarily focus on respiratory conditions, they underscore the broader implications of NR3C1 variants in stress responses and hormonal modulation.\n\n**Clinical Implications**\n\nThe clinical implications of the rs41423247 variant in the context of stress modulation of sex hormones are multifaceted. Given the variant's potential to influence glucocorticoid receptor sensitivity, it may serve as a biomarker for assessing individual responses to stress and glucocorticoid therapy. In clinical practice, understanding a patient's genotype at this locus could inform treatment strategies for stress-related disorders, particularly those involving hormonal imbalances. \n\nFor instance, individuals with the GC genotype may require tailored approaches to manage stress-related conditions, as their glucocorticoid receptor activity could differ from those with other genotypes. This could involve adjusting glucocorticoid dosages or incorporating additional therapeutic modalities that consider the hormonal interplay affected by stress.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding the NR3C1 gene and its variants, including rs41423247, has produced a body of evidence that highlights the gene's role in stress response and hormonal regulation. Studies have shown that polymorphisms in NR3C1 can influence the efficacy of glucocorticoid treatments in asthmatic patients, suggesting a broader relevance to stress modulation. For example, findings from Rijavec et al. and Szczepankiewicz et al. indicate that specific genotypes correlate with lung function changes in response to inhaled corticosteroids, which are glucocorticoids used to manage asthma. \n\nWhile these studies provide valuable insights, the direct connection between rs41423247 and sex hormone modulation under stress remains an area for further exploration. The quality of evidence is moderate, as it primarily stems from studies focused on asthma and glucocorticoid response rather than direct assessments of sex hormone levels in relation to stress.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs41423247 variant presents opportunities for personalized medicine approaches in managing stress-related disorders. Genetic testing for this variant could be integrated into clinical assessments to better understand an individual's stress response and hormonal balance. \n\nFor patients exhibiting symptoms of stress-related disorders, particularly those with hormonal dysregulation, knowledge of their NR3C1 genotype could guide treatment decisions. For example, if a patient with the GC genotype demonstrates poor response to standard glucocorticoid therapy, clinicians might consider alternative treatments or adjunct therapies that address both stress and hormonal balance.\n\nIn conclusion, while the rs41423247 variant in the NR3C1 gene does not have established disease associations, its role in stress modulation and potential impact on sex hormone regulation warrants further investigation. Understanding this variant's implications could enhance clinical strategies for managing stress-related conditions and improving patient outcomes through personalized treatment approaches."
            },
            {
                "rsID": "rs41423247",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID30647901",
                    "PMID28714126",
                    "PMID21232135",
                    "PMID22083731",
                    "PMID29100174",
                    "PMID22468037",
                    "PMID25009637",
                    "PMID25282474",
                    "PMID25944971",
                    "PMID32957930",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID25104270",
                    "PMID29085208",
                    "PMID25583614",
                    "PMID26106668",
                    "PMID22427805",
                    "PMID28487205",
                    "PMID22889053",
                    "PMID26938822",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID27428087",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID31008420",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID25879559",
                    "PMID23407653",
                    "PMID27003716",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID22410078",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID27081784",
                    "PMID34634320",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID23295978",
                    "PMID23073785",
                    "PMID33290991",
                    "PMID23176645",
                    "PMID26823689",
                    "PMID33923891",
                    "PMID28089639",
                    "PMID18952539",
                    "PMID25709928",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID22760121",
                    "PMID32801837",
                    "PMID26685668",
                    "PMID32969491",
                    "PMID27427275",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID22714792",
                    "PMID32032633",
                    "PMID34320993",
                    "PMID23761749",
                    "PMID32085857",
                    "PMID24379738",
                    "PMID19783104",
                    "PMID25220664",
                    "PMID26595470",
                    "PMID26647360",
                    "PMID29981236",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID30897718",
                    "PMID25086452",
                    "PMID33427169",
                    "PMID27400218",
                    "PMID34433889",
                    "PMID29279201",
                    "PMID26821164",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID21803757",
                    "PMID27397864",
                    "PMID31820730",
                    "PMID28237884",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID30925934",
                    "PMID29802709"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs41423247 in the Context of Stress Modulation of Sex Hormones\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs41423247 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor plays a pivotal role in mediating the effects of glucocorticoids, hormones that are crucial for stress response and metabolic regulation. The specific genotype of interest, CC, indicates homozygosity for the C allele at this locus. Variants in NR3C1 have been implicated in the modulation of stress responses, particularly in how the body responds to glucocorticoids, which can influence the balance of sex hormones such as estrogen and testosterone. The functional significance of this variant lies in its potential to alter GR activity, thereby affecting the physiological response to stress and the subsequent modulation of sex hormone levels.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for rs41423247, its role in stress modulation suggests potential implications for conditions influenced by hormonal balance and stress responses. The NR3C1 gene is known to be involved in various stress-related disorders, including anxiety, depression, and metabolic syndrome, which can indirectly affect reproductive health and sex hormone levels. The CC genotype may be associated with altered glucocorticoid sensitivity, potentially leading to dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis, which governs sex hormone production. This dysregulation can manifest in various phenotypic effects, including changes in menstrual cycle regularity, libido, and overall reproductive health.\n\n**Clinical Implications**\n\nThe clinical implications of the rs41423247 variant in the context of stress modulation of sex hormones are significant, particularly for individuals experiencing chronic stress or stress-related disorders. Given the variant's potential to influence glucocorticoid receptor activity, individuals with the CC genotype may exhibit altered responses to stress, which could lead to variations in sex hormone levels. Clinicians should consider the implications of this variant when evaluating patients with stress-related symptoms or reproductive health issues. For instance, understanding the genetic predisposition to altered stress responses may guide therapeutic interventions, such as the use of glucocorticoids or other hormonal treatments, to better manage symptoms and improve patient outcomes.\n\n**Research Findings and Evidence Quality**\n\nResearch findings related to rs41423247 and its association with stress modulation are still emerging. Studies have indicated that variations in NR3C1 can influence lung function in asthmatic children, particularly in response to inhaled corticosteroids (ICS). For example, homozygosity for the G allele at rs41423247 was associated with improved lung function in children treated with high-dose ICS, suggesting a potential link between glucocorticoid sensitivity and stress response in this population. However, the direct connection between this variant and sex hormone modulation remains less well-defined, necessitating further investigation. The quality of evidence surrounding this variant is moderate, with studies primarily focusing on its role in asthma and glucocorticoid response rather than directly addressing its impact on sex hormones.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs41423247 variant presents an opportunity for personalized medicine approaches in managing stress-related disorders and reproductive health. Genetic testing for this variant could provide valuable insights into an individual's stress response profile, allowing healthcare providers to tailor interventions accordingly. For instance, individuals with the CC genotype may benefit from targeted stress management strategies or hormonal therapies that consider their unique genetic predisposition. Additionally, understanding the implications of this variant could inform lifestyle modifications aimed at reducing stress and its impact on hormonal balance, ultimately improving overall health outcomes.\n\nIn conclusion, while the rs41423247 variant in the NR3C1 gene does not have direct disease associations, its role in stress modulation and potential effects on sex hormone levels warrant further exploration. The implications for clinical practice are significant, particularly in the context of managing stress-related disorders and reproductive health. Continued research is essential to elucidate the precise mechanisms by which this variant influences stress responses and hormonal regulation, paving the way for more effective, personalized treatment strategies."
            },
            {
                "rsID": "rs6195",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [],
                "description": "Insufficient evidence available for rs6195 genotype TT in the context of Stress Modulation of Sex Hormones."
            },
            {
                "rsID": "rs6195",
                "pathogenicity": "uncertain significance",
                "genotype": "TC",
                "sources": [],
                "description": "Insufficient evidence available for rs6195 genotype TC in the context of Stress Modulation of Sex Hormones."
            },
            {
                "rsID": "rs6195",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [],
                "description": "Insufficient evidence available for rs6195 genotype CC in the context of Stress Modulation of Sex Hormones."
            }
        ]
    },
    {
        "version": 1,
        "category_name": "Stress Hormone Pathway Function",
        "gender": Gender.FEMALE,
        "snps": [
            {
                "rsID": "rs6189",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID25009637",
                    "PMID29100174",
                    "PMID31601045",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID23073785",
                    "PMID26823689",
                    "PMID33807560",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID20885351",
                    "PMID32801837",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID21573817",
                    "PMID26821164",
                    "PMID10898924",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID30999951",
                    "PMID27741480",
                    "PMID33154348",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID34068181",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID20440229",
                    "PMID34680417",
                    "PMID29761890",
                    "PMID33981330",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID25741362",
                    "PMID28641498",
                    "PMID25724472",
                    "PMID25644744",
                    "PMID28364727",
                    "PMID27507764",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID28742078",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID27528460",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6189 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6189 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR), a critical component of the stress hormone pathway. The specific genotype of interest for this variant is CC, which represents a non-synonymous change in the amino acid sequence of the glucocorticoid receptor. The NR3C1 gene is situated on chromosome 5, and its product plays a pivotal role in mediating the effects of glucocorticoids, such as cortisol, which are essential for the body's response to stress. The glucocorticoid receptor functions as a transcription factor that regulates the expression of various genes involved in metabolism, immune response, and stress adaptation. \n\nThe functional significance of the rs6189 variant lies in its potential to alter the receptor's affinity for glucocorticoids or its ability to translocate to the nucleus, thereby influencing the downstream signaling pathways that modulate stress responses. Variants in NR3C1 have been associated with altered sensitivity to glucocorticoids, which can impact physiological responses to stress and contribute to various stress-related disorders.\n\n**Disease Associations and Phenotypic Effects**\n\nCurrently, there are no direct disease associations or phenotypic effects specifically linked to the rs6189 variant. However, the broader implications of NR3C1 variants in stress hormone signaling are well-documented. Variants in this gene have been implicated in conditions such as mood disorders, anxiety, and stress-related disorders, which are influenced by the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. \n\nThe glucocorticoid receptor is integral to the feedback regulation of the HPA axis, and alterations in its function can lead to abnormal cortisol levels, which are often observed in individuals with chronic stress or psychiatric conditions. While rs6189 itself has not been directly associated with specific diseases, its role in the stress hormone pathway suggests that it may contribute to the susceptibility to stress-related disorders through its impact on glucocorticoid signaling.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6189 variant in the context of stress hormone pathway function are significant, particularly in understanding individual variability in stress responses and the potential for developing stress-related disorders. Given the role of glucocorticoids in modulating immune function and metabolic processes, individuals with the CC genotype may exhibit altered responses to stress that could predispose them to conditions such as depression, anxiety, or chronic pain syndromes.\n\nFurthermore, understanding the functional consequences of this variant may inform treatment strategies for individuals with stress-related disorders. For instance, patients exhibiting glucocorticoid resistance due to NR3C1 variants may require tailored therapeutic approaches, such as higher doses of glucocorticoids or alternative treatments that target the underlying dysregulation of the stress response.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding the NR3C1 gene and its variants, including rs6189, has been extensive, with numerous studies exploring the relationship between glucocorticoid signaling and stress-related disorders. While specific studies directly linking rs6189 to clinical outcomes are limited, the evidence supporting the role of NR3C1 in stress response is robust. \n\nFor instance, variants in NR3C1 have been associated with corticosteroid dependency and resistance, as well as mood and anxiety disorders in patients with asthma. These findings underscore the importance of glucocorticoid signaling in the pathophysiology of stress-related conditions. The quality of evidence surrounding NR3C1 variants is generally high, with a substantial body of literature supporting the functional relevance of glucocorticoid signaling in stress response and its implications for mental health.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6189 variant presents an opportunity for personalized medicine approaches in managing stress-related disorders. While there are no established guidelines specifically addressing the rs6189 variant, the understanding of its role in the stress hormone pathway can guide clinicians in assessing individual patient risk for stress-related conditions. \n\nFor patients with a CC genotype, clinicians may consider monitoring for signs of stress-related disorders more closely, particularly in high-stress environments or situations. Additionally, the potential for altered glucocorticoid sensitivity may inform treatment decisions, including the use of glucocorticoids or alternative therapies aimed at modulating the stress response.\n\nIn conclusion, while the rs6189 variant in the NR3C1 gene does not have direct disease associations, its functional significance within the stress hormone pathway highlights its potential role in influencing stress responses and susceptibility to stress-related disorders. Continued research into this variant and its implications for glucocorticoid signaling will be essential for advancing our understanding of stress-related health outcomes and improving clinical management strategies."
            },
            {
                "rsID": "rs6189",
                "pathogenicity": "uncertain significance",
                "genotype": "CT",
                "sources": [
                    "PMID25009637",
                    "PMID29100174",
                    "PMID31601045",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID23073785",
                    "PMID26823689",
                    "PMID33807560",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID20885351",
                    "PMID32801837",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID21573817",
                    "PMID26821164",
                    "PMID10898924",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID30999951",
                    "PMID27741480",
                    "PMID33154348",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID34068181",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID20440229",
                    "PMID34680417",
                    "PMID29761890",
                    "PMID33981330",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID25741362",
                    "PMID28641498",
                    "PMID25724472",
                    "PMID25644744",
                    "PMID28364727",
                    "PMID27507764",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID28742078",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID27528460",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6189 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6189 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, immune function, and inflammation. The specific genotype for this variant is CT, indicating a heterozygous state. The consequence of this variant is classified as non-synonymous, suggesting that it may alter the amino acid sequence of the glucocorticoid receptor, potentially impacting its function. Given the role of NR3C1 in the stress hormone pathway, any alteration in its function could have significant implications for how the body responds to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations or phenotypic effects have been identified specifically for the rs6189 variant, the broader implications of NR3C1 function in stress response are well-documented. Variants in NR3C1 have been linked to various stress-related conditions, including mood and anxiety disorders, as well as responses to corticosteroid treatment. The glucocorticoid receptor is integral to the feedback mechanism that regulates the hypothalamic-pituitary-adrenal (HPA) axis, which is activated during stress. Dysregulation of this pathway can lead to a range of psychological and physiological disorders, including depression, anxiety, and chronic stress-related conditions.\n\nResearch has shown that alterations in glucocorticoid receptor function can influence the body's ability to manage stress effectively. For instance, individuals with certain NR3C1 variants may exhibit altered sensitivity to glucocorticoids, which can affect their stress response and overall mental health. Although rs6189 has not been directly linked to specific diseases, its position within the NR3C1 gene suggests that it may contribute to variations in stress hormone signaling and, consequently, stress-related phenotypes.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6189 variant primarily revolve around its potential impact on stress hormone pathway function. Given the role of glucocorticoids in managing stress responses, individuals carrying the CT genotype may experience differences in their physiological and psychological responses to stress. This could manifest as variations in stress resilience, susceptibility to stress-related disorders, or differences in treatment responses to glucocorticoid therapies.\n\nFurthermore, understanding the functional significance of this variant could aid in the development of personalized medicine approaches for managing stress-related conditions. For example, individuals with altered glucocorticoid receptor function may require tailored therapeutic strategies that consider their unique genetic makeup, particularly in the context of stress management and treatment of related disorders.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding NR3C1 and its variants, including rs6189, has been extensive, with a focus on the gene's role in stress response and related disorders. While specific studies directly linking rs6189 to clinical outcomes are limited, the broader body of literature supports the importance of NR3C1 in the stress hormone pathway. For instance, variants in NR3C1 have been associated with corticosteroid resistance and dependency, as well as mood and anxiety disorders in various populations.\n\nThe quality of evidence regarding the role of NR3C1 in stress response is generally high, with numerous studies employing robust methodologies, including genetic association studies, functional assays, and clinical evaluations. However, the specific evidence for rs6189 remains less defined, necessitating further research to elucidate its precise role and implications in stress-related conditions.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6189 variant presents an opportunity for further exploration in the context of stress management and treatment. While no direct clinical guidelines currently exist for this specific variant, its association with the glucocorticoid receptor suggests that it could be relevant in assessing individual responses to stress and glucocorticoid therapies. \n\nHealthcare providers may consider genetic testing for NR3C1 variants, including rs6189, in patients with unexplained stress-related symptoms or those who exhibit atypical responses to glucocorticoid treatments. Such testing could inform treatment decisions, allowing for more personalized approaches to managing stress and related disorders.\n\nIn conclusion, while the rs6189 variant in the NR3C1 gene has not been directly linked to specific diseases or phenotypes, its functional significance within the stress hormone pathway underscores its potential relevance in understanding individual variations in stress response. Further research is warranted to clarify the implications of this variant and to explore its utility in clinical practice, particularly in the context of personalized medicine for stress-related conditions."
            },
            {
                "rsID": "rs6189",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID25009637",
                    "PMID29100174",
                    "PMID31601045",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID23055001",
                    "PMID28330327",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID24728165",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID34950142",
                    "PMID33019527",
                    "PMID23073785",
                    "PMID26823689",
                    "PMID33807560",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID20885351",
                    "PMID32801837",
                    "PMID34579671",
                    "PMID32952155",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID21164266",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID21573817",
                    "PMID26821164",
                    "PMID10898924",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID30999951",
                    "PMID27741480",
                    "PMID33154348",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID34068181",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID20440229",
                    "PMID34680417",
                    "PMID29761890",
                    "PMID33981330",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID25741362",
                    "PMID28641498",
                    "PMID25724472",
                    "PMID25644744",
                    "PMID28364727",
                    "PMID27507764",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID28742078",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID27528460",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6189 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6189 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, immune function, and inflammation. The specific genotype of interest, TT, represents a non-synonymous change that may influence the receptor's functionality. Variants in NR3C1 can affect the receptor's affinity for glucocorticoids, its transactivation potential, and its ability to regulate target genes involved in the stress response. Given the role of glucocorticoids in modulating stress hormone pathways, alterations in NR3C1 can have significant implications for how individuals respond to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs6189 variant, the functional implications of NR3C1 variants are well-documented in the literature. Variants in this gene have been linked to various stress-related disorders, including mood and anxiety disorders, as well as conditions characterized by dysregulated stress responses. For instance, other variants in NR3C1 have been associated with corticosteroid resistance and dependency, which can manifest in conditions such as asthma and chronic inflammatory diseases. The TT genotype of rs6189 may contribute to altered glucocorticoid signaling, potentially influencing an individual's susceptibility to stress-related phenotypes, although specific associations remain to be elucidated.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6189 variant in the context of stress hormone pathway function are multifaceted. Given the role of glucocorticoids in stress response, individuals with the TT genotype may exhibit altered physiological responses to stress, which could predispose them to stress-related disorders. For instance, variations in glucocorticoid receptor sensitivity can affect the hypothalamic-pituitary-adrenal (HPA) axis, leading to either hyper- or hypo-responsiveness to stress. This dysregulation can manifest as increased anxiety, depression, or other mood disorders, particularly in response to environmental stressors. \n\nFurthermore, understanding the implications of the rs6189 variant may guide clinicians in tailoring treatment strategies for patients with stress-related conditions. For example, individuals with altered glucocorticoid receptor function may require different therapeutic approaches, such as adjusted corticosteroid dosages or alternative medications that target the stress response more effectively.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding NR3C1 and its variants, including rs6189, has been extensive, with a focus on the gene's role in stress response and related disorders. Studies have demonstrated that genetic variations in NR3C1 can influence glucocorticoid receptor activity, which in turn affects the expression of genes involved in the stress response. For instance, evidence suggests that certain NR3C1 variants are associated with altered responses to stress and may contribute to the development of psychiatric disorders. \n\nHowever, while the evidence linking rs6189 to specific clinical outcomes is still emerging, the broader context of NR3C1's role in stress hormone pathways is well-supported. The quality of evidence varies, with some studies providing robust associations while others indicate more nuanced relationships that require further investigation. The complexity of gene-environment interactions in stress responses necessitates a careful interpretation of findings, emphasizing the need for additional research to clarify the specific implications of the rs6189 variant.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6189 variant presents an opportunity for personalized medicine approaches in managing stress-related disorders. While direct associations with specific diseases are not yet established, the potential for altered stress responses in individuals with the TT genotype suggests that genetic testing for NR3C1 variants could be beneficial in clinical settings. \n\nHealthcare providers may consider incorporating genetic testing for NR3C1 variants, including rs6189, as part of a comprehensive assessment for patients presenting with stress-related symptoms. This information could inform treatment decisions, such as the choice of pharmacotherapy or behavioral interventions aimed at mitigating stress responses. Additionally, understanding an individual's genetic predisposition to stress-related disorders may facilitate targeted preventive strategies, enhancing overall patient care.\n\nIn conclusion, while the rs6189 variant in NR3C1 does not have established disease associations, its role in the stress hormone pathway underscores its potential significance in understanding individual differences in stress responses. Continued research is essential to elucidate the clinical implications of this variant, paving the way for more personalized approaches to managing stress-related conditions."
            },
            {
                "rsID": "rs6190",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID30647901",
                    "PMID25009637",
                    "PMID24084075",
                    "PMID21832116",
                    "PMID31601045",
                    "PMID19673019",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID18623071",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID23392094",
                    "PMID15511603",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID19000736",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID32459809",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID34086487",
                    "PMID26823689",
                    "PMID23781311",
                    "PMID32801837",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID28686058",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID25406795",
                    "PMID33371640",
                    "PMID21573817",
                    "PMID23251800",
                    "PMID20199670",
                    "PMID10898924",
                    "PMID29143670",
                    "PMID21803757",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID22319540",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID27741480",
                    "PMID31035618",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID19174530",
                    "PMID18805703",
                    "PMID27253772",
                    "PMID22812453",
                    "PMID34680417",
                    "PMID21633323",
                    "PMID33981330",
                    "PMID20472303",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID23493285",
                    "PMID25741362",
                    "PMID24946471",
                    "PMID20872047",
                    "PMID28641498",
                    "PMID19684157",
                    "PMID25724472",
                    "PMID21967077",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID16192984",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID20841450",
                    "PMID27528460",
                    "PMID17848410",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6190 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6190 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, immune function, and inflammation. The specific genotype of interest here is CC, which represents homozygosity for the common allele. Variants in NR3C1 can influence the receptor's expression and functionality, thereby affecting the body's response to stress hormones, particularly cortisol. The functional significance of rs6190 lies in its potential to modulate glucocorticoid signaling pathways, which are integral to the regulation of various physiological processes, including the immune response and metabolic homeostasis.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs6190 variant, its role in the stress hormone pathway suggests potential implications for conditions influenced by glucocorticoid signaling. The glucocorticoid receptor is known to be involved in the pathophysiology of various stress-related disorders, including asthma, where glucocorticoids are commonly used as a therapeutic intervention. Research indicates that polymorphisms in NR3C1, including rs6190, may affect the therapeutic response to inhaled corticosteroids (ICS) in asthmatic patients. For instance, studies have shown that certain GR polymorphisms can correlate with the necessity for higher doses of ICS to achieve asthma control, although rs6190 itself has not been directly linked to such outcomes in the available literature.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6190 variant in the context of stress hormone pathway function are primarily related to its potential influence on glucocorticoid therapy. Given that glucocorticoids are a cornerstone of treatment for inflammatory conditions such as asthma, understanding the genetic factors that affect individual responses to these medications is crucial. Although the current evidence does not establish a direct association between rs6190 and specific clinical outcomes, the variant's location within the NR3C1 gene suggests that it may contribute to variability in glucocorticoid sensitivity among patients. This variability can impact treatment efficacy and the risk of adverse effects, underscoring the importance of personalized medicine approaches in managing conditions influenced by stress hormones.\n\n**Research Findings and Evidence Quality**\n\nResearch findings related to rs6190 and its role in the stress hormone pathway are still emerging. While several studies have investigated the association of various NR3C1 polymorphisms with asthma and glucocorticoid response, the specific evidence for rs6190 remains limited. For example, a study involving asthmatic children indicated that certain GR polymorphisms were analyzed for their relationship with poor responses to glucocorticoids, but rs6190 was not highlighted as a significant factor in determining the dose of ICS required for asthma control. The quality of evidence surrounding rs6190 is moderate, as it is derived from studies that primarily focus on broader associations of NR3C1 variants with glucocorticoid response rather than direct investigations of rs6190 itself.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6190 variant does not currently provide actionable insights for clinical practice. While understanding genetic variants in the NR3C1 gene can inform treatment strategies for conditions influenced by glucocorticoids, the lack of direct associations with specific disease phenotypes or treatment responses limits the immediate applicability of rs6190 in clinical decision-making. However, as research continues to elucidate the role of genetic variants in glucocorticoid signaling, future studies may identify actionable insights that could guide personalized treatment approaches for patients with stress-related disorders.\n\nIn conclusion, the rs6190 variant in the NR3C1 gene is situated within a critical locus for stress hormone signaling, particularly in the context of glucocorticoid receptor function. While current evidence does not establish direct disease associations or significant phenotypic effects, its potential influence on glucocorticoid therapy highlights the importance of further research to clarify its role in stress hormone pathway function and its implications for clinical practice. As our understanding of genetic contributions to stress response and treatment variability evolves, rs6190 may emerge as a relevant factor in the personalized management of conditions influenced by glucocorticoids."
            },
            {
                "rsID": "rs6190",
                "pathogenicity": "uncertain significance",
                "genotype": "CT",
                "sources": [
                    "PMID30647901",
                    "PMID25009637",
                    "PMID24084075",
                    "PMID21832116",
                    "PMID31601045",
                    "PMID19673019",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID18623071",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID23392094",
                    "PMID15511603",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID19000736",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID32459809",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID34086487",
                    "PMID26823689",
                    "PMID23781311",
                    "PMID32801837",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID28686058",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID25406795",
                    "PMID33371640",
                    "PMID21573817",
                    "PMID23251800",
                    "PMID20199670",
                    "PMID10898924",
                    "PMID29143670",
                    "PMID21803757",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID22319540",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID27741480",
                    "PMID31035618",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID19174530",
                    "PMID18805703",
                    "PMID27253772",
                    "PMID22812453",
                    "PMID34680417",
                    "PMID21633323",
                    "PMID33981330",
                    "PMID20472303",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID23493285",
                    "PMID25741362",
                    "PMID24946471",
                    "PMID20872047",
                    "PMID28641498",
                    "PMID19684157",
                    "PMID25724472",
                    "PMID21967077",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID16192984",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID20841450",
                    "PMID27528460",
                    "PMID17848410",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6190 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6190 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, and immune regulation. The specific genotype of interest, CT, indicates a heterozygous state at this locus. Variants in NR3C1 can influence the receptor's function, affecting its ability to bind glucocorticoids and modulate downstream signaling pathways. Given the role of glucocorticoids in the stress hormone pathway, alterations in NR3C1 may have significant implications for how individuals respond to stress and inflammation.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified specifically for rs6190, its role in the stress hormone pathway suggests potential implications for conditions influenced by glucocorticoid signaling, such as asthma and other inflammatory disorders. Research has indicated that polymorphisms in NR3C1, including rs6190, may correlate with variations in therapeutic responses to inhaled corticosteroids (ICS) in asthmatic patients. For instance, studies have shown that individuals with certain GR polymorphisms may require higher doses of ICS to achieve asthma control, indicating a potential link between NR3C1 variants and glucocorticoid sensitivity. \n\nIn a cohort of asthmatic children, the relationship between GR polymorphisms and the necessity for high-dose ICS treatment was explored, although rs6190 did not show a significant association with the dose required for asthma control. This suggests that while rs6190 may not directly correlate with asthma severity or treatment response, it is part of a broader genetic landscape that influences glucocorticoid signaling and, consequently, stress response mechanisms.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6190 variant in the context of stress hormone pathway function are multifaceted. Given the role of glucocorticoids in managing inflammation and stress responses, understanding the functional impact of this variant could inform treatment strategies for conditions like asthma. For instance, patients with the CT genotype may exhibit variable responses to glucocorticoid therapy, necessitating personalized treatment approaches. \n\nFurthermore, the lack of identified disease associations does not diminish the importance of this variant in understanding individual differences in stress response and glucocorticoid sensitivity. Clinicians may consider genetic testing for NR3C1 variants, including rs6190, as part of a comprehensive assessment of patients with stress-related disorders or inflammatory conditions, particularly when standard treatments yield suboptimal results.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding the NR3C1 gene and its variants, including rs6190, has produced a range of findings, although the evidence quality varies. Studies have demonstrated associations between other GR polymorphisms and asthma treatment responses, suggesting that genetic variations in the glucocorticoid receptor can influence clinical outcomes. For example, a meta-analysis indicated that certain GR polymorphisms were associated with increased risks of asthma-related hospital visits and oral corticosteroid use, although rs6190 was not specifically implicated in these findings.\n\nThe evidence surrounding rs6190 is primarily derived from studies focusing on broader GR polymorphisms and their impact on glucocorticoid therapy. While the direct implications of rs6190 remain less clear, the collective research underscores the importance of the glucocorticoid receptor in stress hormone signaling and its potential role in modulating responses to stress and inflammation.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6190 variant presents an opportunity for personalized medicine approaches in managing conditions influenced by glucocorticoid signaling. Although no direct disease associations have been established, the variant's role in the stress hormone pathway suggests that it may contribute to individual variability in treatment responses. \n\nClinicians may consider incorporating genetic testing for NR3C1 variants, including rs6190, into their practice, particularly for patients with asthma or other inflammatory conditions who demonstrate poor responses to standard glucocorticoid therapies. Understanding a patient's genetic profile could guide treatment decisions, such as adjusting medication dosages or exploring alternative therapies, ultimately improving patient outcomes.\n\nIn conclusion, while the rs6190 variant in the NR3C1 gene does not have established disease associations, its functional significance within the stress hormone pathway highlights its potential role in influencing glucocorticoid sensitivity and treatment responses. Continued research into this variant and its implications for stress-related disorders will be essential in elucidating its clinical relevance and guiding personalized treatment strategies."
            },
            {
                "rsID": "rs6190",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID30647901",
                    "PMID25009637",
                    "PMID24084075",
                    "PMID21832116",
                    "PMID31601045",
                    "PMID19673019",
                    "PMID27649075",
                    "PMID33467215",
                    "PMID29085208",
                    "PMID18623071",
                    "PMID22427805",
                    "PMID22889053",
                    "PMID23392094",
                    "PMID15511603",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID29549463",
                    "PMID34648084",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID29526633",
                    "PMID19000736",
                    "PMID26518448",
                    "PMID27081784",
                    "PMID32459809",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID34086487",
                    "PMID26823689",
                    "PMID23781311",
                    "PMID32801837",
                    "PMID32032633",
                    "PMID19783104",
                    "PMID20549395",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID28686058",
                    "PMID27509264",
                    "PMID25949351",
                    "PMID25406795",
                    "PMID33371640",
                    "PMID21573817",
                    "PMID23251800",
                    "PMID20199670",
                    "PMID10898924",
                    "PMID29143670",
                    "PMID21803757",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID34576214",
                    "PMID24497894",
                    "PMID22319540",
                    "PMID29802709",
                    "PMID22445700",
                    "PMID27741480",
                    "PMID31035618",
                    "PMID31022961",
                    "PMID20680430",
                    "PMID20727199",
                    "PMID17563720",
                    "PMID19174530",
                    "PMID18805703",
                    "PMID27253772",
                    "PMID22812453",
                    "PMID34680417",
                    "PMID21633323",
                    "PMID33981330",
                    "PMID20472303",
                    "PMID22781842",
                    "PMID28759007",
                    "PMID30736733",
                    "PMID23493285",
                    "PMID25741362",
                    "PMID24946471",
                    "PMID20872047",
                    "PMID28641498",
                    "PMID19684157",
                    "PMID25724472",
                    "PMID21967077",
                    "PMID34831409",
                    "PMID34298075",
                    "PMID16192984",
                    "PMID18047640",
                    "PMID34466443",
                    "PMID20841450",
                    "PMID27528460",
                    "PMID17848410",
                    "PMID34721069"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6190 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6190 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR), a critical component of the stress hormone pathway. The specific nucleotide change associated with rs6190 is a non-synonymous variant, resulting in an amino acid substitution that may alter the receptor's function. The glucocorticoid receptor is pivotal in mediating the effects of glucocorticoids, such as cortisol, which are released in response to stress. These hormones play a vital role in various physiological processes, including metabolism, immune response, and the regulation of mood and behavior.\n\nThe TT genotype at rs6190 has been implicated in altered receptor activity, which can influence the body's response to stress. Variants in the NR3C1 gene can lead to changes in receptor sensitivity and signaling pathways, potentially affecting how individuals respond to stressors and their overall stress hormone regulation.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no specific diseases have been directly associated with the TT genotype of rs6190, research indicates that variations in the NR3C1 gene, including rs6190, are linked to mood and anxiety disorders, particularly in patients with asthma. This association suggests that individuals with the TT genotype may experience heightened sensitivity to stress, which could exacerbate anxiety and mood-related symptoms in the context of chronic health conditions.\n\nThe phenotypic effects of this variant may manifest as altered stress responses, potentially leading to increased vulnerability to stress-related disorders. The glucocorticoid receptor's role in the stress response underscores the importance of this variant in understanding individual differences in stress resilience and susceptibility to stress-related psychopathology.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6190 variant in the context of stress hormone pathway function are significant. Given the association with mood and anxiety disorders, particularly in patients with asthma, healthcare providers may consider genetic testing for this variant in individuals presenting with stress-related symptoms or those with a history of mood disorders. Understanding an individual's genetic predisposition could inform treatment strategies, including the use of glucocorticoids or other pharmacological interventions aimed at modulating the stress response.\n\nFurthermore, the identification of the TT genotype may prompt clinicians to adopt a more holistic approach to patient care, integrating psychological support and stress management techniques alongside traditional medical treatments. This could be particularly relevant for patients with chronic conditions, where stress management is crucial for overall health and well-being.\n\n**Research Findings and Evidence Quality**\n\nResearch findings regarding the rs6190 variant and its association with stress hormone pathway function are supported by a growing body of literature. Notably, studies have demonstrated that variations in the NR3C1 gene can influence the risk of developing mood and anxiety disorders, particularly in populations with chronic health issues such as asthma. The evidence quality surrounding these associations is moderate, with several studies highlighting the role of glucocorticoid receptor signaling in stress-related psychopathology.\n\nFor instance, a study indicated that individuals with the TT genotype at rs6190 exhibited a higher prevalence of mood and anxiety disorders compared to those with other genotypes. This suggests that the variant may serve as a genetic marker for susceptibility to stress-related conditions, although further research is needed to elucidate the precise mechanisms by which this variant influences receptor function and stress response.\n\n**Clinical Actionability**\n\nThe clinical actionability of the rs6190 variant is primarily centered on its potential to inform treatment decisions and patient management strategies. Given its association with mood and anxiety disorders, particularly in the context of asthma, clinicians may consider the following actionable steps:\n\n1. **Genetic Counseling**: Patients with a family history of mood disorders or those presenting with stress-related symptoms may benefit from genetic counseling to discuss the implications of the rs6190 variant.\n\n2. **Personalized Treatment Plans**: The identification of the TT genotype could lead to personalized treatment approaches, including tailored pharmacotherapy that considers the patient's genetic predisposition to stress-related disorders.\n\n3. **Integrated Care Models**: Clinicians may implement integrated care models that address both the physical and psychological aspects of health, particularly for patients with chronic conditions. This could involve collaboration with mental health professionals to provide comprehensive care.\n\n4. **Monitoring and Support**: Patients identified with the TT genotype may require closer monitoring for the development of mood and anxiety disorders, along with proactive support strategies to manage stress effectively.\n\nIn conclusion, the rs6190 variant in the NR3C1 gene plays a significant role in the stress hormone pathway, influencing individual responses to stress and susceptibility to mood and anxiety disorders. Understanding this variant's implications can enhance clinical practice by guiding personalized treatment strategies and improving patient outcomes in the context of stress-related health issues. Further research is warranted to deepen our understanding of the mechanisms underlying this variant's effects and to explore its potential as a biomarker for stress-related disorders."
            },
            {
                "rsID": "rs6198",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID34440447",
                    "PMID22083731",
                    "PMID21232135",
                    "PMID18854398",
                    "PMID34778698",
                    "PMID24084075",
                    "PMID18156379",
                    "PMID16855182",
                    "PMID34160793",
                    "PMID29035323",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID22427805",
                    "PMID18663733",
                    "PMID22889053",
                    "PMID22804097",
                    "PMID23392094",
                    "PMID26938822",
                    "PMID22018181",
                    "PMID34643502",
                    "PMID23392096",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID29549463",
                    "PMID27582458",
                    "PMID32967342",
                    "PMID23055001",
                    "PMID19207316",
                    "PMID28330327",
                    "PMID32882010",
                    "PMID24466047",
                    "PMID30043490",
                    "PMID21764460",
                    "PMID24166410",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID19906238",
                    "PMID30639698",
                    "PMID29526633",
                    "PMID18423443",
                    "PMID19000736",
                    "PMID27388141",
                    "PMID33897615",
                    "PMID22823394",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID33833304",
                    "PMID28867940",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID31369569",
                    "PMID22048965",
                    "PMID26823689",
                    "PMID34067466",
                    "PMID28089639",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID26685668",
                    "PMID26228411",
                    "PMID27427275",
                    "PMID24342845",
                    "PMID30020469",
                    "PMID19571595",
                    "PMID19783104",
                    "PMID24379738",
                    "PMID25849990",
                    "PMID25804222",
                    "PMID18830906",
                    "PMID19940520",
                    "PMID21164266",
                    "PMID28400302",
                    "PMID26228405",
                    "PMID34685575",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID24778998",
                    "PMID24126765",
                    "PMID21573817",
                    "PMID29290688",
                    "PMID18667796",
                    "PMID22426413",
                    "PMID26821164",
                    "PMID24626943",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID34139801",
                    "PMID21803757",
                    "PMID31820730",
                    "PMID34765574",
                    "PMID28237884",
                    "PMID28096796",
                    "PMID21757629",
                    "PMID24497894",
                    "PMID24856550"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6198 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6198 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, immune function, and inflammation. The specific genotype of interest, TT, represents one of the three possible alleles (CC, CT, TT) at this single nucleotide polymorphism (SNP). The presence of the TT genotype has been associated with altered glucocorticoid receptor activity, potentially influencing the formation of the GR/GC (glucocorticoid complex) and its downstream signaling pathways.\n\nResearch indicates that variations in the NR3C1 gene, including rs6198, can affect glucocorticoid sensitivity and resistance, which are critical factors in the stress hormone pathway. The TT genotype may lead to a higher incidence of glucocorticoid dependence, as evidenced by studies showing that individuals with this genotype exhibit altered responses to glucocorticoid therapy. This alteration in receptor function can have significant implications for how the body responds to stress and inflammation.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified specifically for the rs6198 TT genotype, its implications in the stress hormone pathway suggest potential phenotypic effects related to stress response and glucocorticoid sensitivity. The variant has been studied in the context of nephrotic syndrome, where it was observed that individuals with the TT genotype may have a higher incidence of glucocorticoid dependence. This suggests that the variant could influence the clinical management of conditions requiring glucocorticoid therapy, particularly in pediatric populations.\n\nFurthermore, the variant's role in glucocorticoid sensitivity may contribute to the phenotypic variability observed in stress-related disorders, although direct associations with specific diseases remain to be fully elucidated. The evidence suggests that individuals with the TT genotype may experience altered physiological responses to stress, potentially leading to increased susceptibility to stress-related conditions.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6198 TT genotype are particularly relevant in the context of glucocorticoid therapy. Given the variant's association with glucocorticoid dependence, clinicians may need to consider genetic testing for this SNP in patients who are being treated for conditions that require glucocorticoids, such as autoimmune diseases or inflammatory disorders. Understanding a patient's genotype could guide therapeutic decisions, including the choice of glucocorticoid, dosing strategies, and monitoring for potential side effects.\n\nMoreover, the TT genotype may necessitate closer monitoring of patients for signs of glucocorticoid resistance or dependence, particularly in pediatric populations where the long-term effects of glucocorticoid therapy can be more pronounced. The identification of this variant could also inform discussions about the risks and benefits of glucocorticoid therapy, allowing for more personalized treatment approaches.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding the rs6198 variant and its implications in the stress hormone pathway is growing, although the evidence quality varies. Studies have demonstrated associations between the TT genotype and altered glucocorticoid sensitivity, particularly in the context of nephrotic syndrome. For instance, a study indicated that individuals with the TT genotype had a higher incidence of glucocorticoid dependence compared to those with the CC or CT genotypes. However, the overall evidence linking rs6198 directly to specific diseases remains limited, necessitating further research to clarify its role in various stress-related conditions.\n\nThe quality of evidence is bolstered by the inclusion of diverse populations in genetic studies, which enhances the generalizability of findings. Nonetheless, the need for larger, well-designed studies is critical to establish definitive associations and to explore the underlying mechanisms by which the rs6198 variant influences glucocorticoid receptor function and stress response.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6198 TT genotype presents an opportunity for personalized medicine in the management of conditions requiring glucocorticoid therapy. Genetic testing for this variant could be integrated into clinical practice, particularly for patients with a history of glucocorticoid resistance or dependence. By identifying individuals at risk for altered glucocorticoid sensitivity, healthcare providers can tailor treatment plans that optimize therapeutic outcomes while minimizing adverse effects.\n\nFurthermore, understanding the implications of the rs6198 variant in the context of stress hormone pathway function can inform preventive strategies for stress-related disorders. Clinicians may consider lifestyle interventions, psychological support, and alternative therapies for patients with the TT genotype, aiming to mitigate the potential impact of glucocorticoid dependence and enhance overall health outcomes.\n\nIn conclusion, the rs6198 variant in the NR3C1 gene is a significant factor in the stress hormone pathway, with implications for glucocorticoid sensitivity and dependence. While direct disease associations remain to be fully established, the variant's influence on stress response and treatment outcomes underscores the importance of genetic considerations in clinical practice. Further research is warranted to elucidate the full spectrum of effects associated with this variant and to enhance its clinical utility in managing stress-related conditions."
            },
            {
                "rsID": "rs6198",
                "pathogenicity": "likely pathogenic",
                "genotype": "TC",
                "sources": [
                    "PMID34440447",
                    "PMID22083731",
                    "PMID21232135",
                    "PMID18854398",
                    "PMID34778698",
                    "PMID24084075",
                    "PMID18156379",
                    "PMID16855182",
                    "PMID34160793",
                    "PMID29035323",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID22427805",
                    "PMID18663733",
                    "PMID22889053",
                    "PMID22804097",
                    "PMID23392094",
                    "PMID26938822",
                    "PMID22018181",
                    "PMID34643502",
                    "PMID23392096",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID29549463",
                    "PMID27582458",
                    "PMID32967342",
                    "PMID23055001",
                    "PMID19207316",
                    "PMID28330327",
                    "PMID32882010",
                    "PMID24466047",
                    "PMID30043490",
                    "PMID21764460",
                    "PMID24166410",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID19906238",
                    "PMID30639698",
                    "PMID29526633",
                    "PMID18423443",
                    "PMID19000736",
                    "PMID27388141",
                    "PMID33897615",
                    "PMID22823394",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID33833304",
                    "PMID28867940",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID31369569",
                    "PMID22048965",
                    "PMID26823689",
                    "PMID34067466",
                    "PMID28089639",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID26685668",
                    "PMID26228411",
                    "PMID27427275",
                    "PMID24342845",
                    "PMID30020469",
                    "PMID19571595",
                    "PMID19783104",
                    "PMID24379738",
                    "PMID25849990",
                    "PMID25804222",
                    "PMID18830906",
                    "PMID19940520",
                    "PMID21164266",
                    "PMID28400302",
                    "PMID26228405",
                    "PMID34685575",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID24778998",
                    "PMID24126765",
                    "PMID21573817",
                    "PMID29290688",
                    "PMID18667796",
                    "PMID22426413",
                    "PMID26821164",
                    "PMID24626943",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID34139801",
                    "PMID21803757",
                    "PMID31820730",
                    "PMID34765574",
                    "PMID28237884",
                    "PMID28096796",
                    "PMID21757629",
                    "PMID24497894",
                    "PMID24856550"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6198 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6198 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR). This receptor is pivotal in mediating the effects of glucocorticoids, hormones that play a crucial role in the stress response, metabolism, immune function, and inflammation. The rs6198 variant results in a single nucleotide polymorphism (SNP) where a cytosine (C) is replaced by a thymine (T) at a specific position in the NR3C1 gene. The presence of the T allele is associated with altered receptor function, potentially affecting the binding affinity of glucocorticoids and the subsequent transcriptional regulation of target genes involved in the stress hormone pathway.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for rs6198, its functional implications in the stress hormone pathway suggest a potential influence on various stress-related conditions. Research indicates that carriers of the T allele may experience altered responses to glucocorticoid treatment, as evidenced by a study that found individuals with the TC genotype required shorter treatment durations with dexamethasone compared to those with the TT genotype (p = 0.043). Furthermore, the TC genotype was associated with a higher likelihood of switching therapy to methylprednisolone (odds ratio [OR] = 2.711; 95% confidence interval [CI] = 1.0187.22; p = 0.046). These findings suggest that the rs6198 variant may influence the pharmacodynamics of glucocorticoids, potentially leading to variations in treatment efficacy and patient outcomes.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6198 variant in the context of the stress hormone pathway are significant. Given the role of glucocorticoids in managing inflammatory and autoimmune conditions, understanding the impact of this SNP on treatment response is crucial. The requirement for shorter dexamethasone treatment in TC carriers may indicate a more efficient response to glucocorticoid therapy, which could inform personalized treatment strategies. However, the increased odds of switching to methylprednisolone also highlight the need for careful monitoring of treatment outcomes in these patients, as it may reflect a suboptimal response to initial therapy.\n\nMoreover, the association of the rs6198 variant with the severity of conditions such as COVID-19 underscores its potential relevance in acute stress responses. The study findings suggest that individuals with the T allele may experience a poorer course of COVID-19, which could be attributed to an enhanced inflammatory state mediated by glucocorticoid signaling pathways. This highlights the importance of considering genetic variants like rs6198 in the context of stress-related diseases and their management.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs6198 variant is derived from a study that investigated its frequency and association with treatment outcomes in patients with various conditions, including IgA nephropathy (IgAN) and minimal change nephropathy (MN). The study's findings provide novel insights into the role of NR3C1 polymorphisms in influencing treatment responses and disease severity. While the associations reported are statistically significant, further research is warranted to validate these findings across diverse populations and clinical settings. The quality of evidence is moderate, as it is based on observational data, and additional studies are needed to elucidate the underlying mechanisms by which rs6198 affects glucocorticoid signaling and stress responses.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6198 variant presents an opportunity for personalized medicine approaches in the management of conditions influenced by glucocorticoids. Genetic testing for this SNP could be integrated into clinical practice to identify patients who may benefit from tailored glucocorticoid therapy. For instance, individuals with the TC genotype may be candidates for alternative treatment regimens or adjusted dosing strategies to optimize therapeutic outcomes. Additionally, understanding the implications of this variant in the context of stress-related diseases could inform preventive strategies and enhance patient care.\n\nIn conclusion, the rs6198 variant in the NR3C1 gene plays a significant role in the stress hormone pathway, influencing glucocorticoid receptor function and treatment responses. While further research is needed to fully elucidate its clinical significance, the current evidence suggests that this SNP may have important implications for personalized treatment strategies in stress-related conditions."
            },
            {
                "rsID": "rs6198",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID34440447",
                    "PMID22083731",
                    "PMID21232135",
                    "PMID18854398",
                    "PMID34778698",
                    "PMID24084075",
                    "PMID18156379",
                    "PMID16855182",
                    "PMID34160793",
                    "PMID29035323",
                    "PMID27649075",
                    "PMID28992366",
                    "PMID22427805",
                    "PMID18663733",
                    "PMID22889053",
                    "PMID22804097",
                    "PMID23392094",
                    "PMID26938822",
                    "PMID22018181",
                    "PMID34643502",
                    "PMID23392096",
                    "PMID20547006",
                    "PMID21225419",
                    "PMID29549463",
                    "PMID27582458",
                    "PMID32967342",
                    "PMID23055001",
                    "PMID19207316",
                    "PMID28330327",
                    "PMID32882010",
                    "PMID24466047",
                    "PMID30043490",
                    "PMID21764460",
                    "PMID24166410",
                    "PMID26873309",
                    "PMID33562675",
                    "PMID19906238",
                    "PMID30639698",
                    "PMID29526633",
                    "PMID18423443",
                    "PMID19000736",
                    "PMID27388141",
                    "PMID33897615",
                    "PMID22823394",
                    "PMID33019527",
                    "PMID26611548",
                    "PMID33833304",
                    "PMID28867940",
                    "PMID28334414",
                    "PMID33133738",
                    "PMID34086487",
                    "PMID31369569",
                    "PMID22048965",
                    "PMID26823689",
                    "PMID34067466",
                    "PMID28089639",
                    "PMID33807560",
                    "PMID27688786",
                    "PMID22507373",
                    "PMID23781311",
                    "PMID26685668",
                    "PMID26228411",
                    "PMID27427275",
                    "PMID24342845",
                    "PMID30020469",
                    "PMID19571595",
                    "PMID19783104",
                    "PMID24379738",
                    "PMID25849990",
                    "PMID25804222",
                    "PMID18830906",
                    "PMID19940520",
                    "PMID21164266",
                    "PMID28400302",
                    "PMID26228405",
                    "PMID34685575",
                    "PMID34681832",
                    "PMID30210047",
                    "PMID25949351",
                    "PMID34091591",
                    "PMID24778998",
                    "PMID24126765",
                    "PMID21573817",
                    "PMID29290688",
                    "PMID18667796",
                    "PMID22426413",
                    "PMID26821164",
                    "PMID24626943",
                    "PMID20199670",
                    "PMID29879676",
                    "PMID33456587",
                    "PMID34139801",
                    "PMID21803757",
                    "PMID31820730",
                    "PMID34765574",
                    "PMID28237884",
                    "PMID28096796",
                    "PMID21757629",
                    "PMID24497894",
                    "PMID24856550"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6198 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6198 is located within the NR3C1 gene, which encodes the glucocorticoid receptor (GR), a critical component of the stress hormone pathway. The NR3C1 gene is situated on chromosome 5q31.3 and plays a pivotal role in mediating the effects of glucocorticoids, such as cortisol, which are essential for the regulation of various physiological processes, including metabolism, immune response, and stress adaptation. The CC genotype of rs6198 is associated with altered receptor function, potentially impacting the GR's ability to bind glucocorticoids and transduce their signals effectively. This alteration can lead to dysregulation of the stress response, influencing both physiological and psychological outcomes.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs6198 CC genotype, research indicates that variations in the NR3C1 gene, including rs6198, may predispose individuals to an enhanced inflammatory state and autoimmune disorders. The glucocorticoid receptor is integral to the negative feedback mechanism that regulates the hypothalamic-pituitary-adrenal (HPA) axis, and any dysfunction in this pathway can lead to chronic stress responses. The CC genotype may be linked to increased susceptibility to conditions characterized by chronic inflammation, although specific phenotypic effects remain to be fully elucidated. \n\nResearch findings suggest that individuals with the CC genotype may exhibit altered responses to stress, potentially leading to increased levels of anxiety, depression, and other stress-related disorders. The variant's influence on the stress hormone pathway could also affect the duration and severity of stress responses, as indicated by the median duration of hospitalization and oxygen supplementation in patients with different genotypes. For instance, individuals with the CC genotype demonstrated a median hospitalization duration of 45 days, significantly longer than those with the TT genotype, suggesting a potential link between this variant and prolonged stress responses.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6198 CC genotype in the context of stress hormone pathway function are multifaceted. Given the role of glucocorticoids in modulating immune responses and inflammation, individuals with this genotype may require closer monitoring for stress-related health issues. The potential for altered glucocorticoid sensitivity could influence treatment strategies for conditions such as autoimmune diseases, where glucocorticoids are commonly used as anti-inflammatory agents. \n\nFurthermore, understanding the impact of the rs6198 variant on stress responses may inform psychological interventions and lifestyle modifications aimed at mitigating stress-related health risks. Clinicians may consider genetic testing for this variant in patients presenting with stress-related disorders or chronic inflammatory conditions, as it could provide valuable insights into individual susceptibility and treatment responsiveness.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs6198 variant and its role in stress hormone pathway function is derived from various studies, including case-control genetic association studies. These studies have demonstrated statistically significant associations between the rs6198 genotype and various clinical outcomes, such as the duration of hospitalization and the severity of stress responses. For example, the research indicates that individuals with the CC genotype may experience longer hospital stays and more severe stress-related symptoms compared to those with the TT genotype.\n\nHowever, while the associations are statistically significant, the quality of evidence varies, and further research is needed to establish a direct causal relationship between the rs6198 variant and specific phenotypic outcomes. The current body of literature suggests a potential link between NR3C1 polymorphisms and stress-related health issues, but additional studies are necessary to clarify the mechanisms involved and to explore the implications for clinical practice.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6198 CC genotype may serve as a biomarker for assessing individual risk for stress-related disorders and chronic inflammatory conditions. Genetic counseling may be beneficial for individuals with this genotype, particularly those with a family history of stress-related illnesses or autoimmune disorders. \n\nMoreover, clinicians may consider personalized treatment approaches that take into account the patient's genetic predisposition. For instance, individuals with the CC genotype may benefit from tailored stress management programs, including cognitive-behavioral therapy, mindfulness practices, and lifestyle modifications aimed at reducing stress exposure and enhancing coping mechanisms.\n\nIn conclusion, the rs6198 variant in the NR3C1 gene is a significant factor in the stress hormone pathway, with potential implications for individual susceptibility to stress-related disorders and chronic inflammation. While further research is warranted to fully elucidate its clinical significance, the current evidence suggests that this variant may play a crucial role in understanding and managing stress-related health outcomes."
            },
            {
                "rsID": "rs1360780",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID31455063",
                    "PMID27126851",
                    "PMID27941579",
                    "PMID31465499",
                    "PMID22234543",
                    "PMID22979952",
                    "PMID26885402",
                    "PMID25517604",
                    "PMID34753443",
                    "PMID24756342",
                    "PMID33866068",
                    "PMID33161050",
                    "PMID26100613",
                    "PMID31000782",
                    "PMID31133831",
                    "PMID32157595",
                    "PMID19829169",
                    "PMID30700816",
                    "PMID31877761",
                    "PMID28850857",
                    "PMID21935478",
                    "PMID26588823",
                    "PMID26442668",
                    "PMID24636505",
                    "PMID32547886",
                    "PMID32625080",
                    "PMID34438242",
                    "PMID34178482",
                    "PMID33030232",
                    "PMID20504254",
                    "PMID28018293",
                    "PMID34163384",
                    "PMID27664120",
                    "PMID33690643",
                    "PMID20393453",
                    "PMID31971968",
                    "PMID27462283",
                    "PMID23062294",
                    "PMID33255215",
                    "PMID26685668",
                    "PMID30890970",
                    "PMID29867390",
                    "PMID31668388",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID34377567",
                    "PMID25139739",
                    "PMID34423378",
                    "PMID28654774",
                    "PMID24845178",
                    "PMID25913301",
                    "PMID29579395",
                    "PMID29535036",
                    "PMID30503303",
                    "PMID25086452",
                    "PMID33052028",
                    "PMID29669535",
                    "PMID25408895",
                    "PMID32997444",
                    "PMID32488091",
                    "PMID29984166",
                    "PMID28229114",
                    "PMID22213790",
                    "PMID20008943",
                    "PMID32151655",
                    "PMID30791339",
                    "PMID28878180",
                    "PMID26399750",
                    "PMID27078785",
                    "PMID31106715",
                    "PMID34068181",
                    "PMID24099078",
                    "PMID30532644",
                    "PMID34972124",
                    "PMID30524168",
                    "PMID30510440",
                    "PMID30963102",
                    "PMID30279666",
                    "PMID29623448",
                    "PMID28393267",
                    "PMID30532646",
                    "PMID27601205",
                    "PMID29305195",
                    "PMID28242325",
                    "PMID26005424",
                    "PMID30678080",
                    "PMID28364727",
                    "PMID24253961",
                    "PMID26813705",
                    "PMID31949407",
                    "PMID30273884",
                    "PMID28434943",
                    "PMID32421620",
                    "PMID30032404",
                    "PMID32125935",
                    "PMID29302075",
                    "PMID29190830",
                    "PMID33673722",
                    "PMID33415193",
                    "PMID25088286"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs1360780 in the Context of Stress Hormone Pathway Function\n\n#### 1. Variant Location and Functional Significance\nThe genetic variant rs1360780 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51), a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. This variant is a single nucleotide polymorphism (SNP) that results in a T allele, which has been associated with altered FKBP51 expression and function. FKBP51 acts as a co-chaperone for steroid hormone receptors, including the glucocorticoid receptor (GR), modulating the receptor's sensitivity to glucocorticoids such as cortisol. The TT genotype of rs1360780 has been implicated in the modulation of stress response, potentially influencing the physiological and psychological outcomes of stress exposure.\n\n#### 2. Disease Associations and Phenotypic Effects\nWhile no direct disease associations have been conclusively identified for the rs1360780 variant, research indicates that it may influence the interaction between genetic predisposition and environmental factors, particularly childhood trauma. For instance, Roy et al. (2019) demonstrated that the TT genotype of rs1360780 interacts with childhood trauma to affect the likelihood of suicide attempts in an African American population. This suggests that individuals with this genotype may have an altered stress response, which could predispose them to adverse mental health outcomes when exposed to traumatic experiences. Furthermore, studies have shown that the FKBP5 rs1360780 variant is associated with variations in brain structure, particularly in regions involved in emotional regulation, such as the thalamus, which may further elucidate its role in stress-related phenotypes.\n\n#### 3. Clinical Implications\nThe clinical implications of the FKBP5 rs1360780 variant are significant, particularly in the context of stress-related disorders. Given its role in modulating the HPA axis and stress response, individuals with the TT genotype may exhibit heightened sensitivity to stress and an increased risk for developing stress-related conditions, such as depression and anxiety disorders. Understanding the genetic predisposition conferred by this variant could inform personalized treatment approaches, including targeted psychological interventions and pharmacotherapy aimed at modulating the stress response. Additionally, the identification of individuals at risk due to their genotype may facilitate early intervention strategies to mitigate the impact of stressors.\n\n#### 4. Research Findings and Evidence Quality\nResearch surrounding the FKBP5 rs1360780 variant has produced a growing body of evidence linking it to stress response and mental health outcomes. Studies have consistently shown that this variant interacts with environmental stressors, such as childhood trauma, to influence psychological resilience and vulnerability. For example, the work by Matsudaira et al. (2019) highlights the association between maternal acceptance and regional gray matter volume in children, suggesting that the FKBP5 variant may play a role in neurodevelopmental processes influenced by early life experiences. The quality of evidence is bolstered by multiple studies across diverse populations, although further research is needed to clarify the mechanisms by which this variant affects stress hormone pathways and to establish causative links to specific mental health outcomes.\n\n#### 5. Clinical Actionability\nThe clinical actionability of the FKBP5 rs1360780 variant is primarily centered on its potential to inform risk assessment and intervention strategies in the context of stress-related disorders. Genetic testing for this variant could be considered in individuals with a history of trauma or those presenting with stress-related symptoms. By identifying individuals with the TT genotype, healthcare providers may tailor interventions that address the heightened risk for adverse psychological outcomes. Furthermore, understanding the role of FKBP5 in the stress response may lead to the development of novel therapeutic targets aimed at modulating the effects of glucocorticoids in susceptible individuals. As research continues to elucidate the functional implications of this variant, it may become increasingly relevant in clinical practice, particularly in the fields of psychiatry and psychology.\n\nIn summary, the FKBP5 rs1360780 variant plays a critical role in the stress hormone pathway, influencing individual responses to stress and susceptibility to mental health disorders. Its implications for clinical practice underscore the importance of integrating genetic insights into the management of stress-related conditions, paving the way for personalized approaches to mental health care."
            },
            {
                "rsID": "rs1360780",
                "pathogenicity": "uncertain significance",
                "genotype": "TC",
                "sources": [
                    "PMID31455063",
                    "PMID27126851",
                    "PMID27941579",
                    "PMID31465499",
                    "PMID22234543",
                    "PMID22979952",
                    "PMID26885402",
                    "PMID25517604",
                    "PMID34753443",
                    "PMID24756342",
                    "PMID33866068",
                    "PMID33161050",
                    "PMID26100613",
                    "PMID31000782",
                    "PMID31133831",
                    "PMID32157595",
                    "PMID19829169",
                    "PMID30700816",
                    "PMID31877761",
                    "PMID28850857",
                    "PMID21935478",
                    "PMID26588823",
                    "PMID26442668",
                    "PMID24636505",
                    "PMID32547886",
                    "PMID32625080",
                    "PMID34438242",
                    "PMID34178482",
                    "PMID33030232",
                    "PMID20504254",
                    "PMID28018293",
                    "PMID34163384",
                    "PMID27664120",
                    "PMID33690643",
                    "PMID20393453",
                    "PMID31971968",
                    "PMID27462283",
                    "PMID23062294",
                    "PMID33255215",
                    "PMID26685668",
                    "PMID30890970",
                    "PMID29867390",
                    "PMID31668388",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID34377567",
                    "PMID25139739",
                    "PMID34423378",
                    "PMID28654774",
                    "PMID24845178",
                    "PMID25913301",
                    "PMID29579395",
                    "PMID29535036",
                    "PMID30503303",
                    "PMID25086452",
                    "PMID33052028",
                    "PMID29669535",
                    "PMID25408895",
                    "PMID32997444",
                    "PMID32488091",
                    "PMID29984166",
                    "PMID28229114",
                    "PMID22213790",
                    "PMID20008943",
                    "PMID32151655",
                    "PMID30791339",
                    "PMID28878180",
                    "PMID26399750",
                    "PMID27078785",
                    "PMID31106715",
                    "PMID34068181",
                    "PMID24099078",
                    "PMID30532644",
                    "PMID34972124",
                    "PMID30524168",
                    "PMID30510440",
                    "PMID30963102",
                    "PMID30279666",
                    "PMID29623448",
                    "PMID28393267",
                    "PMID30532646",
                    "PMID27601205",
                    "PMID29305195",
                    "PMID28242325",
                    "PMID26005424",
                    "PMID30678080",
                    "PMID28364727",
                    "PMID24253961",
                    "PMID26813705",
                    "PMID31949407",
                    "PMID30273884",
                    "PMID28434943",
                    "PMID32421620",
                    "PMID30032404",
                    "PMID32125935",
                    "PMID29302075",
                    "PMID29190830",
                    "PMID33673722",
                    "PMID33415193",
                    "PMID25088286"
                ],
                "description": "### Comprehensive Description of FKBP5 rs1360780 in the Context of Stress Hormone Pathway Function\n\n#### 1. Variant Location and Functional Significance\nThe FKBP5 gene, located on chromosome 6 (6p21.1), encodes the FK506-binding protein 51 (FKBP51), a key regulator of the stress hormone pathway, particularly in the context of glucocorticoid signaling. The variant rs1360780 is a single nucleotide polymorphism (SNP) that results in a T to C transition within an intronic region of the FKBP5 gene. This variant is functionally significant as it has been implicated in the modulation of FKBP51 expression and, consequently, the sensitivity of the glucocorticoid receptor (GR) to stress hormones such as cortisol. FKBP51 acts as a co-chaperone that influences GR activity, thereby affecting the body's response to stress.\n\n#### 2. Disease Associations and Phenotypic Effects\nWhile no direct disease associations have been conclusively identified for the rs1360780 variant, its role in the stress hormone pathway suggests potential implications for stress-related disorders. Research indicates that variations in FKBP5, including rs1360780, may influence susceptibility to conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD) by altering the stress response. The TC genotype of rs1360780 has been studied in various populations, including alcohol-dependent individuals, where it was assessed alongside other genetic variants to explore associations with psychological resilience and self-efficacy. However, the findings have not consistently demonstrated a significant correlation between this specific genotype and clinical outcomes, indicating that while FKBP5 is a critical player in stress response, the direct phenotypic effects of rs1360780 remain to be fully elucidated.\n\n#### 3. Clinical Implications\nThe clinical implications of the FKBP5 rs1360780 variant are primarily centered around its potential influence on stress-related disorders. Given FKBP51's role in modulating the glucocorticoid receptor's sensitivity, individuals carrying the TC genotype may exhibit altered stress responses, which could predispose them to various psychiatric conditions. However, the lack of robust associations with specific diseases in the current literature suggests that rs1360780 alone may not serve as a reliable biomarker for clinical risk assessment. Instead, it may be more informative when considered as part of a broader genetic profile, particularly in conjunction with other variants in the FKBP5 gene and related pathways.\n\n#### 4. Research Findings and Evidence Quality\nResearch findings regarding FKBP5 rs1360780 have yielded mixed results. For instance, studies have explored its association with completed suicide in specific populations, suggesting that the TC haplotype, which includes rs1360780, may be linked to increased risk. However, the evidence quality varies, with some studies reporting significant associations while others do not find conclusive links. The statistical analyses, including Chi-square tests and Fisher's exact tests, have often yielded p-values that do not reach conventional thresholds for significance, indicating that further research is necessary to clarify the role of this variant in stress-related phenotypes. The current body of literature suggests that while FKBP5 is a critical component of the stress hormone pathway, the specific contributions of rs1360780 require more extensive investigation to establish definitive clinical relevance.\n\n#### 5. Clinical Actionability\nIn terms of clinical actionability, the FKBP5 rs1360780 variant does not currently provide actionable insights for patient management or treatment strategies. While understanding an individual's genetic predisposition to stress-related disorders can be valuable, the current evidence does not support the use of this variant as a standalone marker for clinical decision-making. Instead, it may be beneficial to consider rs1360780 within the context of a comprehensive genetic assessment that includes multiple variants influencing the stress response. Future research may elucidate more precise roles for FKBP5 variants in predicting treatment responses to psychotropic medications or behavioral interventions aimed at stress management.\n\n### Conclusion\nIn summary, FKBP5 rs1360780 is a genetic variant situated within a gene that plays a pivotal role in the stress hormone pathway. While it has potential implications for stress-related disorders, the current evidence does not support strong associations with specific diseases or phenotypes. The clinical implications remain limited, and the variant's actionability is not established. Continued research is essential to better understand the functional significance of rs1360780 and its potential role in modulating stress responses, which may ultimately inform clinical practices in the management of stress-related conditions."
            },
            {
                "rsID": "rs1360780",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID31455063",
                    "PMID27126851",
                    "PMID27941579",
                    "PMID31465499",
                    "PMID22234543",
                    "PMID22979952",
                    "PMID26885402",
                    "PMID25517604",
                    "PMID34753443",
                    "PMID24756342",
                    "PMID33866068",
                    "PMID33161050",
                    "PMID26100613",
                    "PMID31000782",
                    "PMID31133831",
                    "PMID32157595",
                    "PMID19829169",
                    "PMID30700816",
                    "PMID31877761",
                    "PMID28850857",
                    "PMID21935478",
                    "PMID26588823",
                    "PMID26442668",
                    "PMID24636505",
                    "PMID32547886",
                    "PMID32625080",
                    "PMID34438242",
                    "PMID34178482",
                    "PMID33030232",
                    "PMID20504254",
                    "PMID28018293",
                    "PMID34163384",
                    "PMID27664120",
                    "PMID33690643",
                    "PMID20393453",
                    "PMID31971968",
                    "PMID27462283",
                    "PMID23062294",
                    "PMID33255215",
                    "PMID26685668",
                    "PMID30890970",
                    "PMID29867390",
                    "PMID31668388",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID34377567",
                    "PMID25139739",
                    "PMID34423378",
                    "PMID28654774",
                    "PMID24845178",
                    "PMID25913301",
                    "PMID29579395",
                    "PMID29535036",
                    "PMID30503303",
                    "PMID25086452",
                    "PMID33052028",
                    "PMID29669535",
                    "PMID25408895",
                    "PMID32997444",
                    "PMID32488091",
                    "PMID29984166",
                    "PMID28229114",
                    "PMID22213790",
                    "PMID20008943",
                    "PMID32151655",
                    "PMID30791339",
                    "PMID28878180",
                    "PMID26399750",
                    "PMID27078785",
                    "PMID31106715",
                    "PMID34068181",
                    "PMID24099078",
                    "PMID30532644",
                    "PMID34972124",
                    "PMID30524168",
                    "PMID30510440",
                    "PMID30963102",
                    "PMID30279666",
                    "PMID29623448",
                    "PMID28393267",
                    "PMID30532646",
                    "PMID27601205",
                    "PMID29305195",
                    "PMID28242325",
                    "PMID26005424",
                    "PMID30678080",
                    "PMID28364727",
                    "PMID24253961",
                    "PMID26813705",
                    "PMID31949407",
                    "PMID30273884",
                    "PMID28434943",
                    "PMID32421620",
                    "PMID30032404",
                    "PMID32125935",
                    "PMID29302075",
                    "PMID29190830",
                    "PMID33673722",
                    "PMID33415193",
                    "PMID25088286"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs1360780 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs1360780 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51), a key regulator of the stress hormone pathway, particularly in the context of glucocorticoid receptor (GR) signaling. FKBP51 is known to modulate the sensitivity of cells to glucocorticoids, such as cortisol, which are critical hormones involved in the body's response to stress. The CC genotype at rs1360780 has been associated with altered FKBP5 expression and function, influencing the regulatory dynamics between FKBP5 and the glucocorticoid receptor. This interaction is particularly relevant in the context of stress response, as FKBP51 can either enhance or inhibit GR activity depending on its expression levels and the presence of specific polymorphisms.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs1360780 variant, research indicates that it plays a significant role in modulating neurobiological responses to stress, particularly in children and adolescents. A study published in PLoS ONE demonstrated that the CC genotype of rs1360780 modulates the relationship between maternal acceptance and regional gray matter volume (rGMV) in the thalamus, a brain region implicated in emotional processing and stress regulation. This suggests that individuals with the CC genotype may experience different neurodevelopmental outcomes based on their early caregiving environments, potentially influencing their stress resilience or vulnerability later in life.\n\nThe thalamus is known to express both FKBP5 and GR, making it a critical area for understanding how genetic variations can affect stress-related neurodevelopment. The findings indicate that the CC genotype may enhance the sensitivity of the thalamus to emotional stimuli, particularly in the context of maternal acceptance, which is crucial for healthy emotional and psychological development.\n\n**Clinical Implications**\n\nThe clinical implications of the rs1360780 variant in FKBP5 are particularly relevant in the context of stress-related disorders. Although no specific diseases have been directly linked to this variant, its influence on stress hormone pathways suggests that it may contribute to the risk of developing conditions such as anxiety, depression, or post-traumatic stress disorder (PTSD) in susceptible individuals. Understanding the role of FKBP5 in stress response can inform therapeutic strategies, particularly in populations at risk due to genetic predispositions.\n\nMoreover, the modulation of brain structure and function associated with the CC genotype highlights the importance of early environmental factors, such as maternal acceptance, in shaping stress responses. This knowledge can guide interventions aimed at improving caregiving practices and enhancing resilience in children, particularly those with the CC genotype.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs1360780 variant and its role in stress hormone pathway function is derived from robust research methodologies, including neuroimaging studies that assess brain structure in relation to genetic variation. The study by Matsudaira et al. (2019) provides compelling evidence that the CC genotype influences the association between maternal acceptance and rGMV in the thalamus, underscoring the variant's relevance in the context of stress response and emotional regulation.\n\nWhile the evidence quality is high, it is important to note that the findings are primarily correlational and do not establish direct causation. Further research is needed to elucidate the precise mechanisms by which FKBP5 and its variants influence stress-related outcomes and to explore potential interactions with environmental factors.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs1360780 variant presents opportunities for personalized approaches to mental health care. Genetic testing for this variant could be considered in populations at risk for stress-related disorders, particularly in children with adverse early life experiences. Identifying individuals with the CC genotype may prompt early interventions focused on enhancing supportive caregiving environments and developing resilience-building strategies.\n\nAdditionally, understanding the role of FKBP5 in stress hormone regulation could inform pharmacological approaches targeting the glucocorticoid receptor pathway. For instance, therapies that modulate FKBP51 activity or enhance GR sensitivity may be beneficial for individuals with specific genotypes, including those carrying the CC variant.\n\nIn conclusion, the FKBP5 variant rs1360780 plays a significant role in the stress hormone pathway, influencing neurodevelopmental outcomes and potentially contributing to the risk of stress-related disorders. Its implications for clinical practice underscore the importance of integrating genetic insights into mental health care, particularly in vulnerable populations. Further research is warranted to deepen our understanding of this variant's functional significance and its potential as a target for therapeutic intervention."
            },
            {
                "rsID": "rs3800373",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID30532645",
                    "PMID23324805",
                    "PMID26100613",
                    "PMID18597649",
                    "PMID21790481",
                    "PMID24128936",
                    "PMID32157595",
                    "PMID27527158",
                    "PMID19880459",
                    "PMID20856915",
                    "PMID32965433",
                    "PMID22738351",
                    "PMID27107574",
                    "PMID34681002",
                    "PMID21225419",
                    "PMID26630184",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID23733030",
                    "PMID19199039",
                    "PMID29101603",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26588823",
                    "PMID27721799",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID33206780",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID31023072",
                    "PMID30669684",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID20504254",
                    "PMID32892762",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID22241248",
                    "PMID33925151",
                    "PMID26424511",
                    "PMID26447706",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29764284",
                    "PMID21536970",
                    "PMID23274505",
                    "PMID28709695",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID18191112",
                    "PMID21978546",
                    "PMID30242809",
                    "PMID25408895",
                    "PMID17081296",
                    "PMID31655035",
                    "PMID25532758",
                    "PMID19676097",
                    "PMID34149370",
                    "PMID31780969",
                    "PMID22213790",
                    "PMID32056869",
                    "PMID30498461",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID20008943",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID32967089",
                    "PMID29162188",
                    "PMID31564884"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs3800373 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs3800373 is located within the 3' untranslated region (3' UTR) of the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51). This protein is a key regulator of the stress hormone pathway, particularly in the context of glucocorticoid receptor (GR) signaling. FKBP51 acts as a co-chaperone that modulates the activity of GR, influencing the cellular response to stress hormones such as cortisol. The CC genotype of rs3800373 has been associated with altered expression levels of FKBP5, which can impact the sensitivity of cells to glucocorticoids and, consequently, the physiological response to stress.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs3800373 variant, its role in the stress hormone pathway suggests potential implications for stress-related disorders. Research indicates that FKBP5 polymorphisms, including rs3800373, may interact with environmental stressors to influence psychological outcomes, particularly in the context of post-traumatic stress disorder (PTSD). Although the CC genotype has not been directly linked to specific diseases, it may contribute to variations in stress resilience and vulnerability to stress-related conditions. \n\nIn studies examining the relationship between FKBP5 polymorphisms and PTSD, the CC genotype of rs3800373 was part of a broader analysis that included other FKBP5 variants. The findings suggested that individuals with certain genotypes, including CC at rs3800373, may exhibit differential responses to trauma, particularly in memory performance and emotional regulation. This indicates that while the CC genotype may not be directly associated with a specific disease, it could influence phenotypic traits related to stress response and psychological resilience.\n\n**Clinical Implications**\n\nThe clinical implications of the rs3800373 variant in the context of stress hormone pathway function are significant, particularly for understanding individual differences in stress response and susceptibility to stress-related disorders. Given FKBP51's role in modulating GR activity, variations in FKBP5 expression due to the CC genotype may affect cortisol signaling pathways, which are critical in stress response regulation. \n\nClinicians may consider the implications of this variant when assessing patients with stress-related symptoms or disorders. For instance, individuals with the CC genotype may require tailored therapeutic approaches that account for their unique stress hormone regulation. This could include personalized stress management strategies or pharmacological interventions that consider the altered glucocorticoid sensitivity associated with this genotype.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding the FKBP5 gene and its variants, including rs3800373, has been extensive, with a focus on their role in stress response and psychological outcomes. Studies have demonstrated that FKBP5 polymorphisms can interact with environmental factors, such as trauma exposure, to influence psychological resilience and vulnerability. However, the evidence quality varies, with some studies reporting significant associations while others yield inconclusive results due to small sample sizes or methodological differences.\n\nFor example, one study highlighted the interactive effect of FKBP5 polymorphisms, including rs3800373, on memory performance in individuals exposed to trauma. This suggests that the CC genotype may play a role in cognitive and emotional processing following stress exposure. However, the need for larger, more robust studies is evident to establish definitive links between this variant and specific phenotypic outcomes.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs3800373 variant presents opportunities for personalized medicine approaches in managing stress-related conditions. While the direct clinical utility of genotyping for this specific variant may not yet be fully realized, understanding its role in the stress hormone pathway can inform treatment strategies. \n\nFor instance, clinicians may utilize this information to guide discussions with patients regarding their stress responses and potential vulnerabilities. Additionally, awareness of the CC genotype's implications could lead to more proactive monitoring of individuals at risk for stress-related disorders, allowing for early intervention and tailored therapeutic approaches.\n\nIn conclusion, the rs3800373 variant in the FKBP5 gene is a significant factor in the stress hormone pathway, influencing glucocorticoid receptor activity and potentially affecting individual responses to stress. While direct disease associations remain to be fully elucidated, the implications for stress resilience and psychological health are noteworthy. Continued research is essential to clarify the clinical significance of this variant and to enhance our understanding of its role in stress-related disorders."
            },
            {
                "rsID": "rs3800373",
                "pathogenicity": "likely pathogenic",
                "genotype": "CT",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID30532645",
                    "PMID23324805",
                    "PMID26100613",
                    "PMID18597649",
                    "PMID21790481",
                    "PMID24128936",
                    "PMID32157595",
                    "PMID27527158",
                    "PMID19880459",
                    "PMID20856915",
                    "PMID32965433",
                    "PMID22738351",
                    "PMID27107574",
                    "PMID34681002",
                    "PMID21225419",
                    "PMID26630184",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID23733030",
                    "PMID19199039",
                    "PMID29101603",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26588823",
                    "PMID27721799",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID33206780",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID31023072",
                    "PMID30669684",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID20504254",
                    "PMID32892762",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID22241248",
                    "PMID33925151",
                    "PMID26424511",
                    "PMID26447706",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29764284",
                    "PMID21536970",
                    "PMID23274505",
                    "PMID28709695",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID18191112",
                    "PMID21978546",
                    "PMID30242809",
                    "PMID25408895",
                    "PMID17081296",
                    "PMID31655035",
                    "PMID25532758",
                    "PMID19676097",
                    "PMID34149370",
                    "PMID31780969",
                    "PMID22213790",
                    "PMID32056869",
                    "PMID30498461",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID20008943",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID32967089",
                    "PMID29162188",
                    "PMID31564884"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs3800373 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs3800373 is located within the FKBP5 gene, which encodes the FK506 binding protein 5, a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. This variant is situated in the 3' untranslated region (3' UTR) of the FKBP5 gene, which plays a crucial role in post-transcriptional regulation of gene expression. The CT genotype of rs3800373 indicates the presence of a T allele and a C allele, which has been associated with altered FKBP5 expression levels. Variants in FKBP5, including rs3800373, have been shown to influence the protein's interaction with glucocorticoid receptors, thereby modulating the cellular response to stress hormones such as cortisol.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs3800373 variant, research indicates that it interacts with environmental stressors, particularly childhood trauma, to influence psychological outcomes. Studies have demonstrated that individuals carrying the CT genotype of rs3800373 may exhibit altered responses to stress, particularly in the context of post-traumatic stress disorder (PTSD) and depressive symptoms. For instance, Roy et al. highlighted significant gene-environment interactions where the presence of the T allele in conjunction with childhood trauma was linked to an increased risk of suicide attempts. Similarly, a cross-sectional study involving urban, low-income populations revealed that the rs3800373 variant, along with other FKBP5 SNPs, modified the severity of PTSD symptoms in response to childhood abuse.\n\nThe functional implications of the rs3800373 variant extend to its role in the regulation of cortisol levels. Sarapas et al. found that homozygosity for recessive alleles at FKBP5 SNPs, including rs3800373, was associated with lower FKBP5 expression, which correlated with reduced cortisol levels and heightened PTSD symptom severity. This suggests that the variant may contribute to dysregulation of the HPA axis, a critical pathway in stress response.\n\n**Clinical Implications**\n\nThe clinical implications of the rs3800373 variant are particularly relevant in the context of stress-related disorders. Given its role in modulating the stress response, individuals with the CT genotype may be at an increased risk for developing stress-related psychopathologies, especially when exposed to adverse childhood experiences. This highlights the importance of considering genetic predispositions in clinical assessments and interventions for individuals with a history of trauma.\n\nFurthermore, understanding the interaction between rs3800373 and environmental factors can inform personalized treatment approaches. For example, individuals with this variant may benefit from targeted therapeutic strategies that address both their genetic susceptibility and their environmental stressors. This could include trauma-informed care, cognitive-behavioral therapies, or pharmacological interventions aimed at regulating the HPA axis.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding the FKBP5 rs3800373 variant and its implications for stress hormone pathway function is growing, with several studies providing evidence for its role in gene-environment interactions. The quality of evidence varies, with some studies employing robust methodologies, such as large sample sizes and well-defined measures of trauma exposure and psychological outcomes. For instance, the findings from Roy et al. and the cross-sectional study on PTSD symptoms provide compelling evidence for the variant's significance in the context of stress response.\n\nHowever, it is important to note that while associations have been observed, the evidence is primarily correlational, and further research is needed to establish causative links. The complexity of gene-environment interactions necessitates a nuanced understanding of how genetic variants like rs3800373 operate within broader biological and psychosocial contexts.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs3800373 variant presents opportunities for enhanced risk assessment and intervention strategies in populations at risk for stress-related disorders. Genetic testing for this variant could be integrated into clinical practice, particularly for individuals with a history of trauma or those presenting with stress-related symptoms. By identifying individuals who may be genetically predisposed to heightened stress sensitivity, clinicians can tailor interventions that are more likely to be effective.\n\nMoreover, the insights gained from understanding the role of FKBP5 in the stress hormone pathway can inform public health initiatives aimed at mitigating the effects of childhood trauma and promoting resilience. Interventions that focus on early identification and support for at-risk populations could ultimately reduce the incidence of stress-related disorders linked to genetic susceptibility.\n\nIn conclusion, the FKBP5 variant rs3800373 plays a significant role in the stress hormone pathway, influencing individual responses to stress and susceptibility to psychological disorders. Continued research into this variant and its interactions with environmental factors will enhance our understanding of stress-related psychopathology and inform clinical practices aimed at improving mental health outcomes."
            },
            {
                "rsID": "rs3800373",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID30532645",
                    "PMID23324805",
                    "PMID26100613",
                    "PMID18597649",
                    "PMID21790481",
                    "PMID24128936",
                    "PMID32157595",
                    "PMID27527158",
                    "PMID19880459",
                    "PMID20856915",
                    "PMID32965433",
                    "PMID22738351",
                    "PMID27107574",
                    "PMID34681002",
                    "PMID21225419",
                    "PMID26630184",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID23733030",
                    "PMID19199039",
                    "PMID29101603",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26588823",
                    "PMID27721799",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID33206780",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID31023072",
                    "PMID30669684",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID20504254",
                    "PMID32892762",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID22241248",
                    "PMID33925151",
                    "PMID26424511",
                    "PMID26447706",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29764284",
                    "PMID21536970",
                    "PMID23274505",
                    "PMID28709695",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID18191112",
                    "PMID21978546",
                    "PMID30242809",
                    "PMID25408895",
                    "PMID17081296",
                    "PMID31655035",
                    "PMID25532758",
                    "PMID19676097",
                    "PMID34149370",
                    "PMID31780969",
                    "PMID22213790",
                    "PMID32056869",
                    "PMID30498461",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID20008943",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID32967089",
                    "PMID29162188",
                    "PMID31564884"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs3800373 in the Context of Stress Hormone Pathway Function\n\n#### 1. Variant Location and Functional Significance\nThe genetic variant rs3800373 is located in the 3' untranslated region (3' UTR) of the FKBP5 gene, which encodes the FK506 binding protein 5. This protein plays a crucial role in the regulation of the stress hormone pathway, particularly in the modulation of glucocorticoid receptor (GR) signaling. The FKBP5 protein acts as a co-chaperone that influences the sensitivity of GRs to glucocorticoids, which are pivotal hormones in the body's response to stress. The TT genotype of rs3800373 has been associated with altered expression levels of FKBP5, potentially leading to dysregulation of the stress response. This dysregulation can affect the body's ability to manage stress effectively, thereby influencing various physiological and psychological outcomes.\n\n#### 2. Disease Associations and Phenotypic Effects\nWhile no direct disease associations have been conclusively identified for the rs3800373 variant, research indicates that it may interact with environmental factors, particularly childhood trauma, to influence stress-related phenotypes. For instance, studies have shown that individuals with the TT genotype may exhibit maladaptive emotional regulation patterns, such as rumination and catastrophizing, particularly in the context of early-life stressors. This suggests that the variant may not directly cause disease but could contribute to vulnerability to stress-related disorders, including anxiety and depression, when combined with adverse environmental experiences.\n\nIn a study involving African American populations, the interaction between FKBP5 variants, including rs3800373, and childhood trauma was linked to an increased risk of suicide attempts. This highlights the potential for the TT genotype to exacerbate the effects of traumatic experiences, leading to significant psychological distress and maladaptive behaviors. Furthermore, in a Chinese cohort, individuals with the TT genotype reported higher alcohol use disorder (AUD) symptoms and lifetime maximum drinks, indicating a possible link between this variant and substance use as a maladaptive coping mechanism in response to stress.\n\n#### 3. Clinical Implications\nThe clinical implications of the rs3800373 variant in the context of stress hormone pathway function are multifaceted. Given its role in modulating the stress response, individuals with the TT genotype may require tailored approaches in clinical settings, particularly in mental health and addiction treatment. Understanding the genetic predisposition to stress sensitivity can inform therapeutic strategies, including psychotherapy and pharmacotherapy, aimed at enhancing emotional regulation and coping mechanisms.\n\nMoreover, the identification of this variant could serve as a biomarker for assessing risk in populations exposed to high levels of stress or trauma. Clinicians may consider genetic testing for FKBP5 variants, including rs3800373, as part of a comprehensive assessment for individuals presenting with stress-related disorders or those with a history of trauma. This could facilitate early intervention and personalized treatment plans that address both genetic and environmental factors.\n\n#### 4. Research Findings and Evidence Quality\nResearch findings regarding the FKBP5 rs3800373 variant and its role in the stress hormone pathway are supported by a growing body of literature. Studies have demonstrated significant associations between the TT genotype and various stress-related phenotypes, particularly in populations exposed to childhood trauma. The evidence quality is bolstered by the replication of findings across diverse ethnic groups, including African Americans and Chinese populations, which enhances the generalizability of the results.\n\nHowever, it is important to note that while associations have been observed, the complexity of gene-environment interactions necessitates further investigation. The evidence suggests that the effects of rs3800373 are not isolated but rather part of a broader network of genetic and environmental influences on stress response. Future research should aim to elucidate the mechanisms by which FKBP5 variants interact with environmental stressors and contribute to psychological outcomes.\n\n#### 5. Clinical Actionability\nThe clinical actionability of the rs3800373 variant is significant, particularly in the context of preventive mental health strategies. Given its association with stress sensitivity and maladaptive coping mechanisms, clinicians can utilize this information to identify at-risk individuals and implement early interventions. For example, individuals with the TT genotype who have experienced childhood trauma may benefit from targeted therapeutic approaches that focus on resilience-building and adaptive coping strategies.\n\nAdditionally, the variant's influence on alcohol use disorder symptoms suggests that screening for FKBP5 variants could be integrated into addiction treatment protocols. By identifying individuals who may be genetically predisposed to maladaptive behaviors in response to stress, healthcare providers can tailor interventions that address both the psychological and physiological aspects of stress management.\n\nIn conclusion, the FKBP5 rs3800373 variant plays a critical role in the stress hormone pathway, influencing individual responses to stress and potential vulnerability to psychological disorders. Understanding its implications can enhance clinical practice and inform personalized treatment strategies, ultimately improving outcomes for individuals affected by stress-related conditions."
            },
            {
                "rsID": "rs9296158",
                "pathogenicity": "uncertain significance",
                "genotype": "AA",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID25311155",
                    "PMID26100613",
                    "PMID20231322",
                    "PMID21790481",
                    "PMID26632991",
                    "PMID32157595",
                    "PMID31161843",
                    "PMID20856915",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID31185043",
                    "PMID28413930",
                    "PMID29101603",
                    "PMID23847551",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID30669684",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID27754486",
                    "PMID34589890",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29867390",
                    "PMID32216170",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID23274505",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID23429203",
                    "PMID31510784",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID32170058",
                    "PMID33427169",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID20376328",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID28845179",
                    "PMID24658422",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID30524168",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID19750552",
                    "PMID30984237",
                    "PMID27030168",
                    "PMID34205191",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID29163241",
                    "PMID27389186",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs9296158 in the Context of Stress Hormone Pathway Function\n\n#### 1. Variant Location and Functional Significance\nThe genetic variant rs9296158 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51), a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the body's response to stress, mediating the release of cortisol, a primary stress hormone. The AA genotype of rs9296158 has been associated with altered FKBP51 expression and function, which can influence cortisol sensitivity and the overall stress response. FKBP51 acts as a co-chaperone for steroid hormone receptors, including the glucocorticoid receptor (GR), modulating their activity and thereby affecting the transcription of genes involved in stress response and adaptation.\n\n#### 2. Disease Associations and Phenotypic Effects\nWhile no direct disease associations have been identified for the rs9296158 variant, its role in the stress hormone pathway suggests potential implications for various stress-related conditions. Research indicates that individuals with the AA genotype may exhibit heightened sensitivity to environmental stressors, particularly in the context of early life adversity (ELA). This genotype has been linked to cognitive performance variations, particularly in tasks that require working memory, where individuals carrying the AA genotype showed increased Stroop task interference compared to GG homozygotes. This suggests that the AA genotype may predispose individuals to cognitive impairments under stress, potentially influencing susceptibility to mental health disorders such as anxiety and depression, although direct associations with specific diseases remain to be fully elucidated.\n\n#### 3. Clinical Implications\nThe clinical implications of the rs9296158 variant are significant, particularly in understanding individual differences in stress response and vulnerability to stress-related disorders. The AA genotype may serve as a biomarker for increased risk of cognitive deficits in stressful situations, which could inform therapeutic strategies. For instance, individuals with this genotype might benefit from interventions aimed at enhancing cognitive resilience or stress management techniques. Furthermore, understanding the role of FKBP5 in the stress response could lead to targeted therapies that modulate its activity, potentially improving outcomes for individuals with stress-related conditions.\n\n#### 4. Research Findings and Evidence Quality\nResearch surrounding the FKBP5 variant rs9296158 has provided valuable insights into its role in stress hormone regulation. A study published in PLoS ONE demonstrated that the AA genotype interacts with subjective trauma severity to affect memory performance, highlighting the variant's relevance in cognitive function under stress. The evidence quality from this study is moderate, as it involves a well-defined cohort and employs robust statistical analyses to support its findings. However, further research is needed to establish a clearer causal relationship between the rs9296158 variant and specific cognitive or psychological outcomes, as well as to explore the underlying mechanisms by which FKBP5 influences stress response.\n\n#### 5. Clinical Actionability\nIn terms of clinical actionability, the rs9296158 variant presents opportunities for personalized medicine approaches in managing stress-related conditions. Genetic testing for this variant could be integrated into assessments of stress vulnerability, allowing healthcare providers to tailor interventions based on an individual's genetic predisposition. For example, individuals identified as AA homozygotes may be prioritized for cognitive-behavioral therapies or pharmacological treatments that target the HPA axis. Additionally, lifestyle modifications, such as stress management programs, could be recommended to mitigate the potential cognitive impacts associated with this genotype. Overall, the integration of FKBP5 genetic testing into clinical practice could enhance the understanding of stress-related disorders and improve patient outcomes through personalized interventions.\n\n### Conclusion\nThe FKBP5 variant rs9296158 (AA genotype) plays a significant role in the stress hormone pathway, influencing cortisol sensitivity and cognitive performance under stress. While direct disease associations remain to be fully established, the variant's implications for stress response and cognitive function highlight its potential as a biomarker for vulnerability to stress-related disorders. Continued research is essential to elucidate the mechanisms underlying these associations and to explore the clinical applications of this knowledge in personalized medicine."
            },
            {
                "rsID": "rs9296158",
                "pathogenicity": "uncertain significance",
                "genotype": "AG",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID25311155",
                    "PMID26100613",
                    "PMID20231322",
                    "PMID21790481",
                    "PMID26632991",
                    "PMID32157595",
                    "PMID31161843",
                    "PMID20856915",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID31185043",
                    "PMID28413930",
                    "PMID29101603",
                    "PMID23847551",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID30669684",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID27754486",
                    "PMID34589890",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29867390",
                    "PMID32216170",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID23274505",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID23429203",
                    "PMID31510784",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID32170058",
                    "PMID33427169",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID20376328",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID28845179",
                    "PMID24658422",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID30524168",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID19750552",
                    "PMID30984237",
                    "PMID27030168",
                    "PMID34205191",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID29163241",
                    "PMID27389186",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of the Genetic Variant rs9296158 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs9296158 is located within the FKBP5 gene, situated on chromosome 6. FKBP5 encodes the FK506 binding protein 5, a key regulator of the glucocorticoid receptor (GR) signaling pathway, which is integral to the stress hormone response. The variant is a single nucleotide polymorphism (SNP) resulting in an A to G substitution, with the AG genotype indicating heterozygosity. FKBP5 plays a crucial role in modulating the sensitivity of cells to glucocorticoids, the hormones released in response to stress. Variants in FKBP5, including rs9296158, have been shown to influence the expression and function of FKBP5, thereby affecting the stress response and the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified specifically for rs9296158, research indicates that this SNP may interact with environmental factors, particularly in the context of stress exposure. Studies have demonstrated that individuals carrying the A-allele (AG or AA genotypes) exhibit heightened sensitivity to environmental stressors, which can manifest in various psychological outcomes, including post-traumatic stress disorder (PTSD). For instance, a study highlighted that A-allele carriers exposed to early life adversity (ELA) showed increased Stroop task interference, suggesting that these individuals may experience greater cognitive and emotional dysregulation under stress compared to GG homozygotes. This finding underscores the potential phenotypic effects of rs9296158 in modulating stress-related cognitive processes.\n\n**Clinical Implications**\n\nThe clinical implications of the rs9296158 variant are particularly relevant in the context of stress-related disorders. Given its role in the stress hormone pathway, this SNP may serve as a biomarker for susceptibility to stress-related conditions, including PTSD and major depressive disorder (MDD). The interaction of rs9296158 with environmental stressors suggests that individuals with this variant may require tailored therapeutic approaches, particularly in psychotherapeutic settings. Understanding the genetic predisposition conferred by rs9296158 could inform clinicians about the potential need for more intensive interventions for those at risk of developing stress-related psychopathology.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding FKBP5 and its variants, including rs9296158, has garnered significant attention in the field of psychoneuroendocrinology. Evidence from longitudinal studies indicates that FKBP5 SNPs, including rs9296158, are implicated in the persistence and severity of PTSD symptoms. For example, a study involving treatment-seekers diagnosed with acute PTSD found associations between FKBP5 variants and memory performance, suggesting that genetic predisposition may influence cognitive outcomes following trauma. The quality of evidence is bolstered by the use of experience sampling methods (ESM) in some studies, which enhance ecological validity by capturing real-time data on stress responses in daily life. However, the overall body of research remains heterogeneous, with varying sample sizes and methodologies, necessitating further investigation to establish robust conclusions regarding the clinical significance of rs9296158.\n\n**Clinical Actionability**\n\nThe clinical actionability of the rs9296158 variant is primarily centered on its potential to inform risk assessment and personalized treatment strategies for stress-related disorders. While no direct therapeutic interventions are currently available that target this specific SNP, understanding an individual's genotype can guide clinicians in developing tailored treatment plans. For instance, individuals with the AG genotype may benefit from early intervention strategies, including cognitive-behavioral therapy (CBT) or pharmacotherapy, particularly in the context of trauma exposure. Additionally, genetic counseling may be warranted for individuals with a family history of stress-related disorders, as the presence of the A-allele could indicate a heightened vulnerability to stress and its psychological sequelae.\n\nIn conclusion, the rs9296158 variant in the FKBP5 gene is a significant factor in the stress hormone pathway, influencing individual responses to stress and susceptibility to stress-related disorders. While further research is needed to elucidate the full clinical implications of this variant, its role in modulating the stress response highlights the importance of integrating genetic insights into clinical practice for the management of stress-related conditions."
            },
            {
                "rsID": "rs9296158",
                "pathogenicity": "uncertain significance",
                "genotype": "GG",
                "sources": [
                    "PMID31455063",
                    "PMID27552816",
                    "PMID25379217",
                    "PMID28944401",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID34516490",
                    "PMID28002634",
                    "PMID33161050",
                    "PMID25311155",
                    "PMID26100613",
                    "PMID20231322",
                    "PMID21790481",
                    "PMID26632991",
                    "PMID32157595",
                    "PMID31161843",
                    "PMID20856915",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID31185043",
                    "PMID28413930",
                    "PMID29101603",
                    "PMID23847551",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID26442668",
                    "PMID32547886",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID30669684",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID27754486",
                    "PMID34589890",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID29867390",
                    "PMID32216170",
                    "PMID21536970",
                    "PMID27709495",
                    "PMID23274505",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID23429203",
                    "PMID31510784",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID28654774",
                    "PMID27028297",
                    "PMID32170058",
                    "PMID33427169",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID34765574",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID20376328",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID28845179",
                    "PMID24658422",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID30524168",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID19750552",
                    "PMID30984237",
                    "PMID27030168",
                    "PMID34205191",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID29163241",
                    "PMID27389186",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of the FKBP5 Variant rs9296158 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs9296158 is located within the FKBP5 gene, situated on chromosome 6 at position 35,599,305. FKBP5 encodes a protein that is a key regulator of the glucocorticoid receptor (GR) signaling pathway, which is crucial for the body's response to stress. The GG genotype of rs9296158 is characterized as a homozygous variant, which has been associated with altered FKBP5 expression and function. Specifically, FKBP5 acts as a co-chaperone that modulates the sensitivity of GRs to glucocorticoids, thereby influencing the stress hormone pathway. Variants in FKBP5, including rs9296158, can affect the binding affinity of GRs to their ligands, potentially leading to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which is central to the stress response.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the GG genotype of rs9296158, research indicates that this variant interacts with environmental stressors, particularly trauma, to influence psychological outcomes. Studies have shown that individuals with the GG genotype exhibit different cognitive and emotional responses to stress compared to those with other genotypes. For instance, in a cohort of clinically depressed adolescents, the interaction between FKBP5 polymorphisms, including rs9296158, and subjective trauma severity was statistically significant, suggesting that this variant may modulate the impact of stress on mental health outcomes. Furthermore, the GG genotype has been linked to performance on cognitive tasks, such as the Stroop task, where individuals carrying this genotype showed no significant interference effects from early life adversity (ELA), contrasting with A-allele carriers who demonstrated increased Stroop task interference with higher instances of ELA.\n\n**Clinical Implications**\n\nThe clinical implications of the rs9296158 GG genotype are particularly relevant in the context of stress-related disorders. Given its role in modulating the stress response, individuals with this genotype may exhibit resilience or vulnerability to stress-related conditions, such as depression or post-traumatic stress disorder (PTSD). The lack of direct disease associations does not diminish the importance of this variant; rather, it highlights the complexity of gene-environment interactions in the context of stress. Clinicians should consider the FKBP5 genotype when assessing patients with a history of trauma or chronic stress, as it may inform treatment strategies and therapeutic approaches. For example, individuals with the GG genotype may benefit from interventions that specifically target stress management and resilience-building.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the FKBP5 rs9296158 variant is derived from multiple studies that have explored its interaction with environmental factors, particularly trauma and stress. Research findings indicate that the GG genotype may confer a unique cognitive profile in response to stress, as evidenced by significant G x E interactions observed in various studies. For instance, analyses have shown that the GG genotype is associated with a lack of cognitive interference in stressful situations, suggesting a potential protective effect against the cognitive impairments often seen in individuals exposed to high levels of stress. However, the quality of evidence varies, with some studies demonstrating robust associations while others yield mixed results. The complexity of gene-environment interactions necessitates further research to elucidate the precise mechanisms by which FKBP5 variants influence stress hormone pathways and related phenotypes.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs9296158 variant presents opportunities for personalized medicine approaches in managing stress-related disorders. While direct interventions based solely on genotype may not be currently feasible, understanding an individual's FKBP5 genotype can guide clinicians in tailoring treatment plans. For instance, patients with the GG genotype may be more responsive to therapies that focus on cognitive-behavioral strategies aimed at enhancing resilience and coping mechanisms in the face of stress. Additionally, monitoring stress hormone levels and HPA axis function in individuals with this genotype could provide valuable insights into their stress response and inform therapeutic decisions.\n\nIn conclusion, the FKBP5 rs9296158 GG genotype plays a significant role in the stress hormone pathway function, influencing how individuals respond to stress and trauma. While direct disease associations remain to be fully elucidated, the variant's impact on cognitive and emotional responses to stress underscores its relevance in clinical settings. Continued research into FKBP5 and its interactions with environmental factors will enhance our understanding of stress-related disorders and inform future therapeutic strategies."
            },
            {
                "rsID": "rs9470080",
                "pathogenicity": "likely pathogenic",
                "genotype": "TT",
                "sources": [
                    "PMID27552816",
                    "PMID27941579",
                    "PMID28944401",
                    "PMID25379217",
                    "PMID21440309",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID23982148",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID26872620",
                    "PMID22536069",
                    "PMID34516490",
                    "PMID26100613",
                    "PMID32157595",
                    "PMID20856915",
                    "PMID34034139",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID27315459",
                    "PMID23847551",
                    "PMID33924903",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID23723703",
                    "PMID29867390",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID32021198",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID29888766",
                    "PMID23282179",
                    "PMID33427169",
                    "PMID31655035",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID33038818",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID24959896",
                    "PMID34687596",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID33154348",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID26424418",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID30984237",
                    "PMID21316860",
                    "PMID31949409",
                    "PMID27030168",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID26740367",
                    "PMID29163241",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of FKBP5 Variant rs9470080 in the Context of Stress Hormone Pathway Function\n\n**1. Variant Location and Functional Significance**\n\nThe genetic variant rs9470080 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51), a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. The variant is characterized by a single nucleotide polymorphism (SNP) where the wild-type allele is C and the variant allele is T. Individuals with the TT genotype, as in the case of the subject in question, may exhibit altered FKBP51 expression and function, which can influence the sensitivity of glucocorticoid receptors (GR) and subsequently affect cortisol signaling. This alteration is significant as FKBP51 is known to modulate the negative feedback mechanism of the HPA axis, which is crucial for maintaining homeostasis in response to stress.\n\n**2. Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs9470080 variant alone, its role in the stress hormone pathway suggests potential implications for stress-related disorders. Research indicates that the TT genotype may interact with environmental factors, such as childhood trauma, to influence emotional regulation and stress response. Specifically, studies have shown that individuals carrying the T allele, particularly in the context of a haplotype that includes rs1360780, exhibit maladaptive emotional regulation patterns, such as rumination and catastrophizing, during adolescence. This suggests that the variant may contribute to a heightened vulnerability to stress-related psychopathology, particularly in individuals with a history of adverse childhood experiences.\n\n**3. Clinical Implications**\n\nThe clinical implications of the rs9470080 TT genotype are particularly relevant in the context of stress-related disorders, including post-traumatic stress disorder (PTSD). Evidence suggests that this genotype may moderate the risk of developing PTSD in individuals with a history of childhood abuse, particularly among Afro-American populations. The interaction between the TT genotype and childhood trauma highlights the importance of considering genetic predispositions when assessing an individual's risk for stress-related disorders. Clinicians may need to adopt a more nuanced approach to treatment and prevention strategies, particularly for individuals with known adverse childhood experiences, as they may be at increased risk for maladaptive stress responses.\n\n**4. Research Findings and Evidence Quality**\n\nResearch findings regarding the FKBP5 rs9470080 variant and its role in the stress hormone pathway are supported by a growing body of literature. For instance, studies have demonstrated that the T allele is associated with lower basal cortisol levels and increased amygdala reactivity, which are critical factors in the stress response. The evidence quality is bolstered by multiple studies that have explored the interactions between FKBP5 variants and environmental stressors, particularly childhood trauma. However, it is important to note that the findings may vary across different populations, as indicated by the differential effects observed between Afro-American and European-American participants. This variability underscores the need for further research to elucidate the mechanisms by which FKBP5 variants influence stress responses and to determine the generalizability of these findings across diverse populations.\n\n**5. Clinical Actionability**\n\nIn terms of clinical actionability, the rs9470080 TT genotype may inform personalized approaches to mental health care, particularly for individuals with a history of trauma. Genetic testing for FKBP5 variants could be considered in clinical settings to identify individuals at higher risk for stress-related disorders. Such information could guide interventions aimed at enhancing emotional regulation and resilience in vulnerable populations. Additionally, understanding the role of FKBP5 in the stress hormone pathway may lead to the development of targeted therapies that modulate HPA axis function, potentially improving outcomes for individuals with stress-related psychopathologies.\n\nIn conclusion, the FKBP5 rs9470080 variant, particularly in the TT genotype, plays a significant role in the stress hormone pathway by influencing cortisol signaling and emotional regulation. While direct disease associations remain to be fully elucidated, the variant's interaction with environmental stressors, such as childhood trauma, highlights its potential impact on stress-related disorders. Continued research is essential to further clarify the clinical implications and actionability of this variant in the context of stress hormone pathway function."
            },
            {
                "rsID": "rs9470080",
                "pathogenicity": "uncertain significance",
                "genotype": "TC",
                "sources": [
                    "PMID27552816",
                    "PMID27941579",
                    "PMID28944401",
                    "PMID25379217",
                    "PMID21440309",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID23982148",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID26872620",
                    "PMID22536069",
                    "PMID34516490",
                    "PMID26100613",
                    "PMID32157595",
                    "PMID20856915",
                    "PMID34034139",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID27315459",
                    "PMID23847551",
                    "PMID33924903",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID23723703",
                    "PMID29867390",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID32021198",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID29888766",
                    "PMID23282179",
                    "PMID33427169",
                    "PMID31655035",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID33038818",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID24959896",
                    "PMID34687596",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID33154348",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID26424418",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID30984237",
                    "PMID21316860",
                    "PMID31949409",
                    "PMID27030168",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID26740367",
                    "PMID29163241",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs9470080 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs9470080 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51). This protein is a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. FKBP51 functions as a co-chaperone for steroid hormone receptors, including the glucocorticoid receptor (GR). By modulating GR activity, FKBP51 plays a crucial role in the cellular response to stress and the regulation of cortisol, the primary stress hormone. The TC genotype at rs9470080 suggests a heterozygous state, which may influence FKBP51 expression and function, thereby impacting the stress response.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs9470080 variant, its involvement in the stress hormone pathway suggests potential implications for stress-related disorders. Research indicates that this SNP interacts significantly with the severity of childhood abuse to predict adult PTSD symptoms, highlighting its relevance in the context of trauma and stress response. Specifically, the interaction of rs9470080 with childhood trauma has been shown to influence the severity of PTSD symptoms in adulthood, suggesting that individuals with this genotype may exhibit altered stress reactivity and resilience.\n\nThe evidence indicates that while FKBP5 SNPs, including rs9470080, do not directly predict PTSD symptom outcomes, they may modulate the effects of environmental stressors, such as childhood abuse, on psychological health. This underscores the importance of genetic factors in the phenotypic expression of stress-related disorders, particularly in individuals with a history of trauma.\n\n**Clinical Implications**\n\nThe clinical implications of the rs9470080 variant in the context of stress hormone pathway function are significant, particularly for individuals with a history of trauma. Understanding the genetic predisposition to altered stress responses can inform treatment strategies for stress-related disorders, including PTSD. For instance, individuals carrying the TC genotype may benefit from targeted therapeutic interventions that consider their genetic background, potentially leading to more personalized approaches in managing stress-related conditions.\n\nMoreover, the interaction of rs9470080 with childhood trauma suggests that genetic screening for this variant could be beneficial in identifying individuals at higher risk for developing PTSD or other stress-related disorders. This could facilitate early intervention strategies, allowing for timely psychological support and therapeutic measures aimed at mitigating the long-term effects of trauma.\n\n**Research Findings and Evidence Quality**\n\nThe research surrounding rs9470080 and its role in the stress hormone pathway is supported by a growing body of evidence, although the quality of evidence varies. The findings from studies examining the interaction of FKBP5 SNPs with childhood trauma and PTSD symptom severity are robust, with significant statistical associations reported (minimum P = 0.0004). However, it is important to note that while these associations are compelling, they do not establish a direct causal relationship between the variant and PTSD outcomes. The complexity of gene-environment interactions in the context of stress response necessitates further research to elucidate the precise mechanisms by which rs9470080 influences stress-related phenotypes.\n\nAdditionally, the evidence quality is bolstered by the replication of findings across multiple studies, which strengthens the validity of the observed associations. Nonetheless, the absence of direct disease associations for rs9470080 highlights the need for continued exploration of its functional implications within the stress hormone pathway.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs9470080 variant presents opportunities for personalized medicine approaches in the management of stress-related disorders. Genetic testing for this variant could be integrated into clinical practice, particularly for individuals with a history of trauma or those presenting with stress-related symptoms. By identifying individuals with the TC genotype, clinicians can tailor interventions that address the unique stress reactivity associated with this genetic background.\n\nFurthermore, understanding the role of FKBP5 in the stress hormone pathway can inform the development of pharmacological agents targeting FKBP51 or related pathways. Such interventions could potentially enhance resilience to stress and improve treatment outcomes for individuals predisposed to stress-related disorders.\n\nIn conclusion, the rs9470080 variant in the FKBP5 gene is a significant genetic marker within the context of stress hormone pathway function. Its interactions with childhood trauma and implications for PTSD symptom severity underscore the importance of genetic factors in stress response and mental health. Continued research and clinical exploration of this variant hold promise for advancing personalized approaches to the prevention and treatment of stress-related disorders."
            },
            {
                "rsID": "rs9470080",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID27552816",
                    "PMID27941579",
                    "PMID28944401",
                    "PMID25379217",
                    "PMID21440309",
                    "PMID22979952",
                    "PMID25047302",
                    "PMID28865405",
                    "PMID23982148",
                    "PMID32109789",
                    "PMID21483441",
                    "PMID34753443",
                    "PMID26872620",
                    "PMID22536069",
                    "PMID34516490",
                    "PMID26100613",
                    "PMID32157595",
                    "PMID20856915",
                    "PMID34034139",
                    "PMID21225419",
                    "PMID34681002",
                    "PMID28889074",
                    "PMID27589660",
                    "PMID27315459",
                    "PMID23847551",
                    "PMID33924903",
                    "PMID27760575",
                    "PMID28850857",
                    "PMID30349266",
                    "PMID32709656",
                    "PMID33019527",
                    "PMID21333900",
                    "PMID34178482",
                    "PMID24103155",
                    "PMID34163384",
                    "PMID18349090",
                    "PMID26982819",
                    "PMID27754486",
                    "PMID33690643",
                    "PMID33925151",
                    "PMID21865530",
                    "PMID20393453",
                    "PMID23062294",
                    "PMID23723703",
                    "PMID29867390",
                    "PMID26032970",
                    "PMID22459275",
                    "PMID32952155",
                    "PMID31510784",
                    "PMID29953524",
                    "PMID34423378",
                    "PMID20549395",
                    "PMID26647360",
                    "PMID29466454",
                    "PMID32576619",
                    "PMID28654774",
                    "PMID32021198",
                    "PMID24845178",
                    "PMID32170058",
                    "PMID29888766",
                    "PMID23282179",
                    "PMID33427169",
                    "PMID31655035",
                    "PMID30036794",
                    "PMID34149370",
                    "PMID22213790",
                    "PMID26535939",
                    "PMID26260058",
                    "PMID34765574",
                    "PMID33038818",
                    "PMID22134958",
                    "PMID30781888",
                    "PMID24856550",
                    "PMID24959896",
                    "PMID34687596",
                    "PMID29162188",
                    "PMID31564884",
                    "PMID33154348",
                    "PMID19540311",
                    "PMID27078785",
                    "PMID34068181",
                    "PMID24161451",
                    "PMID26689393",
                    "PMID33825945",
                    "PMID26424418",
                    "PMID30711865",
                    "PMID24741566",
                    "PMID23201972",
                    "PMID33994278",
                    "PMID30984237",
                    "PMID21316860",
                    "PMID31949409",
                    "PMID27030168",
                    "PMID28891785",
                    "PMID29249826",
                    "PMID28242325",
                    "PMID26740367",
                    "PMID29163241",
                    "PMID33362593",
                    "PMID20090668"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs9470080 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs9470080 is located within the FKBP5 gene, which encodes the FK506-binding protein 51 (FKBP51). This protein is a key regulator of the stress hormone pathway, particularly in the context of the hypothalamic-pituitary-adrenal (HPA) axis. FKBP51 functions as a co-chaperone for steroid hormone receptors, including the glucocorticoid receptor (GR), modulating their activity and influencing the cellular response to stress. The CC genotype of rs9470080 has been associated with altered FKBP51 expression and function, which may impact the body's response to stressors by affecting cortisol signaling and feedback mechanisms within the HPA axis.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the CC genotype of rs9470080, its role in the stress hormone pathway suggests potential implications for stress-related disorders. Research indicates that variations in FKBP5, including rs9470080, may interact with environmental factors, such as trauma, to influence psychological outcomes. Specifically, studies have shown that individuals with the CC genotype of rs9470080, in conjunction with other FKBP5 polymorphisms, exhibit differential memory performance in response to trauma severity. This suggests that the CC genotype may confer a unique phenotypic response to stress, potentially predisposing individuals to altered cognitive and emotional processing under stress.\n\n**Clinical Implications**\n\nThe clinical implications of the rs9470080 variant are primarily relevant in the context of stress response and mental health. Given FKBP5's role in modulating the HPA axis, individuals with the CC genotype may experience heightened sensitivity to stress, which could manifest as increased vulnerability to stress-related disorders, such as anxiety and depression. However, the absence of direct disease associations necessitates caution in interpreting the clinical significance of this variant. It is essential for clinicians to consider the broader context of an individual's genetic makeup, environmental exposures, and psychosocial factors when assessing the potential impact of the rs9470080 variant on stress-related health outcomes.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding FKBP5 and its polymorphisms, including rs9470080, has garnered significant attention in the field of psychoneuroendocrinology. Evidence suggests that FKBP5 variants can influence the stress response and psychological resilience. For instance, studies have demonstrated that the CC genotype of rs9470080 interacts with trauma exposure to affect cognitive performance, particularly in memory tasks. The quality of evidence supporting these findings is bolstered by the use of robust methodologies, including genotyping assays and statistical analyses that account for confounding variables. However, it is important to note that while associations have been observed, causative links remain to be fully elucidated, and further research is warranted to clarify the mechanisms by which FKBP5 variants influence stress-related phenotypes.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs9470080 variant presents a nuanced scenario. While the CC genotype may indicate a predisposition to altered stress responses, the lack of direct disease associations limits the immediate clinical utility of this information. However, understanding an individual's genotype in the context of FKBP5 may inform personalized approaches to stress management and mental health interventions. For example, individuals with the CC genotype may benefit from targeted therapeutic strategies that address stress resilience, such as cognitive-behavioral therapy or mindfulness practices. Additionally, clinicians may consider monitoring stress-related symptoms more closely in patients with this genotype, particularly in the context of trauma exposure.\n\nIn conclusion, the rs9470080 variant in the FKBP5 gene plays a significant role in the stress hormone pathway, influencing the body's response to stress through its effects on the HPA axis. While direct disease associations remain unestablished, the variant's implications for stress sensitivity and psychological outcomes warrant further investigation. Clinicians should consider the potential impact of this variant in the context of stress management and mental health, recognizing the importance of a comprehensive approach that integrates genetic, environmental, and psychosocial factors. Continued research into FKBP5 and its variants will enhance our understanding of the genetic underpinnings of stress-related disorders and inform future clinical practices."
            },
            {
                "rsID": "rs110402",
                "pathogenicity": "likely pathogenic",
                "genotype": "GG",
                "sources": [
                    "PMID19596121",
                    "PMID28793974",
                    "PMID27073970",
                    "PMID21810631",
                    "PMID23018797",
                    "PMID26543368",
                    "PMID32361186",
                    "PMID22536069",
                    "PMID28265716",
                    "PMID26271720",
                    "PMID29241359",
                    "PMID29170760",
                    "PMID30837010",
                    "PMID25583614",
                    "PMID25888454",
                    "PMID28993814",
                    "PMID21223300",
                    "PMID23473364",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22957021",
                    "PMID29317606",
                    "PMID21225419",
                    "PMID23388219",
                    "PMID34681002",
                    "PMID20161813",
                    "PMID30807663",
                    "PMID34279801",
                    "PMID23077729",
                    "PMID28413930",
                    "PMID24166410",
                    "PMID27717506",
                    "PMID27214850",
                    "PMID25541005",
                    "PMID22537725",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID34900142",
                    "PMID18250257",
                    "PMID24456850",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID21918603",
                    "PMID28867940",
                    "PMID32697690",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID24103155",
                    "PMID24623788",
                    "PMID20010888",
                    "PMID21438878",
                    "PMID22748421",
                    "PMID21193270",
                    "PMID27544317",
                    "PMID23723703",
                    "PMID26206446",
                    "PMID23274505",
                    "PMID24379738",
                    "PMID26595470",
                    "PMID30452941",
                    "PMID27894002",
                    "PMID32576619",
                    "PMID32021198",
                    "PMID21711518",
                    "PMID29888766",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID22573456",
                    "PMID33427169",
                    "PMID23294766",
                    "PMID28229114",
                    "PMID26030911",
                    "PMID30953926",
                    "PMID26260058",
                    "PMID28237884",
                    "PMID28054193",
                    "PMID25802844",
                    "PMID30622500",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID19736354",
                    "PMID30447186",
                    "PMID22559122",
                    "PMID28461011",
                    "PMID29755375",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID32395111",
                    "PMID19906236",
                    "PMID19878140",
                    "PMID19750552",
                    "PMID17467808",
                    "PMID32305063",
                    "PMID20374216",
                    "PMID19409562",
                    "PMID31637879",
                    "PMID33546600",
                    "PMID22378896",
                    "PMID27642547",
                    "PMID28364727"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs110402 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs110402 is located within the corticotropin-releasing hormone receptor 1 (CRHR1) gene on chromosome 17. Specifically, this single nucleotide polymorphism (SNP) is situated in intron 2 of the CRHR1 gene, which encodes a receptor that plays a pivotal role in the hypothalamic-pituitary-adrenal (HPA) axis, a central component of the stress hormone pathway. The CRHR1 receptor is activated by corticotropin-releasing hormone (CRH), leading to the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. This pathway is crucial for the bodys response to stress, influencing various physiological and psychological processes.\n\nThe GG genotype of rs110402 has been associated with altered receptor function and expression levels, potentially impacting the sensitivity of the HPA axis to stressors. Variants in CRHR1, including rs110402, may modulate the receptor's signaling pathways, thereby influencing the overall stress response and susceptibility to stress-related disorders.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively established for the rs110402 variant, research indicates suggestive trends linking this SNP to major depressive disorder (MDD), particularly in the context of early life stressors such as childhood abuse. Studies have shown that individuals carrying the GG genotype may exhibit a protective effect against developing MDD in the presence of moderate to severe childhood abuse, suggesting a complex interaction between genetic predisposition and environmental factors.\n\nFurthermore, the presence of the GG genotype has been implicated in increased vulnerability to stress-related phenotypes, including anxiety and depression. The evidence suggests that individuals with this genotype may experience heightened sensitivity to stress, potentially leading to maladaptive responses and increased risk for mood disorders. The association of rs110402 with the T-A-T haplotype further supports its relevance in the context of stress response and mental health.\n\n**Clinical Implications**\n\nThe clinical implications of the rs110402 variant in the context of stress hormone pathway function are significant. Understanding the role of this SNP in modulating the HPA axis response to stress can inform risk assessment for stress-related disorders. For individuals with the GG genotype, particularly those with a history of childhood adversity, there may be a need for targeted interventions that address both genetic and environmental factors contributing to their mental health.\n\nMoreover, the identification of this variant can aid in the development of personalized treatment strategies. For instance, pharmacological interventions that target the CRHR1 signaling pathway may be more effective in individuals with specific genotypes, including those carrying the GG variant. This approach could enhance treatment outcomes for patients with stress-related disorders by tailoring therapies to their genetic profiles.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs110402 variant and its association with stress hormone pathway function is derived from multiple studies, including those that have identified significant associations with MDD and other stress-related phenotypes. Notably, research has demonstrated that the GG genotype may confer a protective effect against depression in individuals with adverse childhood experiences, highlighting the importance of gene-environment interactions.\n\nHowever, while the findings are suggestive, the quality of evidence varies. Some studies have reached conventional levels of statistical significance (P < 0.05), indicating a potential association, but further research is needed to establish causality and elucidate the underlying mechanisms. The complexity of the stress response and the multifactorial nature of mood disorders necessitate additional investigations to clarify the role of rs110402 in the broader context of stress-related pathophysiology.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs110402 variant presents opportunities for personalized medicine approaches in managing stress-related disorders. Genetic testing for this SNP could be integrated into clinical practice to identify individuals at higher risk for stress-related conditions, particularly those with a history of trauma or adverse life experiences. \n\nFurthermore, understanding the implications of the GG genotype may guide clinicians in recommending specific therapeutic strategies, including psychotherapy and pharmacotherapy tailored to the individual's genetic background. For example, patients with the GG genotype may benefit from interventions that specifically target the HPA axis, such as CRHR1 antagonists or therapies aimed at enhancing resilience to stress.\n\nIn conclusion, the rs110402 variant in the CRHR1 gene plays a significant role in the stress hormone pathway, influencing the body's response to stress and susceptibility to mood disorders. While further research is warranted to fully elucidate its clinical significance, the current evidence underscores the importance of considering genetic factors in the context of stress-related health outcomes."
            },
            {
                "rsID": "rs110402",
                "pathogenicity": "uncertain significance",
                "genotype": "GA",
                "sources": [
                    "PMID19596121",
                    "PMID28793974",
                    "PMID27073970",
                    "PMID21810631",
                    "PMID23018797",
                    "PMID26543368",
                    "PMID32361186",
                    "PMID22536069",
                    "PMID28265716",
                    "PMID26271720",
                    "PMID29241359",
                    "PMID29170760",
                    "PMID30837010",
                    "PMID25583614",
                    "PMID25888454",
                    "PMID28993814",
                    "PMID21223300",
                    "PMID23473364",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22957021",
                    "PMID29317606",
                    "PMID21225419",
                    "PMID23388219",
                    "PMID34681002",
                    "PMID20161813",
                    "PMID30807663",
                    "PMID34279801",
                    "PMID23077729",
                    "PMID28413930",
                    "PMID24166410",
                    "PMID27717506",
                    "PMID27214850",
                    "PMID25541005",
                    "PMID22537725",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID34900142",
                    "PMID18250257",
                    "PMID24456850",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID21918603",
                    "PMID28867940",
                    "PMID32697690",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID24103155",
                    "PMID24623788",
                    "PMID20010888",
                    "PMID21438878",
                    "PMID22748421",
                    "PMID21193270",
                    "PMID27544317",
                    "PMID23723703",
                    "PMID26206446",
                    "PMID23274505",
                    "PMID24379738",
                    "PMID26595470",
                    "PMID30452941",
                    "PMID27894002",
                    "PMID32576619",
                    "PMID32021198",
                    "PMID21711518",
                    "PMID29888766",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID22573456",
                    "PMID33427169",
                    "PMID23294766",
                    "PMID28229114",
                    "PMID26030911",
                    "PMID30953926",
                    "PMID26260058",
                    "PMID28237884",
                    "PMID28054193",
                    "PMID25802844",
                    "PMID30622500",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID19736354",
                    "PMID30447186",
                    "PMID22559122",
                    "PMID28461011",
                    "PMID29755375",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID32395111",
                    "PMID19906236",
                    "PMID19878140",
                    "PMID19750552",
                    "PMID17467808",
                    "PMID32305063",
                    "PMID20374216",
                    "PMID19409562",
                    "PMID31637879",
                    "PMID33546600",
                    "PMID22378896",
                    "PMID27642547",
                    "PMID28364727"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs110402 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs110402 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the stress hormone pathway by mediating the effects of corticotropin-releasing hormone (CRH), a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the body's response to stress, influencing the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. The genotype for this variant is GA, indicating a heterozygous state that may influence receptor function and downstream signaling pathways.\n\nFunctional studies have suggested that variations in the CRHR1 gene can affect receptor expression and sensitivity to CRH, potentially altering the physiological response to stress. The GA genotype may lead to differential receptor activity, which could modulate the stress response and influence various stress-related disorders.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs110402 variant, its location within the CRHR1 gene suggests potential implications for stress-related phenotypes. The CRHR1 receptor is implicated in various psychiatric conditions, including major depressive disorder (MDD) and anxiety disorders, due to its role in the stress response. \n\nResearch findings from the Granadp study indicate that the rs110402 variant is associated with an odds ratio (OR) of 1.487 (P = 0.036) in relation to MDD, suggesting a potential link between this variant and increased susceptibility to mood disorders. Although the association is not definitive, it highlights the importance of CRHR1 in the context of stress-related psychiatric conditions. The phenotypic effects of this variant may manifest as altered stress reactivity, which could contribute to the development of mood disorders under chronic stress conditions.\n\n**Clinical Implications**\n\nThe clinical implications of the rs110402 variant in the context of stress hormone pathway function are significant, particularly for individuals with a family history of stress-related disorders or those experiencing chronic stress. Understanding the genetic predisposition conferred by this variant may aid in the identification of individuals at higher risk for developing stress-related psychiatric conditions. \n\nFurthermore, the potential for personalized medicine approaches is evident, as individuals with the GA genotype may benefit from targeted interventions aimed at modulating the stress response. For instance, pharmacological treatments that influence CRHR1 signaling or behavioral therapies that address stress management could be tailored based on an individual's genetic profile.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs110402 variant and its association with stress-related phenotypes is derived from population-based studies, including the Granadp study, which provides a robust framework for understanding the genetic underpinnings of stress response. The association with MDD, while statistically significant, requires further investigation to establish causality and elucidate the underlying mechanisms. \n\nThe quality of evidence is moderate, as the findings are based on association analyses that may be influenced by confounding factors such as environmental stressors, lifestyle, and other genetic variants. Future research should focus on functional studies that explore the biological impact of the GA genotype on CRHR1 receptor activity and downstream signaling pathways, as well as longitudinal studies that assess the long-term effects of this variant on stress-related outcomes.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs110402 variant presents opportunities for risk stratification and personalized treatment strategies in the context of stress-related disorders. Genetic testing for this variant could be considered in clinical settings, particularly for individuals presenting with symptoms of anxiety or depression, or those with a known family history of such conditions. \n\nHealthcare providers may utilize this information to guide discussions about lifestyle modifications, stress management techniques, and potential pharmacological interventions. Additionally, understanding the role of the CRHR1 receptor in stress response could inform the development of novel therapeutic agents targeting this pathway, ultimately enhancing treatment efficacy for individuals affected by stress-related disorders.\n\nIn conclusion, the rs110402 variant in the CRHR1 gene is a significant genetic marker within the stress hormone pathway, with implications for understanding individual differences in stress reactivity and susceptibility to mood disorders. Continued research is essential to fully elucidate its role and to translate these findings into clinical practice, thereby improving outcomes for individuals affected by stress-related conditions."
            },
            {
                "rsID": "rs110402",
                "pathogenicity": "uncertain significance",
                "genotype": "AA",
                "sources": [
                    "PMID19596121",
                    "PMID28793974",
                    "PMID27073970",
                    "PMID21810631",
                    "PMID23018797",
                    "PMID26543368",
                    "PMID32361186",
                    "PMID22536069",
                    "PMID28265716",
                    "PMID26271720",
                    "PMID29241359",
                    "PMID29170760",
                    "PMID30837010",
                    "PMID25583614",
                    "PMID25888454",
                    "PMID28993814",
                    "PMID21223300",
                    "PMID23473364",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22957021",
                    "PMID29317606",
                    "PMID21225419",
                    "PMID23388219",
                    "PMID34681002",
                    "PMID20161813",
                    "PMID30807663",
                    "PMID34279801",
                    "PMID23077729",
                    "PMID28413930",
                    "PMID24166410",
                    "PMID27717506",
                    "PMID27214850",
                    "PMID25541005",
                    "PMID22537725",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID34900142",
                    "PMID18250257",
                    "PMID24456850",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID21918603",
                    "PMID28867940",
                    "PMID32697690",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID24103155",
                    "PMID24623788",
                    "PMID20010888",
                    "PMID21438878",
                    "PMID22748421",
                    "PMID21193270",
                    "PMID27544317",
                    "PMID23723703",
                    "PMID26206446",
                    "PMID23274505",
                    "PMID24379738",
                    "PMID26595470",
                    "PMID30452941",
                    "PMID27894002",
                    "PMID32576619",
                    "PMID32021198",
                    "PMID21711518",
                    "PMID29888766",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID22573456",
                    "PMID33427169",
                    "PMID23294766",
                    "PMID28229114",
                    "PMID26030911",
                    "PMID30953926",
                    "PMID26260058",
                    "PMID28237884",
                    "PMID28054193",
                    "PMID25802844",
                    "PMID30622500",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID19736354",
                    "PMID30447186",
                    "PMID22559122",
                    "PMID28461011",
                    "PMID29755375",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID32395111",
                    "PMID19906236",
                    "PMID19878140",
                    "PMID19750552",
                    "PMID17467808",
                    "PMID32305063",
                    "PMID20374216",
                    "PMID19409562",
                    "PMID31637879",
                    "PMID33546600",
                    "PMID22378896",
                    "PMID27642547",
                    "PMID28364727"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs110402 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs110402 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the stress hormone pathway by mediating the effects of corticotropin-releasing hormone (CRH), a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the body's response to stress, influencing the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. The genotype AA at rs110402 has been associated with altered receptor function, potentially impacting the physiological response to stress.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs110402 variant, its functional implications within the stress hormone pathway suggest a potential influence on stress-related disorders. Research indicates that variations in the CRHR1 gene can modulate susceptibility to psychiatric conditions, particularly major depressive disorder (MDD). In the Granadp study, the rs110402 variant was associated with an odds ratio (OR) of 1.487 (P = 0.036), suggesting a potential risk factor for depression, particularly in the context of adverse early life experiences. This association underscores the importance of CRHR1 in the modulation of stress responses and its potential role in the etiology of stress-related psychiatric disorders.\n\n**Clinical Implications**\n\nThe clinical implications of the rs110402 variant are significant, particularly in the context of stress-related disorders. Given its role in the stress hormone pathway, individuals with the AA genotype may exhibit altered stress responses, which could predispose them to mood disorders, especially in the presence of environmental stressors. Understanding the genetic predisposition conferred by this variant can aid in the identification of individuals at higher risk for developing stress-related conditions, allowing for targeted interventions and preventive strategies.\n\nFurthermore, the CRHR1 receptor is a potential therapeutic target for pharmacological interventions aimed at modulating the stress response. Variants like rs110402 may inform the development of personalized treatment approaches, particularly in the management of depression and anxiety disorders. For instance, individuals with the AA genotype may benefit from therapies that specifically address dysregulation in the HPA axis.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs110402 variant and its association with stress-related disorders is derived from multiple studies, including the Granadp study, which provides a robust statistical analysis of the variant's impact on MDD. The association with an OR of 1.487 indicates a statistically significant relationship, although further research is warranted to elucidate the precise mechanisms by which this variant influences stress responses and psychiatric outcomes. The quality of evidence is bolstered by the replication of findings across different populations and the integration of functional studies that demonstrate the impact of CRHR1 variants on receptor activity and downstream signaling pathways.\n\nDespite the absence of direct disease associations, the implications of rs110402 in the context of stress hormone regulation are supported by a growing body of literature linking CRHR1 variants to behavioral phenotypes and stress-related disorders. Future research should focus on longitudinal studies to assess the functional consequences of this variant in diverse populations and its interaction with environmental factors.\n\n**Clinical Actionability**\n\nThe clinical actionability of the rs110402 variant is primarily centered on its potential role in identifying individuals at risk for stress-related disorders. Genetic testing for this variant could be integrated into clinical practice, particularly for patients with a family history of mood disorders or those presenting with stress-related symptoms. By identifying individuals with the AA genotype, clinicians can implement early intervention strategies, including lifestyle modifications, psychological support, and pharmacotherapy tailored to the individual's genetic profile.\n\nMoreover, understanding the implications of the rs110402 variant can enhance patient education regarding the biological underpinnings of stress responses and the importance of managing stress effectively. This knowledge empowers patients to engage in proactive health behaviors and seek appropriate support when faced with stressors.\n\nIn conclusion, the rs110402 variant in the CRHR1 gene represents a significant factor in the stress hormone pathway, with implications for understanding individual differences in stress responses and susceptibility to mood disorders. Continued research into this variant will further elucidate its role in the complex interplay between genetics, stress, and mental health, ultimately guiding clinical practice and improving patient outcomes in the context of stress-related conditions."
            },
            {
                "rsID": "rs7209436",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID31455063",
                    "PMID21711518",
                    "PMID19878140",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID21691274",
                    "PMID31959877",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID21605337",
                    "PMID28407408",
                    "PMID26543368",
                    "PMID30390684",
                    "PMID22573456",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID24791650",
                    "PMID33427169",
                    "PMID28867940",
                    "PMID19409562",
                    "PMID32697690",
                    "PMID28229114",
                    "PMID31637879",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID28265716",
                    "PMID26030911",
                    "PMID29170760",
                    "PMID26369836",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21223300",
                    "PMID21438878",
                    "PMID25791402",
                    "PMID23473364",
                    "PMID26447706",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID25188543",
                    "PMID30319260",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID30949563",
                    "PMID23250817",
                    "PMID21225419",
                    "PMID29755375",
                    "PMID20161813",
                    "PMID33725938",
                    "PMID19455174",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID23077729",
                    "PMID19455149",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID19906236",
                    "PMID24596569",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs7209436 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs7209436 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the stress hormone pathway by mediating the effects of corticotropin-releasing hormone (CRH), a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the physiological response to stress, influencing the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. The CC genotype of rs7209436 has been associated with variations in receptor function, potentially impacting the sensitivity of the HPA axis to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs7209436 variant, its functional implications within the stress hormone pathway suggest a potential influence on stress-related disorders. The CRHR1 receptor is implicated in various psychiatric conditions, including anxiety and depression, which are often characterized by dysregulation of the HPA axis. Research indicates that variations in CRHR1 can affect individual responses to stress, potentially leading to altered susceptibility to stress-related phenotypes. In a study analyzing the impact of various single nucleotide polymorphisms (SNPs) on the development of moderate to severe depression, rs7209436 was included in a broader analysis of genetic factors influencing mood disorders, although it did not emerge as a significant predictor in isolation.\n\n**Clinical Implications**\n\nThe CC genotype of rs7209436 may have clinical implications in the context of stress response and mental health. Individuals with this genotype may exhibit altered HPA axis reactivity, which could influence their vulnerability to stress-related conditions. Given the role of CRHR1 in modulating stress responses, understanding the implications of this variant could be beneficial in personalized medicine approaches for managing stress-related disorders. However, the absence of direct disease associations necessitates caution in interpreting the clinical significance of this variant. Further research is required to elucidate the specific phenotypic effects associated with the CC genotype and its potential role in stress-related pathologies.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding rs7209436 primarily stems from studies investigating its association with stress response and mood disorders. In a stepwise regression model assessing the development of moderate to severe depression, the variant was included among other SNPs, with a reported p-value of 0.0489, indicating a marginally significant association with phenotypic outcomes. However, the overall evidence quality remains moderate, as the variant has not been consistently linked to specific diseases or phenotypes in larger cohorts. The lack of robust associations in multiple studies suggests that while rs7209436 may contribute to individual differences in stress response, it is likely one of many genetic factors influencing the complex interplay between genetics and environmental stressors.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the current understanding of rs7209436 does not support direct interventions based on genotype alone. While the variant's role in the stress hormone pathway suggests potential implications for stress management and mental health, the absence of clear disease associations limits its utility in clinical practice. Genetic counseling may be beneficial for individuals with a family history of stress-related disorders, particularly in understanding the multifactorial nature of these conditions. Future research may provide insights into how this variant, in conjunction with other genetic and environmental factors, could inform personalized approaches to stress management and mental health care.\n\nIn conclusion, the rs7209436 variant in the CRHR1 gene represents a genetic factor that may influence the stress hormone pathway and individual responses to stress. While its functional significance within the HPA axis is clear, the current evidence does not support strong disease associations or clinical actionability. Continued research is essential to fully elucidate the implications of this variant in the context of stress-related disorders and to explore its potential role in personalized medicine strategies."
            },
            {
                "rsID": "rs7209436",
                "pathogenicity": "uncertain significance",
                "genotype": "CT",
                "sources": [
                    "PMID31455063",
                    "PMID21711518",
                    "PMID19878140",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID21691274",
                    "PMID31959877",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID21605337",
                    "PMID28407408",
                    "PMID26543368",
                    "PMID30390684",
                    "PMID22573456",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID24791650",
                    "PMID33427169",
                    "PMID28867940",
                    "PMID19409562",
                    "PMID32697690",
                    "PMID28229114",
                    "PMID31637879",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID28265716",
                    "PMID26030911",
                    "PMID29170760",
                    "PMID26369836",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21223300",
                    "PMID21438878",
                    "PMID25791402",
                    "PMID23473364",
                    "PMID26447706",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID25188543",
                    "PMID30319260",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID30949563",
                    "PMID23250817",
                    "PMID21225419",
                    "PMID29755375",
                    "PMID20161813",
                    "PMID33725938",
                    "PMID19455174",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID23077729",
                    "PMID19455149",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID19906236",
                    "PMID24596569",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs7209436 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs7209436 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the hypothalamic-pituitary-adrenal (HPA) axis, a central component of the stress response system. The CRHR1 receptor is primarily involved in mediating the effects of corticotropin-releasing hormone (CRH), which is released in response to stress and is crucial for the regulation of various physiological processes, including the release of adrenocorticotropic hormone (ACTH) from the pituitary gland. The CT genotype of rs7209436 suggests a heterozygous state, which may influence receptor function and downstream signaling pathways associated with stress hormone regulation.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs7209436 variant, research indicates that it may interact with environmental factors, particularly in the context of stress and trauma. For instance, Ben-Efraim et al. reported significant gene-environment interactions between the CRHR1 rs7209436 SNP and experiences of physical attack or assault during childhood and adolescence, which were linked to an increased risk of suicide attempts in both male and female patients. This suggests that the variant may modulate individual susceptibility to stress-related psychopathology, particularly in the context of adverse childhood experiences.\n\nFurthermore, Bradley et al. demonstrated that genetic variants in CRHR1, including rs7209436, serve as moderators of the effects of child abuse on adult depressive symptoms. This highlights the potential phenotypic effects of the variant in relation to stress-induced mood disorders, suggesting that individuals carrying the CT genotype may exhibit altered responses to stressors, potentially leading to increased vulnerability to depression and anxiety disorders.\n\n**Clinical Implications**\n\nThe implications of the rs7209436 variant in clinical settings are significant, particularly in the assessment and management of stress-related disorders. Given its role in the stress hormone pathway, this variant may serve as a biomarker for identifying individuals at higher risk for developing stress-related psychopathologies, especially in the context of adverse life events. Clinicians may consider incorporating genetic testing for this variant as part of a comprehensive assessment for patients presenting with stress-related symptoms or a history of trauma.\n\nMoreover, understanding the influence of the CRHR1 rs7209436 variant on stress response may inform personalized treatment approaches. For instance, individuals with the CT genotype may benefit from targeted therapeutic interventions that address their unique stress response profiles, potentially improving treatment outcomes for conditions such as major depressive disorder (MDD) and anxiety disorders.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs7209436 variant is derived from multiple studies that explore its role in the context of stress and mental health. The findings from Ben-Efraim et al. and Bradley et al. provide a foundation for understanding the variant's significance in gene-environment interactions and its potential impact on mental health outcomes. However, it is important to note that while these studies suggest associations, the evidence quality varies, and further research is needed to establish causative links and elucidate the underlying mechanisms.\n\nThe studies referenced indicate a moderate level of evidence, with significant p-values reported in the context of gene-environment interactions and their effects on mental health outcomes. However, the absence of direct disease associations necessitates caution in interpreting these findings, as the complexity of stress-related disorders involves multifactorial influences, including genetic, environmental, and psychosocial factors.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs7209436 variant presents opportunities for enhancing patient care in the realm of mental health. Genetic counseling may be beneficial for individuals with a family history of stress-related disorders, particularly when considering the implications of adverse childhood experiences. Clinicians may utilize this information to develop preventive strategies and interventions tailored to the individual's genetic predisposition and environmental context.\n\nFurthermore, the identification of the CT genotype may prompt clinicians to monitor patients more closely for signs of stress-related psychopathology, allowing for early intervention and support. As research continues to evolve, the integration of genetic insights into clinical practice may lead to more effective management of stress-related disorders, ultimately improving patient outcomes.\n\nIn conclusion, the rs7209436 variant in the CRHR1 gene is a significant marker within the stress hormone pathway, with implications for understanding individual differences in stress response and susceptibility to stress-related disorders. While further research is warranted to clarify its clinical relevance, the current evidence underscores the potential for this variant to inform personalized approaches to mental health care."
            },
            {
                "rsID": "rs7209436",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID31455063",
                    "PMID21711518",
                    "PMID19878140",
                    "PMID26518448",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID21691274",
                    "PMID31959877",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID21605337",
                    "PMID28407408",
                    "PMID26543368",
                    "PMID30390684",
                    "PMID22573456",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID24791650",
                    "PMID33427169",
                    "PMID28867940",
                    "PMID19409562",
                    "PMID32697690",
                    "PMID28229114",
                    "PMID31637879",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID28265716",
                    "PMID26030911",
                    "PMID29170760",
                    "PMID26369836",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21223300",
                    "PMID21438878",
                    "PMID25791402",
                    "PMID23473364",
                    "PMID26447706",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID25188543",
                    "PMID30319260",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID30949563",
                    "PMID23250817",
                    "PMID21225419",
                    "PMID29755375",
                    "PMID20161813",
                    "PMID33725938",
                    "PMID19455174",
                    "PMID20029939",
                    "PMID24741566",
                    "PMID23077729",
                    "PMID19455149",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID19906236",
                    "PMID24596569",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs7209436 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs7209436 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the hypothalamic-pituitary-adrenal (HPA) axis, a central component of the stress response system. The CRHR1 receptor is primarily involved in mediating the effects of corticotropin-releasing hormone (CRH), which is released in response to stress and is crucial for the regulation of various physiological and behavioral responses to stressors. The TT genotype of rs7209436 has been associated with altered receptor function, potentially influencing the sensitivity of the HPA axis to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively identified for the rs7209436 variant, research indicates that it may interact with environmental factors, particularly in the context of stress and trauma. For instance, Ben-Efraim et al. reported significant gene-environment interactions between the CRHR1 rs7209436 SNP and experiences of physical attack or assault during childhood and adolescence, which were linked to suicide attempts in both male and female patients. This suggests that individuals with the TT genotype may exhibit heightened vulnerability to stress-related phenotypes, such as depression and suicidal behavior, particularly when exposed to adverse life experiences.\n\nMoreover, the variant has been implicated in the modulation of behavioral responses to stress, with studies indicating that CRHR1 polymorphisms, including rs7209436, may influence susceptibility to depression and anxiety disorders, especially in the context of early life stress. The TT genotype may confer a protective effect against the development of moderate to severe depression in certain populations, as indicated by the regression models that assessed the impact of various CRHR1 SNPs on depression severity.\n\n**Clinical Implications**\n\nThe clinical implications of the rs7209436 variant in the context of stress hormone pathway function are significant, particularly for individuals with a history of trauma or stress exposure. Understanding the role of this variant can aid in identifying individuals at higher risk for stress-related disorders, including major depressive disorder (MDD) and suicidal behavior. The TT genotype may serve as a biomarker for resilience or vulnerability to stress, guiding clinicians in tailoring preventive and therapeutic strategies for at-risk populations.\n\nFurthermore, the interaction of rs7209436 with environmental stressors underscores the importance of a biopsychosocial approach in clinical settings. Clinicians may consider genetic testing for this variant as part of a comprehensive assessment of an individual's risk profile, particularly in mental health contexts where stress and trauma are prevalent.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding the rs7209436 variant is derived from a variety of studies that explore its role in stress response and related phenotypes. The findings from Ben-Efraim et al. and other studies highlight the significance of gene-environment interactions, suggesting that the TT genotype may influence behavioral outcomes in the face of stress. However, while these studies provide valuable insights, the overall quality of evidence remains moderate, as many findings are correlational and require further investigation to establish causative relationships.\n\nAdditionally, the research indicates that the CRHR1 gene, including rs7209436, is part of a broader network of genetic factors that contribute to stress-related disorders. The complexity of these interactions necessitates further studies to elucidate the precise mechanisms by which this variant influences stress hormone pathway function and its downstream effects on mental health.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs7209436 variant presents opportunities for personalized medicine approaches in mental health care. Given its potential role in modulating stress responses, clinicians may utilize this genetic information to inform treatment decisions, particularly in selecting therapeutic interventions for individuals with a history of trauma or stress-related disorders. For example, individuals with the TT genotype may benefit from targeted psychotherapeutic strategies that address their unique vulnerabilities to stress.\n\nMoreover, the identification of this variant could facilitate the development of preventive measures aimed at reducing the risk of stress-related disorders in at-risk populations. By integrating genetic insights into clinical practice, healthcare providers can enhance the efficacy of interventions and improve patient outcomes in the context of stress hormone pathway function.\n\nIn conclusion, the rs7209436 variant in the CRHR1 gene is a significant factor in the stress hormone pathway, influencing individual responses to stress and susceptibility to related mental health disorders. Continued research is essential to further elucidate its role and enhance clinical applications in the management of stress-related conditions."
            },
            {
                "rsID": "rs242924",
                "pathogenicity": "likely pathogenic",
                "genotype": "GG",
                "sources": [
                    "PMID21711518",
                    "PMID19878140",
                    "PMID19596121",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID31959877",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID26543368",
                    "PMID22573456",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID20374216",
                    "PMID24596569",
                    "PMID33427169",
                    "PMID29853227",
                    "PMID28867940",
                    "PMID28229114",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID33546600",
                    "PMID28265716",
                    "PMID29241359",
                    "PMID26030911",
                    "PMID32828797",
                    "PMID34163384",
                    "PMID25888454",
                    "PMID26369836",
                    "PMID31452059",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21438878",
                    "PMID19906236",
                    "PMID24931706",
                    "PMID23473364",
                    "PMID30874897",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID24243082",
                    "PMID25802844",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID26206446",
                    "PMID25688432",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID28939188",
                    "PMID30949563",
                    "PMID21225419",
                    "PMID28461011",
                    "PMID20161813",
                    "PMID29755375",
                    "PMID33725938",
                    "PMID20468064",
                    "PMID23077729",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID24166410",
                    "PMID25541005",
                    "PMID27214850",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs242924 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs242924 is located within the corticotropin-releasing hormone receptor 1 gene (CRHR1) on chromosome 17. This gene encodes a G-protein coupled receptor that plays a pivotal role in the hypothalamic-pituitary-adrenal (HPA) axis, which is crucial for the body's response to stress. The GG genotype of rs242924 suggests a specific allelic configuration that may influence the receptor's function and, consequently, the physiological response to stressors. Variants in CRHR1 have been implicated in modulating the sensitivity of the HPA axis, which is responsible for the release of corticotropin-releasing hormone (CRH) and subsequent cortisol production, a key stress hormone.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively identified for the rs242924 variant, research indicates suggestive trends linking this SNP to major depressive disorder (MDD) and behavioral outcomes in response to stress. Studies have shown that polymorphisms in CRHR1, including rs242924, are associated with variations in cortisol response to stress, which is a critical factor in the development of stress-related disorders. For instance, Mahon et al. highlighted that individuals with certain CRHR1 polymorphisms, including rs242924, exhibited altered peak cortisol responses, suggesting a potential predisposition to psychiatric disorders under stress conditions. Furthermore, the GG genotype has been associated with increased risk for adverse behavioral outcomes, particularly in populations exposed to early life stressors, indicating a phenotypic effect that may predispose individuals to mood disorders.\n\n**Clinical Implications**\n\nThe clinical implications of the rs242924 variant in the context of stress hormone pathway function are significant. Given its role in the HPA axis, variations in CRHR1 may influence individual responses to stress and susceptibility to stress-related disorders. The GG genotype may be associated with a heightened risk for developing conditions such as depression, particularly in individuals with a history of adverse life experiences. This suggests that genotyping for rs242924 could be beneficial in identifying individuals at risk for stress-related psychiatric conditions, allowing for early intervention and tailored therapeutic strategies.\n\nMoreover, understanding the functional significance of this variant could inform treatment approaches for stress-related disorders. For example, individuals with the GG genotype may benefit from therapies that specifically target the HPA axis or involve stress management techniques. Additionally, the identification of this variant could aid in the development of personalized medicine strategies, where treatment plans are tailored based on an individual's genetic predisposition to stress response.\n\n**Research Findings and Evidence Quality**\n\nResearch findings regarding rs242924 and its association with stress hormone pathway function are supported by a growing body of literature. Studies have demonstrated that CRHR1 polymorphisms, including rs242924, are linked to variations in cortisol levels and stress responses. For instance, evidence from case-control studies indicates that the GG genotype is more prevalent in populations exhibiting aggressive behaviors and higher cortisol responses to stress. The odds ratios reported in these studies suggest a significant association between the GG genotype and increased risk for adverse behavioral outcomes, reinforcing the variant's relevance in the context of stress response.\n\nHowever, it is important to note that while the evidence is suggestive, further research is needed to establish definitive causal relationships between rs242924 and specific stress-related disorders. The quality of evidence varies, with some studies achieving conventional levels of statistical significance (P < 0.05), while others indicate trends that warrant further investigation. The complexity of gene-environment interactions in stress response necessitates a multifaceted approach to understanding the implications of this variant.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs242924 variant presents opportunities for proactive management of stress-related disorders. Genetic testing for this variant could be integrated into clinical practice to identify individuals at higher risk for stress-induced psychiatric conditions. Such identification could facilitate early interventions, including psychological support, lifestyle modifications, and pharmacological treatments aimed at modulating the HPA axis.\n\nFurthermore, the understanding of the functional implications of the GG genotype may guide clinicians in recommending specific therapeutic approaches that address the underlying biological mechanisms associated with stress response. For instance, individuals with the GG genotype may benefit from interventions that focus on stress reduction and resilience-building, potentially improving their overall mental health outcomes.\n\nIn conclusion, the rs242924 variant in the CRHR1 gene is a significant factor in the stress hormone pathway, influencing the HPA axis response to stress and potentially predisposing individuals to stress-related psychiatric disorders. While further research is necessary to clarify its clinical significance, the current evidence underscores the importance of this variant in understanding individual differences in stress response and the potential for personalized interventions in clinical settings."
            },
            {
                "rsID": "rs242924",
                "pathogenicity": "uncertain significance",
                "genotype": "GA",
                "sources": [
                    "PMID21711518",
                    "PMID19878140",
                    "PMID19596121",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID31959877",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID26543368",
                    "PMID22573456",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID20374216",
                    "PMID24596569",
                    "PMID33427169",
                    "PMID29853227",
                    "PMID28867940",
                    "PMID28229114",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID33546600",
                    "PMID28265716",
                    "PMID29241359",
                    "PMID26030911",
                    "PMID32828797",
                    "PMID34163384",
                    "PMID25888454",
                    "PMID26369836",
                    "PMID31452059",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21438878",
                    "PMID19906236",
                    "PMID24931706",
                    "PMID23473364",
                    "PMID30874897",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID24243082",
                    "PMID25802844",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID26206446",
                    "PMID25688432",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID28939188",
                    "PMID30949563",
                    "PMID21225419",
                    "PMID28461011",
                    "PMID20161813",
                    "PMID29755375",
                    "PMID33725938",
                    "PMID20468064",
                    "PMID23077729",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID24166410",
                    "PMID25541005",
                    "PMID27214850",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs242924 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs242924 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the stress hormone pathway by mediating the effects of corticotropin-releasing hormone (CRH), a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the body's response to stress, influencing the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. The GA genotype of rs242924 indicates a heterozygous state, where one allele is G and the other is A. The functional implications of this variant on CRHR1 activity, receptor expression, or downstream signaling pathways remain to be fully elucidated, particularly given the lack of direct associations with specific diseases or phenotypes in the current literature.\n\n**Disease Associations and Phenotypic Effects**\n\nAs of the latest research findings, no direct disease associations or specific phenotypic effects have been identified for the rs242924 variant. However, given the role of CRHR1 in the stress response, it is plausible that variations in this gene could influence susceptibility to stress-related disorders, such as anxiety, depression, or post-traumatic stress disorder (PTSD). The absence of significant associations in the studies reviewed, including the Granadp study, suggests that while rs242924 may not be a primary risk factor for these conditions, it could still play a role in modulating stress responses in a broader genetic context.\n\n**Clinical Implications**\n\nThe clinical implications of the rs242924 variant are currently limited due to the lack of established associations with specific diseases. However, understanding the role of CRHR1 in the stress hormone pathway is essential for potential future applications in clinical settings. Variants in CRHR1 could theoretically influence individual responses to stress and stress-related therapies, including pharmacological interventions targeting the HPA axis. For instance, individuals with certain CRHR1 variants may respond differently to antidepressants or anxiolytics, which often aim to modulate the stress response. Therefore, while rs242924 itself may not have immediate clinical significance, it highlights the importance of genetic factors in personalizing treatment approaches for stress-related disorders.\n\n**Research Findings and Evidence Quality**\n\nThe evidence surrounding rs242924 and its role in stress hormone pathway function is primarily derived from association studies, including the Granadp study, which evaluated multiple single nucleotide polymorphisms (SNPs) in relation to major depressive disorder (MDD). The findings for rs242924 indicated a p-value of 0.935, suggesting no significant association with MDD in the studied population. This aligns with other studies that have similarly failed to establish a direct link between this variant and specific stress-related phenotypes. The quality of evidence regarding rs242924 is moderate, as it is based on statistical analyses of population data rather than functional studies that could elucidate the biological mechanisms at play. Future research, particularly functional genomics studies, is needed to clarify the role of this variant in the context of CRHR1 function and stress response.\n\n**Clinical Actionability**\n\nCurrently, the clinical actionability of the rs242924 variant is limited. Given the absence of strong associations with specific diseases or phenotypes, there are no established guidelines for clinical management based on this variant alone. However, the broader implications of CRHR1 in stress-related disorders suggest that continued research into genetic variants within this gene could eventually lead to actionable insights. For instance, if future studies identify specific CRHR1 variants that significantly influence stress response or treatment outcomes, this could pave the way for genetic screening in clinical practice. Such advancements would enable healthcare providers to tailor interventions based on an individual's genetic predisposition to stress-related conditions.\n\nIn conclusion, while the rs242924 variant in the CRHR1 gene is situated within a critical pathway for stress hormone regulation, its current clinical significance remains limited due to a lack of direct associations with diseases or phenotypes. Continued research into the functional implications of this and related variants will be essential for understanding their roles in stress response and potential clinical applications in the future."
            },
            {
                "rsID": "rs242924",
                "pathogenicity": "uncertain significance",
                "genotype": "AA",
                "sources": [
                    "PMID21711518",
                    "PMID19878140",
                    "PMID19596121",
                    "PMID31018568",
                    "PMID19750552",
                    "PMID31959877",
                    "PMID21978546",
                    "PMID25422957",
                    "PMID27073970",
                    "PMID26543368",
                    "PMID22573456",
                    "PMID30390684",
                    "PMID33019527",
                    "PMID32305063",
                    "PMID21918603",
                    "PMID20374216",
                    "PMID24596569",
                    "PMID33427169",
                    "PMID29853227",
                    "PMID28867940",
                    "PMID28229114",
                    "PMID26303675",
                    "PMID24077033",
                    "PMID33546600",
                    "PMID28265716",
                    "PMID29241359",
                    "PMID26030911",
                    "PMID32828797",
                    "PMID34163384",
                    "PMID25888454",
                    "PMID26369836",
                    "PMID31452059",
                    "PMID22467522",
                    "PMID25422958",
                    "PMID21438878",
                    "PMID19906236",
                    "PMID24931706",
                    "PMID23473364",
                    "PMID30874897",
                    "PMID29154563",
                    "PMID24703172",
                    "PMID22748421",
                    "PMID24243082",
                    "PMID25802844",
                    "PMID22122881",
                    "PMID32244319",
                    "PMID19772600",
                    "PMID22957021",
                    "PMID19736354",
                    "PMID25648046",
                    "PMID26206446",
                    "PMID25688432",
                    "PMID21998007",
                    "PMID29317606",
                    "PMID26808377",
                    "PMID23274505",
                    "PMID22559122",
                    "PMID34681002",
                    "PMID28939188",
                    "PMID30949563",
                    "PMID21225419",
                    "PMID28461011",
                    "PMID20161813",
                    "PMID29755375",
                    "PMID33725938",
                    "PMID20468064",
                    "PMID23077729",
                    "PMID25640828",
                    "PMID22018085",
                    "PMID24166410",
                    "PMID25541005",
                    "PMID27214850",
                    "PMID27497153"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs242924 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs242924 is located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1 (CRHR1). This receptor plays a pivotal role in the stress hormone pathway by mediating the effects of corticotropin-releasing hormone (CRH), a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is crucial for the physiological response to stress, influencing the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which subsequently stimulates cortisol production from the adrenal glands. The AA genotype at rs242924 has been associated with altered receptor function, potentially impacting the sensitivity of the HPA axis to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been identified for the rs242924 variant, its location within the CRHR1 gene suggests a potential influence on stress-related disorders. The CRHR1 receptor is implicated in various psychiatric conditions, including major depressive disorder (MDD) and anxiety disorders, due to its role in modulating stress responses. The variant's association with MDD was highlighted in the Granadp study, where it demonstrated a significant odds ratio (OR = 1.502, P = 0.033), indicating a potential link between this variant and increased susceptibility to MDD. However, the absence of direct disease associations in other studies suggests that the phenotypic effects of this variant may be context-dependent and influenced by environmental factors or additional genetic variants.\n\n**Clinical Implications**\n\nThe clinical implications of the rs242924 variant primarily revolve around its potential role in stress response and susceptibility to stress-related disorders. Individuals with the AA genotype may exhibit altered HPA axis reactivity, which could predispose them to heightened stress sensitivity and an increased risk of developing mood disorders. Understanding the functional significance of this variant could inform clinical assessments of stress-related conditions and guide therapeutic interventions. For instance, individuals identified with this genotype may benefit from targeted psychological interventions or pharmacological treatments aimed at modulating the HPA axis activity.\n\n**Research Findings and Evidence Quality**\n\nResearch findings regarding the rs242924 variant and its implications for stress hormone pathway function are emerging but remain limited. The evidence quality is moderate, primarily derived from association studies that suggest a correlation between the variant and stress-related phenotypes. The Granadp study provides a notable example, indicating a significant association with MDD, although further replication studies are necessary to validate these findings across diverse populations. Additionally, the functional studies exploring the impact of the AA genotype on CRHR1 receptor activity are still in the early stages, necessitating more comprehensive investigations to elucidate the biological mechanisms underlying this variant's effects.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs242924 variant presents opportunities for personalized medicine approaches in managing stress-related disorders. Genetic testing for this variant could be integrated into clinical practice to identify individuals at higher risk for stress sensitivity and related psychiatric conditions. Such information could guide clinicians in tailoring prevention strategies and treatment plans, including lifestyle modifications, psychotherapy, or pharmacotherapy targeting the HPA axis. However, the current lack of robust evidence linking this variant to specific clinical outcomes necessitates caution in its application. Clinicians should consider the variant as one component of a multifactorial model of stress response, integrating genetic, environmental, and psychosocial factors in their assessments.\n\nIn conclusion, the rs242924 variant in the CRHR1 gene holds potential significance in the context of stress hormone pathway function, particularly regarding its influence on HPA axis reactivity and susceptibility to stress-related disorders. While preliminary evidence suggests a link to major depressive disorder, further research is essential to clarify its clinical implications and establish actionable guidelines for its use in clinical settings. As our understanding of the genetic underpinnings of stress responses evolves, the integration of such variants into clinical practice may enhance our ability to address the complexities of stress-related health issues."
            },
            {
                "rsID": "rs12086634",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID31118729",
                    "PMID32800398",
                    "PMID24452065",
                    "PMID30507998",
                    "PMID22445027",
                    "PMID21622477",
                    "PMID28750217",
                    "PMID16817821",
                    "PMID34639470",
                    "PMID16551740",
                    "PMID22384521",
                    "PMID25249770",
                    "PMID30944702",
                    "PMID23778418",
                    "PMID31558916",
                    "PMID34548933",
                    "PMID21915484",
                    "PMID24743397",
                    "PMID18603647",
                    "PMID16236446",
                    "PMID23375992",
                    "PMID26056536",
                    "PMID23869418",
                    "PMID21869537",
                    "PMID30774405",
                    "PMID19934376",
                    "PMID33849530"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs12086634 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs12086634 is located within the HSD11B1 gene, which encodes the enzyme 11-hydroxysteroid dehydrogenase type 1 (11-HSD1). This enzyme plays a critical role in the stress hormone pathway by converting inactive cortisone into active cortisol, thereby regulating local glucocorticoid availability. The TT genotype of rs12086634 has been associated with altered enzymatic activity, potentially influencing cortisol metabolism and, consequently, the physiological response to stress. Variants in HSD11B1 can affect the balance of glucocorticoids, which are pivotal in mediating stress responses, metabolism, and immune function.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively identified for the TT genotype of rs12086634, research indicates that variations in the HSD11B1 gene may influence susceptibility to metabolic disorders, including insulin resistance and type 2 diabetes. For instance, studies have suggested a correlation between HSD11B1 polymorphisms and metabolic syndrome, particularly in populations with a predisposition to insulin resistance. The variant's impact on cortisol levels could lead to phenotypic effects such as altered lipid metabolism, body fat distribution, and overall metabolic health, which are critical in the context of stress hormone function.\n\n**Clinical Implications**\n\nThe clinical implications of the rs12086634 variant are significant, particularly in understanding individual responses to stress and the potential for developing stress-related disorders. Given the role of cortisol in various physiological processes, including glucose metabolism and immune response, individuals with the TT genotype may exhibit altered stress responses, which could predispose them to conditions such as obesity, hypertension, and metabolic syndrome. Furthermore, the variant may influence the efficacy of treatments targeting metabolic disorders, as variations in cortisol metabolism could affect drug metabolism and therapeutic outcomes.\n\n**Research Findings and Evidence Quality**\n\nResearch surrounding the HSD11B1 gene and its variants, including rs12086634, has produced mixed results. Some studies have identified associations between HSD11B1 polymorphisms and metabolic syndrome, while others have not found significant correlations. For example, a study by Devang et al. (2018) explored the association of HSD11B1 polymorphisms with polycystic ovary syndrome, suggesting a potential link to metabolic dysregulation. However, the evidence quality varies, with some studies being limited by small sample sizes or population-specific findings. Overall, while there is a growing body of literature examining the role of HSD11B1 in stress hormone function and metabolic health, further research is needed to establish definitive associations and mechanisms.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs12086634 variant presents opportunities for personalized medicine approaches in managing stress-related conditions and metabolic disorders. Understanding an individual's genotype could inform lifestyle interventions, such as dietary modifications and stress management techniques, aimed at mitigating the effects of altered cortisol metabolism. Additionally, the variant may guide clinicians in selecting appropriate pharmacological treatments, particularly in patients with metabolic syndrome or insulin resistance, where glucocorticoid levels play a crucial role. However, the lack of definitive disease associations necessitates caution in clinical decision-making, emphasizing the need for comprehensive genetic counseling and further research to elucidate the variant's implications fully.\n\nIn conclusion, the rs12086634 variant in the HSD11B1 gene is situated at a critical juncture in the stress hormone pathway, influencing cortisol metabolism and potentially impacting metabolic health. While the current evidence base presents a complex picture, the variant's role in stress response and metabolic regulation underscores its significance in clinical contexts. Continued research is essential to clarify the variant's associations with disease and to enhance its utility in personalized medicine strategies targeting stress-related disorders."
            },
            {
                "rsID": "rs12086634",
                "pathogenicity": "likely pathogenic",
                "genotype": "TG",
                "sources": [
                    "PMID31118729",
                    "PMID32800398",
                    "PMID24452065",
                    "PMID30507998",
                    "PMID22445027",
                    "PMID21622477",
                    "PMID28750217",
                    "PMID16817821",
                    "PMID34639470",
                    "PMID16551740",
                    "PMID22384521",
                    "PMID25249770",
                    "PMID30944702",
                    "PMID23778418",
                    "PMID31558916",
                    "PMID34548933",
                    "PMID21915484",
                    "PMID24743397",
                    "PMID18603647",
                    "PMID16236446",
                    "PMID23375992",
                    "PMID26056536",
                    "PMID23869418",
                    "PMID21869537",
                    "PMID30774405",
                    "PMID19934376",
                    "PMID33849530"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs12086634 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs12086634 is located within the HSD11B1 gene, which encodes the enzyme 11-hydroxysteroid dehydrogenase type 1 (11-HSD1). This enzyme plays a critical role in the stress hormone pathway by converting inactive cortisone to active cortisol, thereby modulating the local availability of glucocorticoids in tissues. The TG genotype of rs12086634 has been associated with altered enzymatic activity, potentially leading to dysregulation of cortisol metabolism. Given the pivotal role of cortisol in stress response, metabolism, and inflammation, variations in HSD11B1 can significantly impact physiological processes related to stress hormone function.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no specific diseases have been definitively linked to the rs12086634 variant, research indicates that the TG genotype is associated with an increased risk of metabolic disorders, particularly Type 2 Diabetes (T2D) and Metabolic Syndrome (MetS). In a comprehensive association analysis, the TG genotype was found to confer an odds ratio (OR) of 1.91 (95% CI 1.332.76, p = 0.0005) for T2D and an OR of 2.37 (95% CI 1.394.05, p = 0.0015) for MetS. These findings suggest that individuals with the TG genotype may experience altered cortisol levels, which can contribute to insulin resistance and other metabolic disturbances. \n\nThe phenotypic effects of this variant may not be directly observable as specific diseases but can manifest as a predisposition to conditions characterized by metabolic dysregulation. The association with T2D and MetS highlights the potential for this variant to influence body composition, glucose metabolism, and overall metabolic health, particularly in the context of stress-induced hormonal changes.\n\n**Clinical Implications**\n\nThe clinical implications of the rs12086634 variant in the context of stress hormone pathway function are significant. Given its association with increased risk for T2D and MetS, individuals carrying the TG genotype may benefit from targeted monitoring and preventive strategies aimed at mitigating metabolic risk factors. Clinicians may consider lifestyle interventions, such as dietary modifications and physical activity, to counteract the potential adverse effects of altered cortisol metabolism. \n\nFurthermore, understanding the role of HSD11B1 in stress hormone regulation can inform therapeutic approaches. For instance, pharmacological agents that modulate glucocorticoid activity may be explored as potential interventions for individuals with the TG genotype who exhibit signs of metabolic dysregulation. \n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding the HSD11B1 rs12086634 variant is substantial, with multiple studies corroborating its association with metabolic disorders. Notably, a study by Gandhi et al. (2013) reported a strong association with MetS (OR = 6.64; P < 0.0001), reinforcing the notion that this variant may serve as a genetic marker for metabolic risk. However, it is essential to note that not all studies have found consistent associations, with some reporting no significant links between the variant and obesity or metabolic parameters. \n\nThe variability in findings may be attributed to differences in study populations, sample sizes, and methodologies. Nevertheless, the cumulative evidence suggests a moderate to strong association between the rs12086634 TG genotype and metabolic dysregulation, particularly in populations with a predisposition to stress-related disorders. The quality of evidence is bolstered by the replication of findings across diverse ethnic groups, including American Indian, South Indian, and Japanese cohorts.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the identification of the rs12086634 TG genotype can serve as a valuable tool for risk stratification in clinical practice. Genetic testing for this variant may be considered in individuals with a family history of metabolic disorders or those presenting with early signs of insulin resistance. \n\nHealthcare providers can utilize this information to implement personalized lifestyle interventions and monitor metabolic health more closely. Additionally, the potential for pharmacogenomic applications exists, as understanding an individual's genetic predisposition to altered cortisol metabolism may guide the selection of therapeutic agents aimed at managing stress-related metabolic conditions.\n\nIn conclusion, the HSD11B1 rs12086634 variant plays a significant role in the stress hormone pathway, with implications for metabolic health. Its association with T2D and MetS underscores the importance of considering genetic factors in the management of stress-related disorders. Continued research into the functional consequences of this variant will further elucidate its role in stress hormone regulation and its potential as a target for clinical intervention."
            },
            {
                "rsID": "rs12086634",
                "pathogenicity": "uncertain significance",
                "genotype": "GG",
                "sources": [
                    "PMID31118729",
                    "PMID32800398",
                    "PMID24452065",
                    "PMID30507998",
                    "PMID22445027",
                    "PMID21622477",
                    "PMID28750217",
                    "PMID16817821",
                    "PMID34639470",
                    "PMID16551740",
                    "PMID22384521",
                    "PMID25249770",
                    "PMID30944702",
                    "PMID23778418",
                    "PMID31558916",
                    "PMID34548933",
                    "PMID21915484",
                    "PMID24743397",
                    "PMID18603647",
                    "PMID16236446",
                    "PMID23375992",
                    "PMID26056536",
                    "PMID23869418",
                    "PMID21869537",
                    "PMID30774405",
                    "PMID19934376",
                    "PMID33849530"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs12086634 in the Context of Stress Hormone Pathway Function\n\n**1. Variant Location and Functional Significance**\n\nThe genetic variant rs12086634 is located within the HSD11B1 gene, which encodes the enzyme 11-hydroxysteroid dehydrogenase type 1 (11-HSD1). This enzyme plays a critical role in the stress hormone pathway by converting inactive cortisone to active cortisol, thereby regulating local glucocorticoid availability. The GG genotype at this locus indicates homozygosity for the G allele, which has been associated with altered enzyme activity and, consequently, variations in cortisol metabolism. The functional significance of this variant lies in its potential impact on the physiological response to stress, as cortisol is a key hormone involved in the body's stress response, influencing metabolism, immune response, and various other physiological processes.\n\n**2. Disease Associations and Phenotypic Effects**\n\nCurrently, there are no direct disease associations or phenotypic effects identified specifically linked to the rs12086634 variant. However, given the role of HSD11B1 in cortisol metabolism, it is plausible that variations in this gene could influence susceptibility to stress-related disorders, metabolic syndrome, or conditions characterized by dysregulated cortisol levels. The absence of identified diseases or phenotypes in the literature may reflect a need for further research to elucidate the broader implications of this variant on stress-related health outcomes.\n\n**3. Clinical Implications**\n\nThe clinical implications of the rs12086634 variant primarily revolve around its potential influence on stress hormone regulation. Individuals with the GG genotype may exhibit altered cortisol levels in response to stress, which could have downstream effects on metabolic processes and overall health. While no specific diseases have been directly linked to this variant, understanding its role in the stress hormone pathway could inform clinical assessments of stress-related conditions. For instance, individuals with this genotype may require closer monitoring for stress-related health issues, particularly if they present with symptoms indicative of dysregulated cortisol levels, such as fatigue, weight gain, or mood disorders.\n\n**4. Research Findings and Evidence Quality**\n\nResearch findings regarding the rs12086634 variant indicate that it is in Hardy-Weinberg equilibrium, suggesting that the allele frequencies are stable within the studied populations. The allele distribution data presented in various studies indicate that the GG genotype is prevalent among different demographic groups, with a significant majority of individuals carrying this genotype. However, the evidence quality regarding the direct impact of this variant on stress hormone function remains moderate, as the current literature does not provide robust associations with specific diseases or phenotypes. The lack of identified disease associations may reflect the complexity of the stress response and the multifactorial nature of stress-related disorders, necessitating further investigation into the functional consequences of this variant.\n\n**5. Clinical Actionability**\n\nIn terms of clinical actionability, the rs12086634 variant presents an opportunity for personalized medicine approaches in managing stress-related health issues. While no direct interventions are currently indicated based solely on this variant, healthcare providers may consider incorporating genetic testing for HSD11B1 variants, including rs12086634, in patients presenting with stress-related symptoms or metabolic disorders. Understanding an individual's genotype could guide therapeutic strategies, such as lifestyle modifications, stress management techniques, or pharmacological interventions aimed at modulating cortisol levels. Furthermore, as research continues to elucidate the role of HSD11B1 in stress hormone regulation, future clinical guidelines may emerge that incorporate genetic information to optimize patient care in the context of stress-related health outcomes.\n\nIn conclusion, the rs12086634 variant in the HSD11B1 gene is situated at a crucial intersection of stress hormone regulation, with the potential to influence cortisol metabolism and, by extension, stress-related health outcomes. While current evidence does not link this variant to specific diseases or phenotypes, its functional significance within the stress hormone pathway warrants further investigation to fully understand its implications for health and disease. As research evolves, the integration of genetic insights into clinical practice may enhance our ability to address the complexities of stress and its impact on human health."
            },
            {
                "rsID": "rs6265",
                "pathogenicity": "uncertain significance",
                "genotype": "CC",
                "sources": [
                    "PMID20838776",
                    "PMID26980363",
                    "PMID25470006",
                    "PMID20433887",
                    "PMID31439852",
                    "PMID23543775",
                    "PMID28777866",
                    "PMID26445699",
                    "PMID31470635",
                    "PMID33916879",
                    "PMID28444135",
                    "PMID30929312",
                    "PMID21796141",
                    "PMID23700461",
                    "PMID20702703",
                    "PMID28353608",
                    "PMID18061279",
                    "PMID32375223",
                    "PMID19473353",
                    "PMID23597512",
                    "PMID24946073",
                    "PMID33193575",
                    "PMID27039345",
                    "PMID34650418",
                    "PMID30885256",
                    "PMID26690621",
                    "PMID19829169",
                    "PMID23845938",
                    "PMID27042072",
                    "PMID34827728",
                    "PMID20955337",
                    "PMID30298028",
                    "PMID24269186",
                    "PMID28106810",
                    "PMID28443016",
                    "PMID25084680",
                    "PMID22384057",
                    "PMID26549599",
                    "PMID23884433",
                    "PMID26161003",
                    "PMID24603720",
                    "PMID23531681",
                    "PMID30911751",
                    "PMID33807752",
                    "PMID21228186",
                    "PMID24679122",
                    "PMID22768299",
                    "PMID16446742",
                    "PMID19622243",
                    "PMID27999706",
                    "PMID28840042",
                    "PMID29759928",
                    "PMID33808272",
                    "PMID32655377",
                    "PMID34407417",
                    "PMID24278778",
                    "PMID25582786",
                    "PMID34630181",
                    "PMID26989097",
                    "PMID26736037",
                    "PMID22521161",
                    "PMID22087305",
                    "PMID34281226",
                    "PMID33282679",
                    "PMID19874854",
                    "PMID32299790",
                    "PMID32726311",
                    "PMID26110341",
                    "PMID33685039",
                    "PMID31724031",
                    "PMID24973604",
                    "PMID26598587",
                    "PMID31083176",
                    "PMID20213725",
                    "PMID31440532",
                    "PMID31228957",
                    "PMID26204172",
                    "PMID31591840",
                    "PMID26602365",
                    "PMID19013140",
                    "PMID23360386",
                    "PMID26923993",
                    "PMID27697064",
                    "PMID17197106",
                    "PMID17044097",
                    "PMID33575257",
                    "PMID30643251",
                    "PMID31584111",
                    "PMID19923862",
                    "PMID21300943",
                    "PMID27511011",
                    "PMID32859588",
                    "PMID34640441",
                    "PMID31279827",
                    "PMID20848240",
                    "PMID29288745",
                    "PMID34149478",
                    "PMID17656372",
                    "PMID22940575",
                    "PMID32056765"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6265 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6265, located at chromosome 11 position 27,658,369 (GRCh38.p14), is a single nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene. This variant results in a missense mutation, where the C allele is replaced by the T allele, leading to an amino acid change from valine to methionine at codon 66 (Val66Met). BDNF is a critical neurotrophin involved in neuronal survival, differentiation, and synaptic plasticity, which are essential processes in the brain's response to stress. The Val66Met polymorphism has been shown to influence BDNF secretion and intracellular trafficking, thereby affecting neuroplasticity and the brain's adaptive responses to stressors.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively established for the rs6265 variant, its implications in the stress hormone pathway are significant. Research indicates that the BDNF Val66Met polymorphism may modulate the stress response and susceptibility to stress-related disorders. For instance, Liang et al. (2018) highlighted the role of this SNP in gene-gene interactions that contribute to post-stroke depression (PSD). The study found that individuals carrying the Met allele exhibited a heightened vulnerability to developing major depressive disorder (MDD) when combined with specific environmental stressors, such as negative life events. This suggests that the BDNF variant may influence the neurobiological mechanisms underlying stress resilience and vulnerability.\n\nMoreover, Pujol et al. (2020) reported that the interaction between BDNF rs6265 and the MTHFR rs1801133 SNPs could be a genetic risk factor for reduced hippocampal volume, a phenotype associated with stress and mood disorders. The findings indicate that individuals with the Met allele may experience structural brain changes that could impair their ability to cope with stress, further emphasizing the variant's relevance in the context of stress hormone pathway function.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6265 variant are particularly relevant for understanding individual differences in stress response and susceptibility to stress-related disorders. The BDNF gene is integral to the regulation of the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body's response to stress through the release of cortisol. Variants in BDNF, such as rs6265, may alter the efficiency of this pathway, potentially leading to dysregulation of cortisol levels and increased risk for conditions like anxiety, depression, and PTSD.\n\nGiven the variant's influence on neuroplasticity and stress response, it may serve as a biomarker for identifying individuals at higher risk for stress-related disorders. This could inform personalized treatment strategies, including pharmacogenomic approaches that consider an individual's genetic predisposition when prescribing antidepressants or other interventions aimed at modulating stress responses.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding the rs6265 variant and its role in stress hormone pathway function is growing, with studies providing moderate to strong evidence of its significance. Liang et al. (2018) and Pujol et al. (2020) are among the key studies that elucidate the interactions between BDNF polymorphisms and environmental factors in the context of stress and mental health. These studies utilize robust methodologies, including gene-gene interaction analyses and neuroimaging techniques, to assess the impact of the variant on brain structure and function.\n\nHowever, while the evidence is compelling, it is essential to note that the associations observed may be influenced by various confounding factors, including environmental stressors, lifestyle, and other genetic variants. Therefore, further research is warranted to clarify the mechanisms by which rs6265 influences stress-related phenotypes and to establish causative links.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6265 variant presents opportunities for targeted interventions in mental health care. Understanding an individual's genotype can guide clinicians in tailoring therapeutic approaches, particularly in the context of stress management and treatment of mood disorders. For instance, individuals with the Met allele may benefit from interventions that focus on enhancing neuroplasticity, such as cognitive-behavioral therapy (CBT) or mindfulness-based stress reduction techniques.\n\nAdditionally, the identification of the rs6265 variant could inform preventive strategies for at-risk populations, allowing for early interventions that may mitigate the onset of stress-related disorders. Genetic counseling may also be beneficial for individuals with a family history of stress-related conditions, providing them with insights into their genetic predisposition and potential coping strategies.\n\nIn conclusion, the rs6265 variant in the BDNF gene plays a significant role in the stress hormone pathway, influencing individual responses to stress and susceptibility to related disorders. As research continues to evolve, the integration of genetic insights into clinical practice holds promise for enhancing mental health outcomes and fostering resilience in the face of stress."
            },
            {
                "rsID": "rs6265",
                "pathogenicity": "uncertain significance",
                "genotype": "CT",
                "sources": [
                    "PMID20838776",
                    "PMID26980363",
                    "PMID25470006",
                    "PMID20433887",
                    "PMID31439852",
                    "PMID23543775",
                    "PMID28777866",
                    "PMID26445699",
                    "PMID31470635",
                    "PMID33916879",
                    "PMID28444135",
                    "PMID30929312",
                    "PMID21796141",
                    "PMID23700461",
                    "PMID20702703",
                    "PMID28353608",
                    "PMID18061279",
                    "PMID32375223",
                    "PMID19473353",
                    "PMID23597512",
                    "PMID24946073",
                    "PMID33193575",
                    "PMID27039345",
                    "PMID34650418",
                    "PMID30885256",
                    "PMID26690621",
                    "PMID19829169",
                    "PMID23845938",
                    "PMID27042072",
                    "PMID34827728",
                    "PMID20955337",
                    "PMID30298028",
                    "PMID24269186",
                    "PMID28106810",
                    "PMID28443016",
                    "PMID25084680",
                    "PMID22384057",
                    "PMID26549599",
                    "PMID23884433",
                    "PMID26161003",
                    "PMID24603720",
                    "PMID23531681",
                    "PMID30911751",
                    "PMID33807752",
                    "PMID21228186",
                    "PMID24679122",
                    "PMID22768299",
                    "PMID16446742",
                    "PMID19622243",
                    "PMID27999706",
                    "PMID28840042",
                    "PMID29759928",
                    "PMID33808272",
                    "PMID32655377",
                    "PMID34407417",
                    "PMID24278778",
                    "PMID25582786",
                    "PMID34630181",
                    "PMID26989097",
                    "PMID26736037",
                    "PMID22521161",
                    "PMID22087305",
                    "PMID34281226",
                    "PMID33282679",
                    "PMID19874854",
                    "PMID32299790",
                    "PMID32726311",
                    "PMID26110341",
                    "PMID33685039",
                    "PMID31724031",
                    "PMID24973604",
                    "PMID26598587",
                    "PMID31083176",
                    "PMID20213725",
                    "PMID31440532",
                    "PMID31228957",
                    "PMID26204172",
                    "PMID31591840",
                    "PMID26602365",
                    "PMID19013140",
                    "PMID23360386",
                    "PMID26923993",
                    "PMID27697064",
                    "PMID17197106",
                    "PMID17044097",
                    "PMID33575257",
                    "PMID30643251",
                    "PMID31584111",
                    "PMID19923862",
                    "PMID21300943",
                    "PMID27511011",
                    "PMID32859588",
                    "PMID34640441",
                    "PMID31279827",
                    "PMID20848240",
                    "PMID29288745",
                    "PMID34149478",
                    "PMID17656372",
                    "PMID22940575",
                    "PMID32056765"
                ],
                "description": "### Comprehensive Description of the BDNF Variant rs6265 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6265, also known as the Val66Met polymorphism, is located in the brain-derived neurotrophic factor (BDNF) gene on chromosome 11. This single nucleotide polymorphism (SNP) results in a substitution of valine (Val) with methionine (Met) at codon 66 of the BDNF protein. Functionally, this variant has been shown to significantly impact the intracellular trafficking and activity-dependent secretion of BDNF in neurons. BDNF is a critical neurotrophin involved in neuronal survival, growth, and differentiation, and it plays a pivotal role in synaptic plasticity, which is essential for learning and memory. The Met allele is associated with impaired BDNF secretion, which can disrupt neuroplasticity and has implications for the stress hormone pathway, particularly in how stress responses are modulated at the neurobiological level.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively established for rs6265, its influence on the stress hormone pathway suggests potential implications for various stress-related disorders. Research indicates that the Met allele may predispose individuals to altered stress responses, which can manifest in conditions such as major depressive disorder (MDD) and post-stroke depression (PSD). For instance, studies have identified significant gene-gene interactions involving rs6265 and other genetic variants that contribute to the risk of developing MDD, particularly in the context of negative life events. The interaction between BDNF rs6265 and environmental stressors may exacerbate the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, a central component of the stress response system.\n\nMoreover, the variant has been implicated in neuroanatomical changes, such as reduced hippocampal volume, which is often observed in individuals with mood disorders. The hippocampus is a critical region for stress regulation and is sensitive to the effects of BDNF. Thus, the Met allele may contribute to a vulnerability to stress-related phenotypes through its impact on neuroanatomy and neuroplasticity.\n\n**Clinical Implications**\n\nThe clinical implications of the BDNF rs6265 variant in the context of stress hormone pathway function are multifaceted. Given its role in modulating stress responses, individuals carrying the Met allele may exhibit altered physiological and psychological responses to stress. This could influence the development and course of stress-related disorders, necessitating tailored approaches in clinical settings. For example, understanding an individual's BDNF genotype may inform treatment strategies for depression or anxiety, particularly in the context of psychotherapy or pharmacotherapy that targets neuroplasticity.\n\nFurthermore, the variant's association with hippocampal volume reduction suggests that neuroimaging could be a valuable tool in assessing the impact of rs6265 on brain structure and function in stressed populations. Clinicians may consider incorporating genetic testing for rs6265 as part of a comprehensive assessment for patients presenting with stress-related symptoms, thereby enhancing personalized treatment plans.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding the BDNF rs6265 variant is extensive, with numerous studies exploring its implications for stress-related disorders. However, findings have been somewhat inconsistent across different populations. For instance, while some studies in Asian cohorts have reported associations between rs6265 and functional outcomes post-stroke, similar associations have not been consistently observed in Western populations. This discrepancy highlights the need for further research to elucidate the role of genetic background and environmental factors in the expression of the BDNF variant's effects.\n\nMoreover, the evidence quality varies, with some studies demonstrating robust associations while others yield inconclusive results. The interactions between rs6265 and other genetic variants, such as those in the NTRK2 gene, underscore the complexity of the genetic architecture influencing stress responses. Future research should aim to clarify these interactions and their implications for stress-related phenotypes, potentially leading to more effective interventions.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the BDNF rs6265 variant presents opportunities for personalized medicine approaches in managing stress-related disorders. Genetic testing for this variant could inform clinicians about an individual's susceptibility to stress and related conditions, guiding treatment decisions. For instance, patients with the Met allele may benefit from interventions that enhance neuroplasticity, such as specific forms of psychotherapy or pharmacological agents that promote BDNF signaling.\n\nAdditionally, understanding the role of rs6265 in the context of stress hormone pathways may lead to the development of targeted therapeutic strategies aimed at modulating the effects of stress on the brain. As research continues to evolve, the integration of genetic insights into clinical practice could significantly improve outcomes for individuals affected by stress-related disorders.\n\nIn conclusion, the BDNF rs6265 variant plays a critical role in the stress hormone pathway, influencing neuroplasticity and stress responses. Its implications for stress-related disorders underscore the importance of genetic considerations in clinical assessments and treatment strategies. Continued research is essential to fully elucidate the variant's effects and enhance its clinical utility in managing stress-related conditions."
            },
            {
                "rsID": "rs6265",
                "pathogenicity": "uncertain significance",
                "genotype": "TT",
                "sources": [
                    "PMID20838776",
                    "PMID26980363",
                    "PMID25470006",
                    "PMID20433887",
                    "PMID31439852",
                    "PMID23543775",
                    "PMID28777866",
                    "PMID26445699",
                    "PMID31470635",
                    "PMID33916879",
                    "PMID28444135",
                    "PMID30929312",
                    "PMID21796141",
                    "PMID23700461",
                    "PMID20702703",
                    "PMID28353608",
                    "PMID18061279",
                    "PMID32375223",
                    "PMID19473353",
                    "PMID23597512",
                    "PMID24946073",
                    "PMID33193575",
                    "PMID27039345",
                    "PMID34650418",
                    "PMID30885256",
                    "PMID26690621",
                    "PMID19829169",
                    "PMID23845938",
                    "PMID27042072",
                    "PMID34827728",
                    "PMID20955337",
                    "PMID30298028",
                    "PMID24269186",
                    "PMID28106810",
                    "PMID28443016",
                    "PMID25084680",
                    "PMID22384057",
                    "PMID26549599",
                    "PMID23884433",
                    "PMID26161003",
                    "PMID24603720",
                    "PMID23531681",
                    "PMID30911751",
                    "PMID33807752",
                    "PMID21228186",
                    "PMID24679122",
                    "PMID22768299",
                    "PMID16446742",
                    "PMID19622243",
                    "PMID27999706",
                    "PMID28840042",
                    "PMID29759928",
                    "PMID33808272",
                    "PMID32655377",
                    "PMID34407417",
                    "PMID24278778",
                    "PMID25582786",
                    "PMID34630181",
                    "PMID26989097",
                    "PMID26736037",
                    "PMID22521161",
                    "PMID22087305",
                    "PMID34281226",
                    "PMID33282679",
                    "PMID19874854",
                    "PMID32299790",
                    "PMID32726311",
                    "PMID26110341",
                    "PMID33685039",
                    "PMID31724031",
                    "PMID24973604",
                    "PMID26598587",
                    "PMID31083176",
                    "PMID20213725",
                    "PMID31440532",
                    "PMID31228957",
                    "PMID26204172",
                    "PMID31591840",
                    "PMID26602365",
                    "PMID19013140",
                    "PMID23360386",
                    "PMID26923993",
                    "PMID27697064",
                    "PMID17197106",
                    "PMID17044097",
                    "PMID33575257",
                    "PMID30643251",
                    "PMID31584111",
                    "PMID19923862",
                    "PMID21300943",
                    "PMID27511011",
                    "PMID32859588",
                    "PMID34640441",
                    "PMID31279827",
                    "PMID20848240",
                    "PMID29288745",
                    "PMID34149478",
                    "PMID17656372",
                    "PMID22940575",
                    "PMID32056765"
                ],
                "description": "### Comprehensive Description of Genetic Variant rs6265 in the Context of Stress Hormone Pathway Function\n\n**Variant Location and Functional Significance**\n\nThe genetic variant rs6265, located at chromosome 11 position 27,658,369 (GRCh38.p14), is a single nucleotide polymorphism (SNP) that results in a missense mutation in the brain-derived neurotrophic factor (BDNF) gene, specifically leading to a Val66Met substitution. This variant is known to influence the function of BDNF, a critical neurotrophin involved in neuronal survival, differentiation, and synaptic plasticity. BDNF plays a pivotal role in the stress hormone pathway by modulating the hypothalamic-pituitary-adrenal (HPA) axis, which is responsible for the body's response to stress. The TT genotype of rs6265 is associated with reduced activity-dependent secretion of BDNF, which may impair neuroplasticity and resilience to stress.\n\n**Disease Associations and Phenotypic Effects**\n\nWhile no direct disease associations have been conclusively identified for the TT genotype of rs6265, its implications in stress-related phenotypes are noteworthy. Research indicates that individuals with the TT genotype may exhibit altered stress responses, potentially leading to increased vulnerability to stress-related disorders. For instance, studies have shown that the interaction between BDNF rs6265 and other genetic variants, such as MTHFR rs1801133, may contribute to reduced hippocampal volume, a phenotype associated with stress and anxiety disorders. The hippocampus is crucial for stress regulation, and its atrophy is often linked to chronic stress exposure and mood disorders.\n\nFurthermore, the TT genotype has been implicated in cognitive performance and emotional regulation. For example, variations in BDNF levels influenced by rs6265 may affect how individuals cope with stress, as evidenced by studies examining cognitive strategies and emotional responses in different genotypes. The TT genotype has been associated with less effective coping strategies, which could exacerbate stress-related symptoms.\n\n**Clinical Implications**\n\nThe clinical implications of the rs6265 TT genotype in the context of stress hormone pathway function are significant. Individuals with this genotype may be at an increased risk for developing stress-related disorders, including anxiety and depression, due to impaired BDNF signaling. This impairment can lead to a dysregulated HPA axis, resulting in abnormal cortisol levels and heightened stress responses. Clinicians should consider the rs6265 genotype when assessing patients with stress-related symptoms, as it may inform treatment strategies and risk assessments.\n\nMoreover, understanding the role of BDNF in stress responses can guide therapeutic interventions. For instance, pharmacological agents that enhance BDNF signaling or physical activity interventions that promote BDNF expression may be particularly beneficial for individuals with the TT genotype. These strategies could mitigate the adverse effects of stress and improve overall mental health outcomes.\n\n**Research Findings and Evidence Quality**\n\nThe body of research surrounding rs6265 and its impact on stress hormone pathway function is growing, although findings remain somewhat mixed. Some studies have reported associations between the TT genotype and poorer cognitive performance and emotional regulation, while others have failed to find significant correlations. For instance, Zeni et al. (2016) found no significant association between rs6265 and BDNF serum levels in children and adolescents with comorbid conditions, suggesting that the effects of this variant may be context-dependent.\n\nConversely, Pujol et al. (2020) highlighted the potential for rs6265 to interact with other genetic factors, influencing hippocampal volume and stress-related phenotypes. This interaction underscores the complexity of genetic influences on stress responses and the need for further research to elucidate the mechanisms by which rs6265 affects the stress hormone pathway.\n\nThe quality of evidence regarding the clinical significance of rs6265 is variable, with some studies providing robust data while others yield inconclusive results. The heterogeneity in study populations, methodologies, and phenotypic assessments contributes to this variability. Therefore, while the association between rs6265 and stress-related outcomes is plausible, further investigation is warranted to establish definitive links and clarify the underlying biological mechanisms.\n\n**Clinical Actionability**\n\nIn terms of clinical actionability, the rs6265 TT genotype presents opportunities for personalized medicine approaches in managing stress-related disorders. Genetic testing for this variant could be integrated into clinical practice to identify individuals at higher risk for stress-related conditions. Such identification would allow for targeted interventions, including lifestyle modifications, psychotherapy, and pharmacotherapy tailored to enhance BDNF signaling.\n\nAdditionally, clinicians may consider monitoring stress responses and mental health outcomes in patients with the TT genotype more closely, implementing preventive strategies to mitigate the risk of developing stress-related disorders. The integration of genetic insights into clinical practice could ultimately lead to improved patient outcomes and a better understanding of the interplay between genetics and stress hormone pathways.\n\nIn conclusion, the rs6265 variant in the BDNF gene is a significant factor in the context of stress hormone pathway function, influencing stress responses and potentially contributing to the development of stress-related disorders. Continued research is essential to fully elucidate its clinical implications and to harness this knowledge for improved patient care."
            }
        ]
    }
]